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Bayesian methods have become increasingly used in infectious disease modelling, both
statistical and mathematical models. This evolution of infectious disease modelling
has led to demands for more sophisticated models that make use of expensive, yet
messy, data as efficiently as possible. Fitting such models is challenging, however.
My thesis will address this issue by considering flexible hierarchical models, which
pool information from related datasets to provide more accurate estimates of key
parameters, and use appropriate algorithms to fit data for three infectious disease
applications.
First, we used Bayesian methods to analyse clinical data from patients admitted to
Tan Tock Seng Hospital, Singapore, for either dengue or Chikungunya, two mosquito-
borne infections that have similar presentation. In the first part of this analysis,
a Bayesian logistic regression model was developed to predict the aetiology using
the significant variables found in our previous publication (V. J. Lee et al., 2012),
with different prior distributions for regression coefficients. In the second part of
the analysis, hierarchical models are fitted to clinical or laboratory temporal data
from these patients to infer differences in these two similar diseases over time, to
guide clinical management and diagnosis. Just Another Gibbs Sampler (JAGS) was
used to estimate the key parameters in characterizing the observations trend that
were modelled hierarchically. The routine was repeated for four significant variables,
Haematocrit, Platelet Counts, Leukocytes and patient’s temperature.
Next, we developed a hierarchical model for the 2009 H1N1 pandemic in a network
or basket of countries. Data in relation to the influenza pandemic were collated via
a literature search and Bayesian evidence synthesis was used to combine information
from these data to infer accurate severity metrics. A hierarchical adaptation of the
common Susceptible-Infected-Removed (SIR) compartmental model was fitted to the
ix
Summary
datasets. Markov Chain Monte Carlo (MCMC) was used to establish an initial, rough
estimate of the parameters’ posterior distribution and sequential importance sampling
was used to perform parameter estimations more efficiently.
Last, we examined the age-specific prevalence of Enterovirus 71 (EV71) in Asian
countries using a hierarchical model. An MCMC algorithm is used to build the
posterior samples of the parameters and hyperparameters, which are used within a
Bayesian optimal design routine to plan future studies of EV71 seroprevalence in
other Asian populations. We probe the possibility of different optimization criteria
and design search methodologies. We finally selected the criterion that maximises
the reciprocal of the absolute determinant of the variance-covariance matrix from
a Weibull survival regression model fitted classically, allowing the use of prior in-
formation to design a study that would be analysed within a classical framework.
Using a good experimental design such as that developed in this thesis for expen-




3.1 Comparison of the MLE of logistic regressions of Platelet and
Albumin for the dataset in figure 3.1 panel (a), before the re-
moval of patients with overlapping case, and in panel (b), where
there is Complete Separation problem.
The estimates were attained by fitting the disease outcome to the linear
predictive variables of platelet counts and albumin using a generalised lin-
ear model. The glm function can be found in the stats package in R (R
Core Team, 2013). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
4.1 Summary of the different states and data used in this project.
These are the states that we have considered and the availability column
indicates whether the data could be found in the literature reviews. . . . 49
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represent the empirical mean seropositivity calculated from the dataset
and the thinner red lines represent the confidence interval. The last plot
of green shades shows the seropositivity for any randomly chosen coun-
try, simulated from the hyper-posterior sample, where the median is also
illustrated by the green line. . . . . . . . . . . . . . . . . . . . . . . . . . . 143
5.5 Optimal sample sizes for each age.
The black dots represent the optimal designs from each of the three runs
and the grey bars represent the mean from the three optimal designs.
Panel (a) and (b) are the results when maximum sample size is set at 500
and 1000 respectively. Panel (c) are the sample sizes used in Singapore
from 2008 to 2010. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 144
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5.6 Comparison of the performance of 3 different experimental de-
signs.
The result of sample sizes used by Singapore in 2008–2010 is presented in
panel (a) and (b); one of our optimal designs scaled up to the same total
as that in Singapore (729 sera samples) in panel (c) and (d), and equal
sample size for all ages in panel (e) and (f). Assuming the underlying
prevalence is coming from our hierarchical model, the first row shows the
plot of prevalence against age. The grey shades represent the prediction
interval of the prevalence for each age. The red line is the underlying
prevalence that is simulated from our hierarchical model. The blue lines
are the result of the survival regression where the solid lines are com-
puted from the parameters estimated from the model and the dotted blue
lines are the 95% confidence interval of the computed prevalence using
the Weibull parameters simulated from multivariate normal distribution
with mean and variance-covariance from the estimates in the regression
model. The second row is showing heat map of the Weibull parameters
κ and λ. Yellow represents the point where likelihood is the highest and
red when it is the lowest. . . . . . . . . . . . . . . . . . . . . . . . . . . . 145
5.7 Comparison of the performance of 3 different experimental de-
signs using a different underlying prevalence.
This is done by assuming the underlying prevalence comes from the Sin-
gapore 2008–2010 dataset. The features in this figure is the same as that






Infectious diseases are of great concern for they impact public health and the economy.
Mathematical and statistical models can be developed to understand how diseases
spread and predict the severity of outbreaks in real-time for effective policy making.
Models for real-time analysis allow policy makers and hospitals to prepare by
forecasting the magnitude of outbreak before they happen. Preventive measures can
be assessed on computer experiments to decide the most appropriate response during
the course of the epidemic. The 2009 influenza pandemic illustrated the importance of
disease models, from assessing effectiveness of interventions in silico (Cook, Gibson,
Gottwald, & Gilligan, 2008) to forecasting burden and severity (Ong et al., 2010).
1.2 General Infectious Diseases Modelling
Accurate and useful forecasts require infectious diseases models that have been ap-
propriately selected and rigorously fitted to disease outbreak data. They must encap-
sulate the rate of infection and recovery from disease within host dynamics. Here, we
will discuss two typical infectious diseases models, the Susceptible-Infected-Removed
(SIR) and Susceptible-Infected-Susceptible (SIS) models.
The nature of the disease determines the appropriate model. If recovery confers
immunity, a Susceptible-Infected-Removed (SIR) model may be appropriate. In this
model, there are three classes of people in the population: Susceptible (S), Infected
(I ) and Removed (R). Prior to infection, individuals are classified under S. When
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infection occurs, they shift from S to I. Transition from S to I is controlled by the
rate of infection parameter. Upon recovery, or death, individuals move to the R
class, an event governed by the rate of removal. These two parameters determine
whether the epidemic might spread or become extinct as they determine the Basic
Reproduction Number (R0), a key quantity in infectious disease epidemiology.
R0 is the ratio of the total instantaneous rate of infection to the total instanta-
neous rate of removal in an immunonaive population (Lee, 1997). If R0 > 1, at the
start of an epidemic, each case typically causes more than 1 secondary infections over
his lifetime and thus the infectious disease might persist to cause a large outbreak.
On the other hand, if R0 < 1, more removals happen than infections, so the epidemic
will die out. R0 also determines the strength of the response as interventions must
bring R0 below 1 if they are to contain an outbreak.
Susceptible-Infected-Susceptible (SIS) model is another common infectious dis-
ease model appropriate if one can be reinfected after recovery. There are two groups
of people in the population: Susceptible (S) and Infected (I ). In contrast to the SIR
model, upon recovery, individuals return to the S class. The calculation of R0 in this
model is similar to that in the SIR model.
There are many other infectious disease models other than the two that were
discussed above. Thus, the behavior of the emerging disease outbreak has to be
known first so that the most appropriate model can be chosen and fitted, as described
in chapter 2, to give the most suitable analysis.
1.3 Bayesian Statistics
Parameters for rate of infection and removal are two of the key quantities charac-
terizing an epidemic. At the start of an epidemic, these parameters are unknown
but they must be estimated to understand and forecast the epidemic. Because even
simply stated epidemic models create complex likelihood functions, the difficulty in
parameter estimation is the main problem tackled in this thesis.
Prior information of the parameters can be drawn from observed data or past
experiences to provide information for the actual characteristic of the parameters. In
predicting the type of disease based on simple clinical and laboratory predictors and
observational time course analysis for Dengue Hemorrhagic Fever and Chikungunya
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(Lee et al., 2012), we will demonstrate how different priors of logistic regression
coefficients can affect the probability of making a correct prediction.
Often, the actual number of infected cases cannot be recorded. In the H1N1
example, we will utilise the idea of Bayesian evidence synthesis with strong priors to
gather information about the I and R classes of the SIR model from related data.
In Bayesian parameter estimation, Markov Chain Monte Carlo (MCMC) can be
used. The advantage of MCMC is its ability to fit a complex model without existing
solutions. There are several tools to perform MCMC: Just Another Gibbs Sampler
(JAGS) is a program that will work for simple models (Plummer, 2013). Due to the
rigidness of this program, the intricacy of some problems can only be resolved by
carrying out the analysis in another language, such as R (R Core Team, 2013).
1.4 Hierarchical Modelling
In analyzing an epidemic, observations from similar epidemics can be useful because
epidemics do not always happen in isolation, and so if a disease is affecting a different
population, aspects such as the rate of infection and removal might be similar across
different populations. Although the epidemic trajectories might not always be in
synchrony, some things will generalise, like the removal rate.
H1N1 is an example of a potentially infectious disease that needed to be analysed
while the pandemic was still at an early stage. Opportunities for prediction based
on other countries’ surveillance systems arise. In the early stage of the H1N1 pan-
demic at July 2009, Singapore’s Minster of Health, Mr Khaw had correctly predicted
the peak of the number of H1N1 infections in Singapore based on the information
collected from the New York City which had already experienced their peak (Chua,
2009). This simple approach motivates the formal use of scientific evidence synthesis
with hierarchical modelling for analysis of pandemic progression. We will show that
pooling information from different countries allows better analysis of the infectious
disease using hierarchical modelling via an application to the H1N1 pandemic exam-
ple where the influenza outbreak was observed in 15 different countries or territories
during the worldwide spread in 2009.
Other than forming hierarchical models for different populations, we can apply
the same idea by using data from patients to predict the course of disease better by
3
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pooling information from other patients. Information can be used to guide diagnosis
for unknown pathogen. This concept will be implemented in the Dengue example.
Daily information from each patient is contributed to the hierarchical model that will
characterise the time course of several symptoms for patients with Dengue Hemor-
rhagic Fever or Chikungunya (Lee et al., 2012). Because patients with each disease
are apprehended to provide similar information on the syndromes, a hierarchical
model was used to amalgamate this knowledge. Supplementary to the ability to bor-
row strength, hierarchical model can also measure the variability of the parameters
across different patients.
To decide on the control measures when faced with an outbreak, we need to
know the burden of the infectious disease. This is often done by using serological
studies to access past exposure which is very expensive. If a serological study were
badly designed, it would lead to a wastage of money. The flexibility of hierarchical
models allow parameter modelling for infectious diseases in different countries at
different time point if there is no available information from our country. This will
be demonstrated in the Enterovirus 71 (EV71) serology optimal design experiment.
A hierarchical model will provide information on the means and variances of the
parameters measuring the crucial rates in the epidemic for each population. This
gives insights for the current prevalence situation so that we can derive the best
design experiment that can save time and cost for the best experimental effect.
1.5 Structure of Thesis
In the next chapter, we will illustrate the methodologies that will be used in this
thesis. Following that we will demonstrate the Bayesian logistic regression and the
time course hierarchical modelling on Dengue Hemorrhagic Fever and Chikungunya in
chapter 3. In chapter 4, we will devise the hierarchical model for the H1N1 pandemic
in 2009 based on the Bayesian evidence synthesis techniques to combine multiple
sources of information. In chapter 5, we will analyse past EV71 serological studies
using hierarchical model to provide strong prior information for setting up an optimal




2.1 Modelling of Infectious Diseases
Infectious disease epidemics are one of the leading causes of mortality. On top of
the direct impacts on society—in the form of mortality, admissions to intensive care
units, hospitalisations—are indirect impacts, such as work and school absenteeism
(Meltzer, Cox, Fukuda, et al., 1999), and impacts on tourism. For example, the 2003
SARS outbreak was estimated to have caused a drop of 0.47% to Singapore’s GDP
(Lee & McKibhin, 2004). Policy makers such as ministries of health have to make
decisions whether to implement counter-measures such as quarantine, vaccination, or
school closure, and when to step up and step down such interventions (Cauchemez
et al., 2006), which themselves have costs that impact the economy. Mathematical
modelling can play an important role in guiding these decisions (Hethcote, 2000).
Predicting the spread of an emerging disease outbreak and the effect of control
measures in silico is faster, cheaper and safer than waiting for an actual outbreak to
occur and performing a randomised controlled trial, which may be infeasible on ethical
and practical grounds. It can also play a role in providing real time information to
the public, satiating their demand for information on what is happening and how the
outbreak may evolve (Ong et al., 2010). Forecasting the progression of spread is also
essential for deciding the most appropriate measure against the infectious diseases in
the shortest possible time.
Hammond and Tyrrell (1971) demonstrated the use of deterministic mathematical
model to study upper respiratory tract infection outbreaks in Tristan da Cunha,
an island located in the Southern Atlantic Ocean where, due to its remoteness,
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outbreaks of influenza and similar viruses would occur only after the arrival of a ship
from South Africa. Their approach used a series of ordinary differential equations,
fit to observed data on the number of islanders symptomatic using least squares.
As the solution of ordinary differential equations (ODE) is only one, fixed path for
fixed initial, or boundary, conditions and parameter values, their approach disregards
other possible trajectories that the epidemic might have taken, limiting its usefulness
for forecasting. However, for large outbreaks—unlike those on Tristan da Cunha,
for instance, influenza pandemics in large, globally connected cities—the trajectory
traced by ODE solutions will fall close to that of more complicated, stochastic models,
but with the deterministic model’s output requiring less computing power to derive.
As a result, deterministic mathematical models are popular and efficient, especially
when the involved population is large. This thesis will apply deterministic models to
model influenza A (H1N1-2009) later in Chapter 4.
In contrast to deterministic models, stochastic models are formulated to allow
chance events to impact epidemic trajectory. They are often set up as temporally
inhomogeneous Poisson processes, but may also use estimates of sojourn time to
parametrise non-exponential within-host event times. One method of simulation
uses Gillespie’s algorithm (Keeling & Ross, 2008; Gillespie, 1977) in which the rates
of successive events are recalculated after each event is simulated, reflecting the fact
that rates change with time in an inhomogeneous Poisson process. Such a procedure
has to be repeated until the end of the time period of interest, or until no further
events are possible, and is hard to parallelise, thus making it a computer intensive
process to simulate. Stochastic models are more suitable for small populations or
small outbreaks where chance events can happen. In principle, stochastic models
for large populations are possible, but they will look and behave like deterministic
model which is more computationally efficient for large populations. According to
Barbour (1974), the asymptotic properties of a stochastic model will approximate a
deterministic model by the Central Limit Theorem for a population growth model as
illustrated in the following figure.
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Figure 2.1: Comparison of Deterministic and Stochastic SIR model for
small population (in panel (a)) and large population (in panel (b)).
The solution of deterministic ODE for the number of infected individual is represented
by the solid black lines in both panels. The grey lines are the possible trajectories
simulated using Gillespie’s algorithm on 5 different trials. For both situations, the
rate of infection per Susceptible-Infected pair and rate of removal per infected in-
dividual is 0.25 and 0.2 respectively. The total population sizes used in panel (a)
and (b) are 1 000 and 10 000 respectively, where panel (a) started with 1 infected
individual and panel (b) started with 1 000 infected individual. Computation details
can be found in section 4.3.6.
Because parametrisation, which may involve simulation, will lead to much com-
plication, much work has focused on developing statistical methods to fit these to
observational data, as described in the following paragraphs.
Approximate Bayesian computation (ABC) has become widely used in population
genetics where likelihood cannot be calculated easily (Wilkinson, 2013; McKinley,
Cook, & Deardon, 2009; Marjoram, Molitor, Plagnol, & Tavaré, 2003). It has also
been used for epidemic models (Blum & Tran, 2010) where, similarly, the exact event
times or natures cannot be directly observed. This method works by measuring the
discrepancy between the simulated data, generated using proposed parameter values,
and the observed data. There are many variants but within a Markov chain Monte
Carlo approach, the proposed parameters will be accepted with higher probability if
the discrepancy is smaller (Wilkinson, 2013). On top of the metric for discrepancy, a
tolerance,  > 0, should be set which governs the acceptance or rejection the simulated
parameters (Wilkinson, 2013). In many scenarios, this approach is highly efficient, for
it replaces the need to calculate likelihoods in a Metropolis-Hastings algorithm, which
would otherwise be required to calculate the posterior density. A weakness of ABC,
as described by Robert et al. (2011), is that theoretical discussions on its convergence
properties are missing due to the algorithm’s typical use of non-sufficient summary
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statistics, which lead to an unidentified quantum of loss of information. Robert et
al. (2011) have demonstrated that ABC methodology in some examples is unreliable
for Bayesian model selection, for instance.
Another approach for fitting stochastic models, as used Ross et al. (2006), is the
Cross-Entropy (CE) method to find the parameter that will maximise the likelihood
function of a model. CE involves simulating a large number of potential parameter
values, typically in a swarm around the current best guess, and using these to update
the best guess. The algorithm repeatedly explores the parameter space locally until a
criterion is met for stopping. This method will be presented in the serology example
in Chapter 5.
Another approach that is commonly used in other settings with partially observed
data is the expectation maximization (EM) algorithm. In EM algorithm, there are
two main steps. First, the E step will compute the expected value of the log like-
lihood based on the conditional distribution of the augmented data simulated from
the current set of parameters given the observed data. Second, the M step finds the
parameter that will maximise the expected value from the E step. These two steps
have to be repeated until the parameter converges. However, O’Neill et al. (2000)
have argued that the EM algorithm is not suitable for epidemic outbreak models as
the required conditional expectation is very difficult to compute with the heavily cen-
sored data from epidemics. Instead, they argue that data augmentation is required
for the computation of the likelihood, integrating over unobserved event times and
states. This approach has been widely used to fit temporal and spatio-temporal mod-
els (Cook, Otten, Marion, Gibson, & Gilligan, 2007; Gibson & Renshaw, 1998). It is,
however, extremely computationally expensive if the population is large or the time
frame is long since the augmented parameter space, including actual parameters and
the augmented variables, will in such cases be massive. To illustrate the difficulties,
consider the following example, based on incomplete data on pneumococcal infection
in school children (Cauchemez et al., 2006). They sampled 2 807 children, 3 to 6
years old, from 50 schools in France to collect 5 swabs over 5 months to investigate
transmission of 15 pneumococcoal serotypes. As, however, not all children provided
all 5 swabs, Cauchemez et al. (2006) used data augmentation to infer the missing
number of bacterial serotypes and actual event times. In that analysis, a Bayesian
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hierarchical model was added to reduce the heteroskedasticity of estimates of the
time course of infection for each child. This combination (of data augmentation and
hierarchical modelling) is valuable for the typically highly censored data that are
unavoidable in observational field studies of infectious diseases. In that context, the
approach was feasible as a mere 2 807 children formed the dataset, so the resulting
parameter dimensionality was not excessive. When the population or study size is
large, however, the amount of augmentation required may be prohibitively large.
Statistical modelling of outbreak progression can provide valuable information in
the course prediction for planning. At the early stage of an outbreak, there is insuf-
ficient information from that outbreak to appraise the risk appropriately, as evinced
by the initial uncertainty of the WHO and several governments in their response
to the H1N1 pandemic of 2009 (Chang, Southard, & Sullivan, 2010). However, if
information can be drawn from other sources in real time (to be presented in the
H1N1 example), or historical outbreaks (to be demonstrated in the serology exam-
ple) then better decision making can be made. Bayesian inference provides a natural
mechanism to do this.
2.2 Bayesian Inference
In this thesis, we use Bayesian statistical concepts to estimate model parameters
from, typically, messy and partially observed data. In this section, we will justify
our use of Bayesian statistics and why it is preferred for our applications, as well as
provide a brief overview of how Bayesian statistics works and the distinction with
Classical statistics.
Under the Classical paradigm, parameters are fixed, i.e. non-random, numbers;
in contrast, they are random variables in Bayesian statistics (O’Neill, 2002; Gelman,
Carlin, Stern, & Rubin, 2003), where their distribution characterises the uncertainty
in their values after observing data. Although in many cases, Classical approaches
perform well and may be preferable to Bayesian ones, in others they are too inflexible
for complex modelling problems. Unlike Classical approaches that are often based
on the asymptotic normality assumption, and hence rely on large enough samples to
justify their use, Bayesian methods typically are not (Congdon, 2001), and may be
used for small (or, non-infinite) samples. When its assumptions are violated by the
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data, the result from a Classical analysis may be unacceptably approximate. In such
cases, Bolstad (2004) has claimed that Bayesian methods often outperform Classical
methods, even when judged by Classical criteria.
We illustrate one advantage of Bayesian methods over Classical ones using the
example of the ALVAC/AIDSVAX HIV vaccine trial in Thailand (Rerks-Ngarm et
al., 2009). In their study, Rerks-Ngarm et al. (2009) vaccinated n = 8 197 individuals
of whom x = 51 were infected (similar numbers were given a placebo). If p is the
probability of HIV infection over the study time frame for a vaccinated individual,
we can assume a binomial model as x ∼ Bin(n, p). Under the standard, Classical
approach, p is estimated by pˆ = xn = 0.00622, the maximum likelihood estimate and




n , i.e. (0.00452, 0.00792). This confidence interval calculation assumes
that the sample size is sufficiently large that the MLE is normally distributed. (In
contrast, a Bayesian approach taking a uniform prior for p and using either Markov
Chain Monte Carlo sampling or direct calculation quantifies the full distributional
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Figure 2.2: Comparison of Bayesian and Frequentist estimates for the Thai-
land HIV trial example.
The exact log likelihood of the data based on the binomial distribution is represented
by the solid line. The dotted line is the approximated log likelihood based on a




n . The mean of posterior samples is represented by the solid
dot and the 95% credible interval is represented by the line in the lower panel. The
MLE pˆ and the Classical confidence interval is represented in the lowest panel by the
hollow dot and line.
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Even for the large sample size of 8 197 in the ALVAC/AIDSVAX trial, a pro-
nounced asymmetry in the likelihood can be discerned in figure 2.2, which is not ad-
equately characterised in the Classical confidence interval. In contrast, the Bayesian
credible interval can account for this asymmetry and arguably give a more accurate
depiction of the uncertainty in the parameter.
Typically both approaches employ the same fundamental statistical concept, the
likelihood function. Suppose the observed data are D and the parameter is θ, in
which case the likelihood (function) of θ is the probability of observing the data
given the parameter,
L (θ) = f(D|θ). (2.1)
In many non-infectious disease applications, the likelihood can be factorised into
a product of terms, one for each datum, but as infectious diseases are communicable,
the disease states of different individuals are positively correlated, and so in general
this factorisation cannot be assumed. If a parameter value of θ, and the model
it belongs to, fit the data D well, L(θ) will be relatively large, and this is often
exploited in Classical statistics by calculating the value of the parameter, θˆ, also
known as maximum likelihood estimate (MLE), that will give the largest L(θ), i.e.
θˆ = arg max
θ
L(θ). (2.2)
Although loosely interpreted as the value which promises to be the ‘most likely’ given
the observed data, for that model, such probabilistic statements about parameters
are not permissible in Classical statistics and the term ‘maximum likelihood’ is un-
fortunate.
In contrast, Bayesian estimation uses Bayes’ theorem to combine both sources
of information, prior and data (Bolstad, 2004), by converting from the probability
distribution of the (known) data given knowledge of the (unknown) parameters, to
the probability distribution of the (unknown) parameters given knowledge of the
known data.
For events A and B, Bayes’ rule states that the joint probability of A and B can
be derived from the conditional probability
Pr(A,B) = Pr(A|B) Pr(B) (2.3)
= Pr(B|A) Pr(A). (2.4)
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Through simple manipulation, Bayes’ theorem states that
Pr(A|B) = Pr(B|A) Pr(A)Pr(B) . (2.5)
Replacing variables, we obtain the posterior distribution, Pr(θ|D) (or, henceforth,
f(θ|D) as typically θ is continuous and therefore has a probability density). The prior
is the distribution of the parameter that we assume before accounting for the observed
data. In the Bayesian framework (Gelman et al., 2003), the density of the posterior
can be represented by






f(D|θ) · f(θ)dθ (2.7)
is a constant that can be found by integration but can sometimes be ignored (in
popular methods such as Markov Chain Monte Carlo and importance sampling)
to get a direct proportionality between the posterior density and the product of
likelihood and prior density:
f(θ|D) ∝ f(D|θ) · f(θ) (2.8)
Posterior ∝ Likelihood · Prior. (2.9)
2.2.1 Prior choice
A perceived limitation of Bayesian statistics is the requirement, and occasional diffi-
culty, to select a prior distribution for the parameters. As the posterior distribution,
which leads directly to reported estimates of model parameters, is proportional to
the likelihood and prior distribution, different prior distributions will lead to different
posterior distributions in an apparently subjective way. Although prior distributions
are chosen based on our preliminary beliefs (Lee, 1997), which may differ from analyst
to analyst, Bolstad (2004) and others have argued that in practice, although different
prior distributions may be used, the posterior distributions are typically similar as
the data will swamp the prior if they contain sufficient information content. With
adequate data, the effect of the exact choice of prior specification is minimal com-
pared to the effect of the data themselves (Bolstad, 2004). This will be shown in the
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subsequent example of logistic regression to distinguish Dengue from Chikungunya
infection.
Priors should be chosen based on the objective of the analysis. If there is suffi-
cient information in the data about all the parameters, a flat (or approximately flat)
non-informative prior is commonly used so that the posterior distribution is propor-
tional to the likelihood density. If external data are available and the information
is relevant to the current analysis, an informative prior can be derived from those
data to accumulate more evidence about the parameter values. An example of this
approach to developing an informative prior will be shown for the recovery rate of
H1N1 in Chapter 4, based on an analysis of the time course of infection in a volun-
teer challenge study by Carrat et al. (2008). Conversely, if a subjective prior is not
objectionable, for example if the analysis is being used as a guide to decision making,
it could be set from personal or experts’ belief. Hierarchical models, to be elaborated
in the next section, also act as an indirect form of informative prior, which allows
information to be borrowed between different parts of the datasets by assuming a
common distribution specified by hyper-parameters.
When there are insufficient details of parameter, a non-informative or flat prior,
which does not favour any value, is used to avoid undue influence on the posterior
distribution (Bolstad, 2004) and to allow the data to speak for themselves. By using
a flat prior distribution, no parameter values are given additional ‘weight’ beyond
the information in the data (Congdon, 2001). An extreme example of a flat prior is
a uniform distribution from negative to positive infinity, which gives the same prior
density for any real value. In such cases, the posterior is only proportional to the
likelihood.
Other non-informative priors can also be used, depending on the parameter sup-
port (Gelman et al., 2003). If a parameter should be positive, an exponential distri-
bution or log normal distribution could be used, for instance. For the exponential, a
small rate parameter gives a distribution with a large mean, that may be effectively
flat over the range of values with high likelihood.
Choosing a flat prior distribution is not always the best solution in situations
where we wish or need to pool information from multiple data sources, in which case
an informative prior distribution built from an earlier dataset can allow a better
13
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posterior distribution for the model parameters after analysing a later dataset (Lee,
1997).
If informative priors are chosen, it may be valuable to perform a sensitivity anal-
ysis, performing several analyses using different prior distributions, comparing the
resulting posteriors, and checking the robustness of the conclusions to these assump-
tions, in a similar way that sensitivity analyses of data-model assumptions are some-
times conducted (O’Neill & Roberts, 1999). If all posteriors are similar, any prior
distributions can be adopted with confidence, but if the results are contrasting, extra
care must be taken to ensure the prior used in the reported analysis is appropriate.
2.2.2 Computational issues
Markov Chain Monte Carlo (MCMC) is a technique for computing posterior distri-
butions that are not otherwise analytically tractable. The exact posterior density can
rarely be calculated, because although the posterior is proportional to the product
of prior and likelihood, it is hard to calculate the unknown proportionality constant
f(D) (cf. Section 2.2) for the integral of the posterior to be equal to 1. (This problem
is comparatively harder than maximising the likelihood in Classical statistics due to
the difference in complexity between maximisation and quadrature.) The problem is
especially severe in a high dimensional parameter space. However, for most purposes,
the problem is obviated using MCMC for two reasons, described below.
MCMC is an extension of the Monte Carlo (MC) technique, which involves draw-
ing samples from a distribution. If (large) samples are drawn directly from the
posterior distribution, the statistics required to describe the posterior can be cal-
culated with ease simply by calculating characteristics of the sample (thus avoiding
subsequent integration). For instance, instead of integrating to get the posterior
mean, E(θ|D) = ´R θ · f(θ|D)dθ, it can instead be calculated using the average of




Strong Law of Large Numbers, if {θi : i = 1, . . . , n} are pairwise independent and





θi → E(θ1) almost surely as n→∞ (Gilks, Spiegelhalter, & Richardson, 1996).
If the sample is large enough, the estimate from posterior sample is effectively the
actual quantity from the posterior.
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However, except for special cases, it is difficult to sample from the posterior
distribution as its properties are not generally known. MCMC overcomes this by
drawing samples from a Markov Chain with the posterior as the stationary distribu-
tion. Under certain conditions (ergodicity, irreducibility, and aperiodicity), Markov
chains will converge to a stationary distribution (Gilks et al., 1996). Convergence
can be assessed heuristically after comparing different simulations (Gelman et al.,
2003), which if simulated independently should converge to the same distribution.
The Metropolis-Hastings algorithm is one way to construct a Markov chain such that
its stationary distribution is the posterior of interest, and requires only being able to
evaluate the (log) posterior to a constant of proportionality. The sampled posterior
distribution is a collection of values from a Markov Chain, and as a result the sampled
values are typically autocorrelated. The usual solution to mitigate the dependency of
successive simulations is to thin the posterior sample, where only the kth simulated
value (say, k = 10) is kept, so that the correlation between subsequent simulations
can be reduced (Gelman et al., 2003). Gelman et al. (1995) added that thinning
is beneficial as large numbers of parameters poses a problem for computer storage.
However, with today’s technology, this problem is less of an issue and throwing away
simulations wastes information, and thus thinning is avoided unless the number of
parameters to store is large and the mixing poor.
The general concept of MCMC is to set up a Markov Chain whose stationary
distribution is equal to the unknown posterior distribution. Because even if different
initial values θ0 are used, the resulting chains ought still to converge to the stationary
distribution, multiple chains with different initial values can be simulated and a
comparison of their apparent stationary distribution made to assess this property.
By simulating the Markov Chain, the set of {θt : t > n} is the posterior sample
for analysis of the model. The first n values of the Markov Chain are typically re-
moved from the posterior sample as they might precede convergence to the stationary
distribution. This process is called ‘burn in’. Usually, burn-in discards the first 1%
to 2% of the simulation, provided the simulations have shown convergence (Gilks et
al., 1996).
One way to obtain a Markov chain with the desired stationary distribution, is to
use the popular Metropolis-Hastings Algorithm:
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1. Choose an initial value, θ0.
2. Calculate the posterior density under the chosen parameter, θ0, and represent
it by hold.
3. Simulate θnew using a proposal distribution, where the probability of proposing
θnew from θ0 is represented by q(θold → θnew).
4. Calculate the posterior density under the new parameter, θnew, and represent
it by hnew.
5. A decision to accept or reject θnew is made by calculating the acceptance
probability, Pacc. θnew, will be accepted as the next value in the chain, θ1, with
probability Pacc. Otherwise, θnew will be rejected with probability 1 − Pacc









6. A random number U is generated from a uniform distribution with range [0,1].
If Pacc is more than U , accept θnew. Otherwise, reject θnew and retain θ0.
7. Step 2 to 6 is repeated as θi is updated as θi+1. The length of the chain
determines how many repetitions are required. As mentioned, the first fraction
(say 1%) of the chain will not be stored due to the requirement of burn-in. To
perform thinning, every jth value of the chain will be stored, where j will be
preselected.
The choice of the proposal distribution will affect the jumping rules and efficiency of
the simulations. The ideal Metropolis-Hastings algorithm will simulate parameters
directly from the posterior distribution, in which case the acceptance probability is
1 (Gelman et al., 2003) and the algorithm can be seen to be equivalent to vanilla
Monte Carlo. An alternative is to simulate one parameter, or a block of parameters,
from their conditional distribution given the data and all other parameters, in which
case, again, the acceptance probability is 1. This is known as Gibbs Sampling.
In principle, almost any distribution can be used for proposal distribution (Congdon,
2001). A normal distribution is usually preferred as it is symmetrical which allows
equal chance of positive and negative jumps, if its mean is set to the current value
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of the parameter. This also implies that q(θnew → θold) = q(θold → θnew) which
simplifies the calculation of the acceptance probability, Pacc, as the ratio of the pro-
posal distributions cancels. Thus, all the proposal distributions used in this project
will be normal distributions, unless otherwise stated. The calculation of Pacc for θ










The proportionality constant, where the posterior density is proportional to the
product of likelihood and prior density, will be cancelled in this ratio, making h be





= l(θnew|D) · f(θnew)
l(θold|D) · f(θold)
. (2.14)
Because some probabilities have small values, the calculation of the acceptance
probability is typically done working with a logged likelihood function, log l(θ|D) and
log prior density log f(θ),
Pacc = exp
(




= exp[log l(θnew|D)− log l(θold|D) +
log f(θnew)− log f(θold)]. (2.16)
The variance (or covariance matrix) of the normal distribution used as a proposal
needs to be chosen carefully. To be efficient when the posterior is unknown, the
proposal distribution should be sufficiently wide to allow large jumps so as to achieve
convergence quickly. If the jump steps were too small, i.e. if the proposal distribution
is too narrow, the trace plot will take a long time to reach convergence. However,
the proposal variance cannot be too large, as in this case most of the simulations
will be rejected. Thus, a proposal with appropriately intermediate variance should
be selected for good sized jump steps.
In models with a high dimensional parameter space, the Markov Chain may ex-
hibit ‘stickiness’. This can be due to a weirdly shaped posterior distribution, caused
by correlations between two or more parameters, a poor choice of proposal distribu-
tion, or strong correlations between a multitude of parameters. A ‘stuck’ chain may
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spend an inordinate time at a certain region of the parameter and take a long time to
reach another, well supported region. This is a great challenge faced in this project,
due to the complexity of the models used, and several attempted solutions will be
discussed.
2.3 Bayesian Hierarchical Modelling
Estimation in sparse, scattered datasets can be made more robust by borrowing
strength between the points where evidence, or information, accumulate. When pa-
rameters are analysed individually, similarities between different components of the
model are neglected. Hierarchical modelling allows related identities in different sam-
pling units to be brought together, reducing variability, or uncertainty, in parameters
from different submodels while at the same time measuring the irregularity between
these parameters using a hyper-distribution.
We need a set of parameters for each dataset to be coming from a distribution
that is governed by the second-level parameters called hyper-parameters (Schervish,
1995). The n sets of independently observed data and the parameters θi, i = 1, . . . , n,
are iid and governed by the hyper-parameters (for instance, µ and σ) which will also
have their own distribution.
The prior distributions of the parameters θi (or a transformation to make their
support the real line) are typically represented as normal distributions with mean µ
and standard deviation σ,
θi ∼ N(µ, σ2) (2.17)
where the hyper-prior distributions for η = (µ, σ) might be chosen to be uniform
distributions which are non-informative if there is no prior knowledge or beliefs for
them, for instance
µ ∼ U(−1000, 1000) (2.18)
σ ∼ U(0, 1000). (2.19)
Hence, from the posterior samples of the parameters and hyper-parameters, the char-
acteristics of the posterior distributions of the parameters of interest can be obtained.
MCMC can be used to explore the parameters space of (θi, µ, σ) based on the sta-
tionary property discussed earlier, with some extension to the posterior calculations.
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Using the Bayes’ theorem,
f(θ, η|D) ∝ f(D|θ, η) · f(θ, η) (2.20)
∝ f(D|θ, η) · f(θ|η) · f(η). (2.21)
The algorithm is:
1. Choose the initial values for all the parameters, (θi)0 for i = 1, . . . , n, and
hyper-parameters, η0 = (µ0, σ0).
2. Calculate the posterior density under the chosen parameters, (θi)0, and hyper-
parameters, η0 = (µ0, σ0), and represent it by hold.
3. Fixing the hyper-parameters at their current values, simulate (θi)new using a
proposal distribution, where the probability of proposing (θi)new from (θi)0 is
represented by q((θi)old → (θi)new).
4. Calculate the posterior density under the new parameter, (θi)new and the orig-
inal hyper-parameters, η0 = (µ0, σ0), and represent it by hnew.
5. Decision to accept or reject (θi)new is made by calculating the acceptance
probability, Pacc. The newly simulated parameter, (θi)new, will be accepted
as the next value in the chain, (θi)1, with probability Pacc. Or, (θi)new will be










6. A random number U is generated from a uniform distribution with range [0,1].
If Pacc is more than U , accept (θi)new. Otherwise, reject (θi)new and retain
(θi)0.
7. Having made the decision for (θi)1, use the calculated posterior density under
the parameters, (θi)1, and hyper-parameters, η0 = (µ0, σ0) as hold.
8. Fixing the parameters at their current values, (θi)1, simulate ηnew using a
proposal distribution, where the probability of proposing ηnew from η0 is rep-
resented by q(ηold → ηnew).
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9. Calculate the posterior density under the new hyper-parameters, ηnew, and the
current parameters, (θi)1, and represent it by hnew.
10. Decision to accept or reject ηnew is made by calculating the acceptance prob-
ability, Pacc. The newly simulated parameter, ηnew, will be accepted as the
next value in the chain, η1, with probability Pacc. Otherwise, ηnew will be










11. A random number U is generated from a uniform distribution with range [0,1].
If Pacc is more than U , accept ηnew. Otherwise, reject ηnew and retain η0.
12. Step 2 to 11 is repeated as (θi)j is updated as (θi)j+1 and ηj is updated as
ηj+1. The length of the chain determines how many repetitions are required.
The first 1% of the chain will not be stored due to the requirement of burn-in.
To perform thinning, every kth value of the chain will be stored, where k is
preselected.
There are many calculations and some of them can be reused to save time. In step 5,
as the hyper-parameters are fixed, the hyper-prior densities, f(η), will be the same,





In step 10, the parameters are held fixed, and as a result the likelihood den-
sities, l((θi)1|D), will be the same for both proposed and current values. As long
as the hyper-parameters’ values fall within the interval in the uniform hyper-prior





In step 10, f((θi)1|ηold) can be reused from step 5, taking the same value as
f((θi)new|η) if (θi)new was accepted or f((θi)old|η) otherwise. In the next round
of step 5, f((θi)old|η) can be reused from step 10 in the previous round, taking the
same value as f((θi)1|ηnew) if ηnew was accepted as η1 or f((θi)1|ηold) otherwise.
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With the information on the parameters and hyper-parameters provided by the
observed data, predictions can be done for other datasets. Based on the common de-
pendence of all the parameters on the hyper-parameters characteristic of hierarchical
models, random samples are collected from the hyper-parameters for representing
other similar models (Schervish, 1995). Each set of η = (µ, σ) sampled from their
respective posterior samples is used to generate θk, the parameter for the intended
kth dataset, using the normal distributions stated for the model.
This method can be repeated a large number of times to estimate the distribution
of the forecast θk. Having these as predictive posterior distributions, we can have a
good idea of the range of parameter values that might arise in a similar dataset. This
method of estimating the future when there is only limited information about the
model is known as forecasting (Kleczkowski & Gilligan, 2007). We will demonstrate
this in the dengue disease and serology examples.
Apart from predicting parameters for future data, hierarchical models can also
improve the estimation of parameters for partially collected data. This is more useful
in reality as incomplete real time data from similar populations may be available and
the parameters for these incomplete current data are of public health interest. Pooling
strength from each dataset to supplement the insufficient knowledge in other parts
of the data will be exemplified in the H1N1 example in chapter 4.
2.3.1 Importance Sampling





where f(θ) is the posterior distribution.
This integration can be approximated by taking the average of a large sample of






If it is difficult to sample from the posterior itself, we might instead simulate θ
from another proposal distribution, q(θ). The expectation of g(θ) in this case can be
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where f(θi)q(θi) is termed the weight of the ith draw, and denoted wi. As the large sample
size may still not be exactly a true representation of the actual model distribution,
these weights will compensate for the discrepancy. The larger the probability density
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Figure 2.3: Demonstration of how the weight wl can be larger for better
points with higher posterior density than those points with lower posterior
density in Importance Sampling.
In this example, the actual posterior distribution is represented in (a), normal with
mean 0.65 and standard deviation 0.15. In panel (b), 100 particles are simulated
from a normal proposal distribution with the same mean but the standard deviation
is doubled to 0.3 and the proposal density is represented y axis. In panel (c), we
calculate the weights for the simulated particles as the ratio of posterior to proposal
density. Panel (d) shows the kernel density estimate of the simulated particles based
on the weights in (c).
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The main concept of importance sampling is to sample from an arbitrary dis-
tribution, rather than the (unknown) posterior directly, and correct the sample by
allocating weights to all the sampled particles. The weights will distinguish the better
particles from the inferior ones, but also correct for over or under sampling in some
regions of the parameter space.
Resampling the initial sampled particles based on their weights resembles the
thinning process in MCMC by discarding particles with very low weights, as well
as reducing the problem of memory and storage. This resampling procedure also
converts the weighted samples into equally weighted samples, which allows methods
that require equal weights to be used within this context.
As demonstrated, weights can be associated with the ratio of the posterior density
to the proposal density, where the posterior density is proportional to the likelihood
and prior density.
In the hierarchical model context, many parameters will be involved and as a
result, it may be difficult to achieve convergence in the MCMC routine. We therefore
will demonstrate the use of (sequential) importance sampling in the H1N1 example
in chapter 4 to propose samples based on the output from an MCMC routine which
has not yet converged. Our approach was to approximate the distribution thus
obtained by the product of independent normals with the mean and variance of
each parameter estimated from the (unconverged) MCMC routine and used in the
importance sampler.
After sampling particles from this (multivariate) normal proposal distribution and
calculating the weights, the particles, together with their respective weights, will be
the information used to generate the next round’s multivariate normal proposal dis-
tribution, with weighted mean of the particles and weighted covariance matrix of the
particles. To facilitate gradual refinement of the proposal distribution, we introduce
a temperature variable, like the temperature in simulated annealing. Specifically, we
introduce a temperature variable T that flattens the likelihood function on initial
pilot runs. Under this scheme, the weight of the lth particle at every round, with





Taking logarithms, we can better see how the intensity T will be relating the
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likelihood to the weights
logwl = T log f(D|θl) + log f(θl)− log q(θl). (2.31)
In this way, the proposed values are more diffuse than they ought to be at early
pilot runs, allowing the proposal distribution to be gradually improved, but as the
number of rounds increases, this routine converges towards the desired posterior.
Thus, the values of T will increase stepwise from a small number (we used 0.1) to 1
in each subsequent sampling rounds. Only the sample from the round with T = 1
are used for inference.
As shown in Figure 2.3, parameter values that do not model the data well will
be represented by low weights. The few points that suit the data better will have
much larger weights. The temperature starts small to prevent over-concentration of
the few particles with good weights. As Sequential Importance Sampling progressed
from the first round to the tenth round, the particles will gradually become a good
realization of the posterior.
If we take exponential transformation to convert logwl back to wl for particle l,
many of the values will become 0 as the logwl is close to −∞. Hence, we overcome
numerical overflow issues by transforming the logwl to
(logwl)∗ = logwl −max(logw) (2.32)
before exponentiating to get
w∗l = exp (logwl)∗ (2.33)





so that all the weights, wl, sum to 1.
This approach of flattening the likelihood and gradually returning it to its original
shape, as we develop a better idea of the posterior to sample from, is useful for com-
plex models like those discussed in this thesis where MCMC converge is problematic.
In chapter 4, we will use this technique to explore the high dimensional parameter




Infections in Tan Tock Seng
Hospital
Unlike many other infectious diseases which spread directly from infectious host to
another susceptible individual, both Dengue and Chikungunya are infectious diseases
that transmit through the bites of infected female Aedes mosquitoes (WHO, 2013).
Dengue infections can evolve into a more severe and life threatening condition, named
Dengue Hemorrhagic Fever. While Chikungunya is rarely life threatening, it has long-
term sequellae, and although caused by distinct viruses, the symptomology of the two
diseases is similar and they may be mistaken for one another in places where both
are endemic.
According to the World Health Organization (WHO) (2013), nearly half of the
world population is now at risk of dengue infection, and there is no treatment available
for the infected individuals, although clinical trials are ongoing (Debing, Jochmans,
& Neyts, 2013). As the WHO claim that giving appropriate medical care can reduce
the fatality rate of dengue fever to less than 1%, it is important to be able to develop
ways to identify the infection type as quickly as possible (WHO, 2013), particularly
in low resource settings. We will deal with this identification problem by developing
a Bayesian logistic regression model.
While the aetiological agent can often be classified using highly accurate diag-
nostic tests (Lee et al., 2012), in some settings such resources might not be available
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or affordable. The Times of India (2010) report that, in India, the gold standard
test (reverse transcriptome polymerase chain reaction [RT-PCR]) can cost up to 5000
Rupee (approximately 80 USD), pricing it out of the means of most Indians. There-
fore if an accurate diagnosis could be derived through symptomatic observations or
simple clinical tests, it could be very beneficial in such settings.
Even after diagnosis, patients also need to be monitored over the time course of
illness. Knowing the typical temporal trend of the infection can allow the attending
physician to ascertain changes and anticipate behaviours of the patients’ symptoms
during the time course of illness. It might also prevent misdiagnoses. To this end,
a hierarchical, temporal model of various clinical and laboratory characteristics will
be developed.
3.1 Bayesian logistic regression
This project involved 117 individuals diagnosed with Chikungunya and 917 other
Dengue Fever (DF) patients, including 55 individuals who had Dengue Hemorrhagic
Fever (DHF) (Lee et al., 2012). The symptoms are very similar, including the sudden
onset of an influenza-like illness with fever, muscle pain, headache and rashes, but
Chikungunya can cause joint pains that can continue for months (WHO, 2008). We
use the data collected from these observations on patients suffering from dengue or
Chikungunya when they presented at the hospital to develop a model to predict
what disease/infection the patient has upon admission to hospital, based on routine
data on their symptoms and simple laboratory tests that are available on the day of
admission itself.
These retrospective observations for the Chikungunya were made on hospitalised
patients from Tan Tock Seng Hospital, Singapore, during the dengue outbreak in
August 2008, while those observations for Dengue Fever were made on hospitalised
patients from the same location during the 2004 dengue outbreak (Lee et al., 2012).
The individuals were identified by reverse transcription-polymerase chain reaction
(RT-PCR) and their demographic, epidemiological, serial clinical and laboratory,
radiological, treatment and outcome data were collected but not recorded together
with the patient’s name for privacy issues (Lee et al., 2012).
Our exploration of the demographic and clinical factors associated with Dengue
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Fever (DF) or Chikungunya infection using classical multivariate logistic regression
has previously been published (Lee et al., 2012). In this thesis, we extend the analysis
to use a Bayesian approach.
3.1.1 Data Processing
The variables at our disposal in the multivariate logistic regression model are: age,
gender, hypertension, time since onset (in days), duration of fever (in days), presence
of fever, headache, myalgia/athralgia, rash, any bleeding, sore throat, cough, nausea,
vomiting, diarrhea, abdominal pain, anorexia, maximum temperature (◦C), tachycar-
dia (pulse >100/minute), leukocyte count, hemoglobin, serum hematocrit, platelet
count, lymphocyte proportion, serum sodium, potassium, urea, creatinine, bilirubin,
alanine (ALT) and aspartate aminotransferase (AST), alkaline phosphatase (ALP),
protein and albumin, as measured on the day of hospital presentation (Lee et al.,
2012). Because it involved retrospective chart review, some of these variables were
missing for some patients.
Usually, when faced with missing entries, those individuals’ data would be re-
moved from the analysis. Out of the 917 dengue patients, about 2.5% (23 patients)
have missing entries for the Hematocrit observations. But useful insights can be de-
rived from the entries of other variables, and such cases may arise in regular clinical
management of patients for whom a diagnosis is still required, so instead of discard-
ing such individuals, we replace missing values with the imputed value (Lee et al.,
2012): the mean for continuous variables and 0 for dichotomous variables coded 0
for absent and 1 for present. This will ensure the other variables of those individuals
continue to give information but the imputed values will not distort the information
from the available data. The side effect of this replacement is an unwanted reduction
of the standard error which is indirectly proportional to the sample size (Cohen &
Cohen, 1984).
Another important problem realised in this project is termed separation exhibited
by the independent variables (Heinze & Ploner, 2003; Shen & Gao, 2008). Separation
occurs when the binary outcome (Chikungunya or DF) can be perfectly separated
by a single covariate or combination of several covariates. Quasi-Complete Separa-
tion is a less extreme case, which occurs when some values of the binary outcome
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(Chikungunya or DF) overlap at a single covariate or several covariates. An example
is depicted in the following figure.
Figure 3.1: Differentiating a Quasi-Complete Separation (in panel (a)) from
a Complete Separation case (in panel (b)).
We artificially removed overlapping points which amounts to about 8% (78 out of
979 patients) of the total to achieve the complete separation in panel (b). Both plots
show two obvious regions on the plot of Albumin (g/L) versus Platelet counts (109/L)
that can differentiate the two different diseases.
Figure 3.1 shows that both Chikungunya and DF patients exhibit a similar albu-
min level, but they could be easily distinguishable as suffering from DF if a patient is
having low platelet counts (< 100×109/L) and Chikungunya otherwise. Specifically,
if the patient’s Albumin level in g/L is more than 0.15×Platelet Counts(×109/L)+20,
they are very likely to be infected with Dengue Fever. Although the plots show that
these two variables are highly predictive, there is no finite MLE in a logistic regres-
sion model that uses them as predictors. In simple logistic regression, the estimated
coefficients are the values that will maximise the likelihood. The algorithm used
in the R statistical environment uses a Newton-Raphson approach to search for the
coefficient. But when there is a Separation problem, no finite maximum likelihood
estimates exist (Heinze & Schemper, 2002). The Newton-Raphson method will stop
at the wrong parameter value when it has exhausted the maximum number of itera-
tions or when the difference in log-likelihoods is smaller than a threshold and report
a nonsensical estimate: an odds ratio that is too large, a standard error that is even
more too large, and a p-value that is non-significant despite the obvious wealth of
information (see figure 3.1). To visualise the problem, we present in table 3.1 esti-
mates for two near-identical datasets (illustrated in figure 3.1) with a small number
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(8%, or 78 out of 979) of patients removed from the second. The difference in the
estimates caused by Separation is stark.
Platelets Counts
Data coeff. OR Std. Err p-value
Panel (a) 0.04 1.04 0.003 0
Panel (b) 45 4.2× 1019 670 0.95
Albumin
Data coeff. OR Std. Err p-value
Panel (a) -0.29 0.75 0.045 0
Panel (b) -301 1.6× 10−131 4 500 0.95
Table 3.1: Comparison of the MLE of logistic regressions of Platelet and
Albumin for the dataset in figure 3.1 panel (a), before the removal of
patients with overlapping case, and in panel (b), where there is Complete
Separation problem.
The estimates were attained by fitting the disease outcome to the linear predictive
variables of platelet counts and albumin using a generalised linear model. The glm
function can be found in the stats package in R (R Core Team, 2013).
As demonstrated by Heinze and Schemper (2002), the separation problem often
depends on the sample size. Intuitively, the smaller the collected sample, the higher
the chance of having the responses separated by the independent variables. However,
it is often infeasible to collect more data to resolve what is really a statistical, not a
data, problem. The risk of observing separation also increases with the number of
independent variables (Heinze & Schemper, 2002).
One solution to the separation problem is combining classes of categorical vari-
ables, like classifying ethnicity into four groups—Chinese, Malay, Indian and Others
(Heinze & Schemper, 2002). Alternatively, continuous variables can be structured
into categorical variables which may rectify observed separation.
Another, sadly common, solution for the separation problem is to exclude the
variable responsible. This is unfortunate as the variable itself is typically highly
predictive of the outcome and so discarding it reduces the predictive power. In the
current context, this would lead to more misdiagnoses.
A more satisfying alternative is to used a form of penalised regression (Heinze
and Schemper (2002) recommend Firth’s penalised likelihood method (Firth, 1993),
to estimate adjusted odds ratios with reduced bias relative to maximum likelihood
estimation. If using Firth’s approach, one can derive p-values and confidence intervals
using the profile-penalised likelihood function that could be found from the algorithm
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of Venzon and Moolgavkar (1988) and the logistf package (Heinze, Ploner, Dunkler,
& Southworth, 2013) in the R statistical environment (R Core Team, 2013).
In particular, Firth (1993) proposed an approach that yields parameter estimates
by reducing the score function, U(θ), which is the gradient of the log likelihood, to
U∗(θ) and solving for U∗(θ) = 0. The modified score function,
U∗(θ) = U(θ)− i(θ)b(θ), (3.1)
is the reduction of the original score function, U(θ), by the product of the gradient
of the score function, i(θ), and a bias term, b(θ), that depends on the model. This
modification of the score function will lead to a modified estimate, θ∗, that satisfies
U∗(θ∗) = 0. In our paper, we applied Firth’s logistic regression to solve the Separation
problem without throwing away potentially precious information that was collected
during the study (Lee et al., 2012).
After solving the problem of non-existent MLE, we need to find a way to iden-
tify the significant variables in the model selection step. Two common methods for
determining the significant variables are forward and backward stepwise model se-
lection. The former starts off with the simplest model with no variables and adds
one variable, which provides the most information to the model, at a time until no
other variables can improve the model (Pasha, 2002). On the other hand, backward
selection starts off with all possible variables and removes the variable with least
benefit to the model until the best model is achieved (Pasha, 2002).
In our paper, the backward approach is used by including all the variables in the
logistic regression model at the first step. The variable which corresponds to the
maximum p-value of all parameters was removed one at a time from the model until
all the p-values were below the level α = 0.05. The remaining variables are deemed
statistically significant; they are the duration of illness, duration of fever, whether
there is fever at presentation of illness, any bleeding and platelet counts (Lee et al.,
2012). The variable of platelet counts was initially spotted to exhibit Quasi-Complete
Separation, which led to our adopting a penalised log likelihood approach to avoid
losing valuable information for classifying patients’ risk.
To demonstrate the effects of having the unnecessary, non-significant variables in
the model, we will model the multivariate logistic regression with significant variables
found in the paper (Lee et al., 2012), as well as some other non-significant variables
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with different prior distributions for the regression coefficients within a Bayesian
framework.
3.1.2 Methods
The number of significant variables for the multivariate logistic regression of Chikun-
gunya versus DHF and Chikungunya against DF were 5 and 16, respectively (Lee
et al., 2012), and for this thesis, because of the greater danger attributable to DHF
infections, we focus on predicting whether a patient has Chikungunya versus DHF. A
multivariate logistic regression model is fitted to the data, using variables determined
to be significant in the paper by Lee et al. (2012), as well as the last 5 non-significant
variables that were removed from the model in the backward stepwise model selection,
but this time using a Bayesian approach.
The response variable, Y , is binary and equals to 1 if the patient is diagnosed with
Chikungunya (via RT-PCR) and 0 if DHF (via RT-PCR). Potential predictors are
labelled as X = (X1, X2, X3, X4, X5, X6, X7, X8, X9, X10) which represents the dura-
tion of illness, duration of fever, whether there is fever at presentation of illness, any
bleeding, platelet counts, atypical lymphocytes counts, alkaline phosphatase (ALP)
measurements, whether there is rashes, whether the patient is a Singaporean and
whether the patient feels nausea respectively.
While this seems an odd choice, it makes considerable epidemiological sense for
several reasons. The first diagnosed case of Chikungunya only occurred in Singa-
pore in 2008 (Ng et al., 2009). Due to the lack of past exposure, the immunity of
Singaporeans against Chikungunya would be lower than those foreigners who come
from countries where Chikungunya is endemic. In addition, foreign patients are more
likely outdoor workers who are more likely to be bitten by Aedes albopictus, the pri-
mary vector for Chikungunya. Thus, citizenship will indirectly have an effect on
the probability of identifying whether the patient is infected with Chikungunya or
Dengue.
The model for the jth individual is as follows:
logit(Pr(Yj = 1)) = β0 + β1x1j + β2x2j + . . .+ β10x10j . (3.2)
The odds of Chikungunya (versus DHF) are
Pr(Yj = 1)
1− Pr(Yj = 1) = exp(β0 + β1x1j + β2x2j + . . .+ β10x10j). (3.3)
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Thus, the probability of individual j having Chikungunya conditional on the
model is
Pr(Yj = 1) =
1
1 + exp(−(β0 + β1x1j + β2x2j + . . .+ β10x10j)) . (3.4)
There are five binary and five discrete independent variables. Because the range
of these variables differ, it did not seem appropriate to use the same prior for the
parameters (β0, β1, β2, . . . , β10). Instead, we standardised all the covariates.
If xij is the ith covariate for the jth individual, then zij = xij−x¯isi is the standard-
ised value, where x¯i and si are the mean and standard deviation of the ith covariate.
This ensures that the estimated coefficients are the overall strength of the relationship
between the predictors and the response variable. The model for the jth individual
is changed to the following:
logit(Pr(Yj = 1)) = b0 + b1z1j + b2z2j + . . .+ b10z10j (3.5)
where bi is the new regression coefficient after the standardization.
Since regression coefficients can be positive or negative depending on the rela-
tionship between the predictor variable and the response variable, a Laplace prior
distribution (double exponential distribution) centred at 0 (i.e. bi ∼ Laplace(0, λ)
for i = 0, 1, 2, . . . , 10) was chosen to allow the regression coefficients to take any real
numbers. The probability density function can be represented by




where the mean and variance are 0 and 2λ2 respectively.
Using a Laplace prior distribution acts as a penalizing procedure, like that of the
LASSO estimator. The LASSO estimator can be expressed as
bˆ = arg max
b
logL(D|b) subjected to ‖b‖1 ≤ c (3.7)
= arg max
b
logL(D|b)− λ ‖b‖1 , λ ≥ 0. (3.8)
where L(D|b) is the likelihood density, ‖b‖1 =
∑ |bi|, and λ is the optimal penalty.
We can also represent the logarithm of posterior density by
log Pr(b|D) = c+ logL(D|b) + log f(b) (3.9)
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where f(b) is the Laplace prior density. With the similarity in the two methods,
imposing a Laplace prior distribution has the effect of penalizing the estimating
process. In a Bayesian framework, we will be characterising log Pr(b|D) instead of
finding the value of bˆ.
Other than using a Laplace prior distribution to mimic a penalizing process, a
normal prior distribution with zero mean could also be used. This is similar to a
ridge estimator which is represented by
bˆ = arg max
b
logL(D|b) subjected to ‖b‖22 ≤ c (3.11)
= arg max
b
logL(D|b)− λ ‖b‖22 , λ ≥ 0. (3.12)
where ‖b‖22 =
√∑
b2i . Correspondingly, we can present the logarithm of posterior
density with a normal prior distribution with zero mean and variance σ2 as




Laplace distributions have fatter tails than normal distributions with the same
mean and variance. We need a prior distribution which does not overly favor regres-
sion coefficients values which is close to zero and at the same time allow deviation to
both ends of the real numbers. If the regression coefficients are allowed to take the
appropriate numbers, the probability of getting a correct prediction from the logistic
regression will increase.
To show the different swamping effects in informative and non-informative prior
distributions, the scale parameter, λ, of the Laplace prior distribution is allowed to
vary in the parameter model.
To illustrate the results of using different prior distributions on the Separation is-
sue, repeated Bayesian logistic regression Models with different values of the variance
parameter, λ, are explored.
The algorithm uses MCMC to do so, as follows:
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2. In the model specification, the disease type for jth individual will follow a
Bernoulli distribution with success probability
Pr(Yj = 1) =
1
1 + exp(−(b0 + b1z1j + b2z2j + . . .+ b10z10j)) . (3.15)
3. The posterior distribution of the parameters is sampled using JAGS (Just An-
other Gibbs Sampler) using the precision in the specification of the normal
distribution, instead of the usual standard deviation or variance (Plummer,
2013). Fixing the prior distribution scale parameter, λ, say to 0.001, we use
JAGS to get a posterior sample of bi, using 90% of the data, over four chains
with 1000 burn-in and 2500 iterations each. The training set of 90% of the data
is randomly chosen based on the index of the patient using the sample function
in R (R Core Team, 2013).
4. For each individual from the remaining 10% data, we estimate the probability
of getting Chikungunya by
Pˆr(Yj = 1) =
1
1 + exp(−(bˆ0 + bˆ1z1j + bˆ2z2j + · · ·+ bˆ10z10j))
(3.16)
where a set of regression coefficients, bˆ =
(
bˆ0, bˆ1, bˆ2, · · · , bˆ10
)
, are randomly
sampled from the posterior sample for each individual.




]yj [1− Pˆr(Yj = 1)]1−yj . (3.17)
The score for this λ, the scale parameter of the Laplace prior distribution which
we have fixed in Step 3, is obtained by taking the mean of these probability
values from the 10% data.
6. The mean of each bi, for i = 0, 1, 2, . . . , 10, from the posterior sample are
recorded.
7. Repeat step 3–5 for the same λ ten times, using a different set of 90% of the
data in each round by re-sampling again based on the patients’ index. The
mean of all the ten scores in step 5 for that particular λ is taken to be the
mean.
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8. Then, repeat step 3–7 with different λ taking values from 0.001 to 0.1 with





























Figure 3.2: Probability of correct diagnosis and odds ratio for different λ.
Panel (a) shows the mean of the probability of making a correct diagnosis, p, for
different λ, represented by tiny, coloured points, for ten different runs. The bigger,
black points are the mean of the ten values for each λ value. Panel (b) shows the
mean odds ratios, exp(bi) of all the 10 variables, Xi for i = 1, 2, . . . , 10, for different
λ.
As λ increases, the probability of making a correct diagnosis increases, implying
a more predictive logistic regression model. For large λ, the prior distribution for bi
is effectively flat. Because a flat prior does not give particular weights to any values,
the estimates of the parameters bi are governed by the data. From the second panel,
it further confirms that small λ will only make incorrect focus of bi near 0, which will
result in more failed diagnoses. Choosing the right prior distribution can help focus
the posterior to suitable values while an ill-suited prior may reduce the accuracy of
the model fit or forecast. Thus, when there is no prior belief for the parameter, a flat
prior should be adopted.
Since the regression coefficients are still adjusting themselves to take larger posi-
tive values and smaller negative values (which corresponds to larger odds ratio and
close to zero odds ratio) when the prior distribution permits in the second panel of
figure 3.2, the algorithm stated above is done again with λ taking values from 0.001
to 100.
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Figure 3.3: Probability of correct diagnosis and odds ratio for different λ.
This figure has the same features as in figure 3.2 where λ is extended to 100.
In the first panel of figure 3.3, the probability of making a correct diagnosis, p,
asymptotes between 0.9 and 1, indicating that the regression model cannot perform
any better for even larger values of λ. The odds ratio for the binary variable of
whether the patient is suffering from fever when presented with the illness, X3, and
whether the patient has any bleeding, X4, are still decreasing as presented in the
second panel. On the other hand, the odds ratio for the platelet counts, X5, is still
increasing. But the model’s diagnostic ability is still good for these data implying
that the effects of these deviating values cancel out and they will still continue to
grow if larger λ is used as they will give unnecessary weights to these extreme values.
We observe changes in ‘swamping’—the effect that occurs when the posterior
distribution is mostly driven by the data, and not the prior—as λ varies. In this
case, the predictive accuracy of the model is not influenced when the prior standard
deviation λ increases from 10 to 100, but when λ is smaller than 10, different degrees
of swamping are observed. If the prior distribution is too narrowly focused on 0, the
data are unable to swamp the prior, and the effects are worse predictions.
3.2 Hierarchical Modelling of Disease Time Course
Dengue Hemorrhagic Fever (DHF) and Chikungunya (Chik) have similar symptoms
and the diagnosis is expensive in locations where they cocirculate. It would be ben-
eficial if the symptoms or laboratory observations can be modelled with time from
the onset of illness. By modelling the disease time course for the symptoms or labo-
ratory observations, the daily progression can help to guide the clinical management
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for accurate diagnosis of different type of patients during their course of illness.
The hierarchical model accounts for the correlations within each patient’s obser-
vation. Here, the chosen variables are Haematocrit, Platelet Counts, Leukocytes and
the patient’s temperature. These measurements come from the same dataset. The
choice of these 4 variables was due to their clinical relevance: Haematocrit, Platelet
Counts and Leukocytes are major components of blood. Daily observations of these
variables are easily and readily obtainable through blood tests, while temperature
taking is routine in clinical care for Dengue and Chikungunya patients.
3.2.1 Model and Method
The model was fitted separately for each type of observation and disease. For no-
tational brevity, the measurement and virus are suppressed from the notation that
follows.
We assume that these observations are conditionally independent and follow nor-
mal distributions:
yij ∼ N(µij , σ2) (3.18)
where yij is the observation for patient i on day j, where day 0 corresponds to the day
of symptom onset, and yij may not be completely observed over the whole observation
period.
The observations have variance σ2 which neither changes over time nor differs for
each individual.
The mean observations represented by µij will have both time effects and random
effects. Correlations over time will be induced by the choice of prior. Details of µij
will be described below.
The unknown value of b0 is given a flat, normal prior distribution with large
standard deviation to accommodate different observation types,
b0 ∼ N(0, 1002). (3.19)
We believe, biologically, that bj for day j > 0 will be dependent on the previous
day j − 1. To force this, we set the prior for bj to depend on the previous time point
bj−1 as the mean of its normal distribution,
bj ∼ N(bj−1, σ2b ). (3.20)
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We expect each individual to have a similar values to the mean of all patients’
observations on each day of their time course. Differences between individuals are
characterised via a random effect parameter, βi. If the individual i had a larger ob-
servation than the others on day j, the mean observation µij will be an amplification
of the value of bj if eβi > 1 or a reduction if 0 < eβi < 1,
µij = eβibj . (3.21)
Since there is no existing knowledge of whether each individual i should have
observations greater or smaller than others, a normal prior centred at zero is used
for βi for equal chances of getting eβi > 1 and 0 < eβi < 1,
βi ∼ N(0, σ2β). (3.22)
This project has been done using JAGS (Just Another Gibbs Sampler) where the
precision, σ−2, is used in the specification of normal distribution, instead of the usual
standard deviation σ (Plummer, 2013). The prior distribution for all the precision
values in the normal distribution should be positive and focus near to 0. The choice
used here is gamma distribution with both the shape and scale parameters taking
small value,
σ−2, σ−2β , σ
−2
b ∼ Γ(0.01, 0.01). (3.23)
The final model is thus
yij ∼ N(µij , σ2) (3.24)
µij = eβibj (3.25)
b0 ∼ N(0, 1002) (3.26)
bj ∼ N(bj−1, σ2b ) (3.27)
βi ∼ N(0, σ2β) (3.28)
σ−2, σ−2β , σ
−2
b ∼ Γ(0.01, 0.01). (3.29)
The algorithm is thus:
1. Prepare the data and initialisation for running the MCMC in JAGS within the
R platform (Plummer, 2013).
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2. After the JAGS process, the posterior sample for the parameters mentioned in
the model can be used to get the 95% prediction interval for a certain observa-
tion.
3. Gather the parameter values from the posterior sample, including bj , βi, σ2.
4. Compute the µij for each set of posterior samples using the relation µij = eβibj .
5. µ¯j , the daily mean of all the µijs was computed and plotted in Figure 3.4.
6. The 95% credible interval for µij will be presented in Figure 3.4.
7. Simulate the predicted observation values yˆij from normal distribution with
mean µij and variance σ2.
8. With all the simulated values of yˆij as prediction, the 95% prediction interval is
obtained by calculating the 2.5% and 97.5% quantiles for the simulated values
at each day and plotted in Figure 3.4.
9. Step 1 to 8 should be repeated for the four chosen symptoms and observations
for each of the two diseases.
3.2.2 Results and Inference
The algorithm was executed and the results is shown in Figure 3.4 for both diseases
and the four chosen measurements.
39































































2 4 6 8 10 12 14
Time (in days)
(h)
Figure 3.4: Prediction for time course of the four selected variables, namely
Haematocrit (in volume percentage) (Panel (a) & (e)), Leukocytes (in
volume percentage) (Panel (b) & (f)), Platelet Counts (in ×109/L) (Panel
(c) & (g)), and the patient’s temperature (in ◦C) (Panel (d) & (h)) for
Chikungunya and DHF respectively.
The actual observations of the patients over a period of two weeks were plotted as
light grey lines. The black solid lines show how the mean observations µ¯j of patients
changes along day j; the black dashed lines show the credible interval for the mean




According to Nuraini (2012), haematocrit concentration will increase for dengue
infected diseases and decrease to normal level of 40–50% for males and 37–47% for
females upon recovery. In figure 3.4, panel (a) and (e) showed increment in haema-
tocrit concentration at the start of the time course and a decline near to the end of
observation for both diseases. The decrement in haematocrit concentration for DHF
patients is more obvious than that for Chikungunya patients.
Leukocytes values are predicted to dip faster in DHF patients than Chikungunya
patients (Lee et al., 2012). The normal percentage of leukocytes is 1% and figure
3.4 shows that patients of both diseases had leukocytes more than 1%, a response
to the immune systems defending the body from the disease (Alberts et al., 2002).
We can see that the mean observation µ¯2 at day 2 dropped quickly until µ¯6 for
Chikungunya in panel (b) whereas that for DHF in panel (f) did not decrease that
sharply. However, after the drop, leukocytes values for Chikungunya patients did not
bounce back as quickly as how the DHF patients would have recovered.
Platelet counts are inversely related to Haematocrit concentration (Nuraini &
Tasman, 2012).The predicted platelet counts decrease initially and rise towards the
end of the observation window for both diseases which agrees with the claim by
Nuraini (2012) for platelet counts to be in opposite direction of haematocrit concen-
tration. This time course analysis, presented in Figure 3.4 panel (c) and (g), supports
platelet count as the main variable for differentiating Chikungunya and DHF, as the
average platelet count barely dropped below 200 × 109/L in Chikungunya patients,
but fell below 100× 109/L in DHF patients.
In both diseases, temperature is anticipated to reduce and asymptote at normal
human temperature of slightly less than 37◦C after day 2. As the temperature data
collected from the Chikungunya patients are more coherent, the credible interval for
mean observation µ¯j is narrower as portrayed in panel (d). The temperatures of
DHF patients are more unsteady, leading to a wider credible interval for the mean
temperature µ¯j .
3.3 Conclusion
In the analysis of the clinical and laboratory predictors of Dengue and Chikungunya
Disease, the main issue was the Quasi-Complete Separation problem of the data. In
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the publication, we explored the use of Firth’s penalised likelihood method with the
logistic regression to overcome separation (Heinze et al., 2013).
The alternative described herein is a Bayesian analogue, in which we have shown
the importance of using appropriate prior distributions for better performance in
predicting the correct type of disease.
Data collection is incomplete because data are collected based on clinical need
rather than for statistical purposes. As a result there are not always daily observa-
tions for each patient. The advantage of our hierarchical model is being able to set
the course observation trend with missing observations from certain days by borrow-
ing information from the other patients. This method of putting a hierarchical model
in time course will, we hope, guide clinical management by providing daily trends
for key variables for each type of illness. In the best case, the observation trend
could help physicians in accurate diagnosis of the different type of patients during
the course of illness and detect aberrant patterns that may indicate the patient’s
condition has changed unexpectedly.
The observations described in the hierarchical time course model were the major
indicators of Dengue or Chikungunya diseases. Future work could use other obser-
vations to identify trends of the different observations.
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Hierarchical Model of 2009
Pandemic H1N1 Transmission
4.1 Introduction
In this increasingly globalised world, the volume of people traveling across borders
allows pathogens to spread rapidly from their place of emergence to all corners of
the world. When a new virus emerges and spreads to multiple countries, the World
Health Organization (WHO) will declare pandemic and differentiate the seriousness
with different stages (WHO, 2010).
Countries are mandated to have pandemic preparedness plans which detail their
own policies and measures to deal with the pandemic (Poggensee et al., 2010; Ujike
et al., 2011; Fuhrman et al., 2011). If the pandemic predictions can be improved,
these plans can be tailored to the predicted severity, and better decisions may pre-
vent unnecessary interventions while minimizing economic losses and morbidity and
mortality.
The first new pandemic of the 21st century was announced in early 2009, an
influenza A virus. The impact of this pandemic virus was so great that, in less than
a year, it resulted in more than 15000 confirmed deaths worldwide (Halder, Kelso, &
Milne, 2010).
Mexico was the first country to confirm cases of a novel variant of H1N1 (Trifonov,
Khiabanian, & Rabadan, 2009), thought to be a recombinant version of viruses circu-
lating in swine and birds (Neumann, Noda, & Kawaoka, 2009), in April of that year.
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The Mexican Ministry of Health discontinued all schooling to counteract the spread
of disease by reducing the contacts amongst the younger generations (Chowell et al.,
2011), who constituted the majority of both cases and confirmed deaths in the early
stages of the pandemic (Domínguez-Cherit et al., 2009). Further control measures
to minimise physical interaction included the closure of movie theaters, restaurants,
and other public assemblage locations (Chowell et al., 2011).
Figure 4.1: Singapore’s Health Promotion Board promotion poster.
This poster aims to inform the public about germs being transmitted by hand may
cause serious infection.
Other countries took different approaches to contain or mitigate the pandemic.
For instance, in Germany, improved sanitation methods were widely proposed, in-
cluding public health education on the correct way of hand cleaning (see for example
Singapore’s Health Promotion Board promotion poster reproduced in figure 4.1), the
use of face masks and the isolation of possible infected individuals to abate the cir-
culation of the disease (Poggensee et al., 2010), with claims that carrying out these
non-pharmaceutical interventions within 36 hours of symptom onset can reduce the
rate of diseases spread (Poggensee et al., 2010). In Japan, according to Ujike et al.
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(2011), the inventory of Oseltamivir during the pandemic was doubled. In France,
during the initial phase of the pandemic from 1 May 2009 to 30 June 2009, all verified
and possible cases of H1N1 were hospitalised, regardless of the degree of seriousness
of illness (Fuhrman et al., 2011). This extreme prevention during the containment
period resulted in the unsustainable rising need for hospitalization, requiring this
policy be later amended so that only patients in a critical condition be monitored in
hospitals (Fuhrman et al., 2011).
In contrast to past influenza pandemics, but similar to the situation following the
SARS outbreak of 2003 (Naylor, Chantler, & Griffiths, 2004), attributes of the H1N1
influenza virus from different countries were shared quickly worldwide for the speedy
development of a vaccine and identification of the viral strain (Ikonen et al., 2010).
However, the downside to this was the initial panic caused by the unduly pessimistic
estimates of the severity of the virus from Mexico (Goodwin, Haque, Neto, & My-
ers, 2009). Being able to merge, appropriately, data from multiple countries would
allow better decision making while overcoming the weaknesses or gaps in individual
countries’ surveillance data, reflecting differences in the extensiveness of localized
data.
The virulence of the pathogen, measured by the rate of infection and removal
or the reproduction number, should be similar in different parts of the world, and
although the pandemic virus might mutate during the outbreak, as it did in the
1918 pandemic (Taubenberger & Morens, 2006), we might assume that the viral
characteristic remain unchanged over the first wave of the outbreak, when the data
paucity is most severe. However, fatality, confirmation and hospitalization rates will
depend on countries’ healthcare capacity and surveillance systems and are expected
to differ.
A powerful model should address these similarities and differences. In this chap-
ter, we will present a framework to exploit valuable information on the spread of
a pandemic in different countries combining hierarchical with transmission dynamic
modelling, in particular, a Susceptible-Infected-Removed (SIR) model of a homoge-
neously mixing population is used to model observational data collected from different
countries. Demonstrating the use of this approach via data published on the H1N1
pandemic, we propose that a hypothetical network of surveillance systems could be
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set up to pool data from participating countries that would provide real-time data
for analysis and prediction for a pandemic outbreak.
Several platforms for reporting information on infectious diseases exist but they
do not have committed organizations from worldwide to provide actual real-time ob-
servational data. The Global Public Health Intelligence Network (GPHIN) has been
supplying information to WHO, international governments and non-governmental
organizations since 2004, using information extracted from reports of eight different
languages (Mawudeku & Blench, 2006). From 1994, Program for Monitoring Emerg-
ing Diseases (ProMed-mail) has been sourcing infectious diseases information from
the grey literature—media or official reports—and disseminating the materials to
subscribers by email (Victor & Madoff, 2004a). This has been useful, and it picked
up the emergence of SARS before the Chinese government shared data with the rest
of the world (Victor & Madoff, 2004b), but data are partial, messy, unconfirmed and
have many false alarms. With added languages for sourced documents, HealthMap
is able to collate information automatically in collaboration with ProMed-mail in a
quicker manner since 2006 (Brownstein, Freifeld, Reis, & Mandl, 2008). However,
accuracy problems may arise due to the mechanized routine for data compilation.
The most promising platform is the International Severe Acute Respiratory Infec-
tion Consortium (ISARIC), an international alliance with about 50 to 60 research
networks worldwide for real-time infectious diseases data sharing since 2011 (Yong,
2012). Yet, the synchronization of shared data may be a problem if data were not
collected based on fixed standard criteria, and data from academic institutes may
lack the completeness of national surveillance.
In the situation where many countries experience an outbreak, the experience
of each will differ, with differences in importation and establishment dates (Lau et
al., 2012), interventions, seasonality, and potentially severity indices. This requires
being characterised by a separate parameter vector for each country, resulting in a
high dimensional parameter space for exploration. To perform a model fit, Bayesian
solution can provide accurate information about the parameters using methods such
as the Markov Chain Monte Carlo (MCMC) algorithm. On top of this, hierarchical
modelling is commonly used in non-epidemic settings but heretofore has rarely been
exploited within the infectious disease setting (Kleczkowski & Gilligan, 2007). We
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build a hierarchical epidemic model with hyper-parameters to account for the vari-
ability between outbreaks of different countries and estimate the parameters using
MCMC and importance sampling methods. This approach is demonstrated to be
very successful in pooling information across multiple countries and in characteriz-
ing the variability between outbreaks, showing that non-epidemic methodology can,
with suitable adaptation and development, contribute by giving better estimations
for infectious disease epidemiology.
4.2 Literature review and data sources
On 23 April 2009, the first case of H1N1 was reported to WHO by Mexico (Chang
et al., 2010). H1N1 was the first virus in the 21st century that has spread to most
countries in the world, causing an influenza pandemic (Chang et al., 2010). Upon
contact with an infected individual, a susceptible individual may get infected, poten-
tially leading to confirmed death in the most serious cases (Zuno et al., 2009). The
main symptoms of H1N1 are fever, cough, headache, muscle aches, and rhinorrhoea
(Zuno et al., 2009), i.e. symptoms that are indistinguishable from a regular ‘cold’.
Typically each country collects and analyses their data in isolation. Limited
data, during the start of a pandemic, often may give a misleading impression and
when used in a forecasting routine might not give sensible predictions due to data
incompleteness. But a hierarchical model can be formed to pool information from
different sources, which may collect different types of data, such as on hospitalizations
or community transmission, simultaneously. To evaluate the utility of data sharing
networks for future worldwide outbreaks, H1N1 pandemic data were collected from
a literature review of research publications and government surveillance websites.
Individuals affected during the pandemic can be classified in several ways ac-
cording to the severity of their infection and their healthcare utilisation (see Figure
4.2).
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Figure 4.2: Venn diagram for differentiating individuals at time t during
the pandemic.
The yellow oval represents all the individuals who are infected with H1N1, It.
The aqua oval represents those who consulted a doctor and were reported to show
influenza-like illnesses (ILI) symptoms, Xt, Within these doctor consultations, the
outpatient ILI, Wt, is represented by the lime-green semi-oval; the hospitalised ILI,
Yt, are represented by the teal semi-oval. All patients who are confirmed to be in-
fected with H1N1, Zt, are represented by the indigo oval. The outpatient H1N1, Ut, is
represented by the turquoise semi-oval; the hospitalised H1N1, Vt, are represented by
the purple semi-oval. The red oval represents those who died due to H1N1 infection,
Dt.
Not all individual infected with influenza will visit a doctor, and not all who do
will be diagnosed as having an influenza infection (as opposed to another respiratory
virus), and as a result it is impossible to record all the individuals infected with H1N1
at time t, It, or who have recovered at time t, Rt. The number of ILI, Xt, in the
community is usually measured by a network of influenza sentinel clinics (Truscott et
al., 2012), who can give useful insights to It. Xt does not in general represent the full
number of ILI cases in the country or territory because the surveillance system would
typically not include all the physicians in the country, but as long as the coverage does
not vary over the course of an outbreak, we can justifiably assume proportionality in
the model to overcome this shortcoming.
Influenza sentinel clinics may be hospital-based or clinic-based. ILI patients re-
ported by doctors at outpatient clinics or general practitioners (GP) are represented
by Wt, depicted by the lime-green semi-oval in figure 4.2. Hospitalised ILI patients
are denoted as Yt depicted by the teal semi-oval in figure 4.2. If observed for the
whole population, Wt and Yt should be subsets of Xt, but most studies were done in
a limited number of hospitals, and so the numbers reported were only representative
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of those hospitals. As a result, due to the imperfect data collection and the differences
in the authorities’ practices, the observed data may not satisfy this relationship.
We denote all confirmed H1N1 cases as Zt, hospitalised H1N1 patients as Vt,
those who are not hospitalised as U t, and those who died due to infection as Dt. The
number of confirmed confirmed deaths due to H1N1, Dt, may be an under-recording
of the actual number as H1N1 might not be identified as the cause of confirmed death
for some patients. Among the sources that we have explored, data on Ut and Yt could
not be found, but the remaining data provide rich information for the missing data
of It and Rt. Notation for the states and data are provided in table 4.1.
States Description Availability
It Individuals infected with H1N1 at time t No
Rt Individuals recovered or died due to
H1N1 at time t
No
Dt All confirmed confirmed deaths due to
H1N1 at time t
Yes
Zt Patients diagnosed with H1N1 at time t Yes
Yt Hospitalised ILI patients at time t No
Xt All reported ILI patients at time t
(Hospitalised and outpatient)
Yes
Wt Outpatient ILI patients at time t
(Government clinic and GP)
Yes
Vt Hospitalised H1N1 patients at time t Yes
Ut Outpatient H1N1 patients at time t No
Table 4.1: Summary of the different states and data used in this project.
These are the states that we have considered and the availability column indicates
whether the data could be found in the literature reviews.
Differences in countries’ reporting systems led to non-systematic data for the
categories listed in table 4.1. We harvested data from publications from fourteen
countries with twenty-five datasets, of which Zt, the number of confirmed H1N1
cases, was the most common data type, whereas Ut, the number of outpatient H1N1,
and Yt, the number of hospitalised ILI, were not observed.
ILI counts are considered more reliable than confirmed H1N1 cases because typ-
ically they are collected under a consistent sampling protocol (Mark I-Cheng Chen,
personal correspondence). For countries with a proper surveillance system, ILI data
may be recorded consistently, even before an outbreak. Fox (2009) reports that there
was a sudden increase in demand for influenza tests in the early stage of the pan-
demic, leading to more capacity to confirm suspected infections at this stage. Thus,
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the number of confirmed H1N1 cases is subject to possible biases and might change
with the testing paradigm according to the changing risk perceptions. An example of
this was reviewed by the Australian Government Department of Health and Ageing
(2011), where extensive laboratory tests were carried out at the start of the pan-
demic, but to be more efficient, the protocol was modified to direct the tests towards
the more severe cases and vulnerable individuals to reduce the surge in demand for
tests. As a result, where ILI data were available, we included those alongside H1N1
confirmations, to validate the latter.
The WHO declared the end of H1N1 pandemic on 10 August 2010 (WHO, 2010),
though for most countries, the first wave—the time of greatest uncertainty—was
completed by late 2009. Because our basket of countries have different seasons, and
seasonality has been observed to influence the risk of influenza transmission (Balcan
et al., 2009), we truncated all datasets at 1 October 2009 which marks the common
change of seasons for countries in the northern and southern hemisphere. We initially
attempted to factor in the seasonal effect, but this was deemed unduly complicated,
as will be elaborated in the next subsection. As a result, our model focuses on the
period 23 April 2009 (Day 113 of the year) to 1 October 2009 (Day 274), i.e. an
interval of twenty-three weeks.
Countries were chosen such that they could form a good representation of the
world. They are countries and cities from four continents, namely North America,
South America, Eurasia and Australia; there is a marked paucity of data from Africa
and no good sources could be found. Among these countries, there was a mix of
middle and higher income countries. We will elaborate on how the data have been
collected in the order of the countries’ geographical latitude.
Finland: The first H1N1 confirmed cases occurred on 10 May 2009 (Ikonen et
al., 2010). The National Infectious Disease Registry collated the weekly numbers of
laboratory confirmed infections of the 2009 pandemic influenza A (H1N1) viruses, as
reported by Ikonen et al (2010). The number of H1N1 confirmed cases was digitised
using Engauge Digitiser from the article’s bar chart.
England: Three data types are available, namely, the number of H1N1 confirmed
deaths, the number of hospitalised H1N1 cases and the number of outpatient ILI
cases. During the pandemic, McLean et al. (2010) from the Health Protection
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Agency’s (HPA, now Public Health England) Centre for Infection claimed that the
General Registry Office of England reported daily numbers of confirmed deaths, based
on laboratory confirmation or classification on the confirmed death certificate. Figure
28 of the Epidemiological Report informs about the four countries in United Kingdom
(UK) but only England’s number of H1N1 confirmed death was digitised (McLean
et al., 2010) for consistency with the other sources for the UK.
In another HPA weekly report (McLean & Paterson, 2010), the number of hospi-
talised H1N1 cases and number of outpatient ILI cases for England were digitised from
the same diagram in Figure 8. Under the National Laboratory Reporting Scheme,
230 National Health Service, HPA and independent sector microbiology laboratories
provided data on the number of hospitalised H1N1 cases (McLean et al., 2010). The
outpatient ILI cases were provided by approximately 50 physicians from the Royal
College of General Practitioners (RCGP), who reported the weekly number of ILI
cases to the RCGP Research and Surveillance Centre to provide the data for the
HPA report regularly (McLean et al., 2010; McLean & Paterson, 2010).
France: The French GP sentinel surveillance system has been in place since 1984
to collect the number of ILI consultations and it is still ongoing (Sentinelles, 2012).
The system relies on a 1300 volunteer GPs who submit weekly number of ILI con-
sultations via secure internet connection (Sentinelles, 2012). Subsequently, average
numbers were estimated at the national level. We digitised the graph presented by
Fuhrman et al (2011) for the estimated number of ILI consultations.
New York: We found three datasets, including the number of H1N1 confirmed
deaths, the number of hospitalised H1N1 cases and the number of reported ILI cases.
The surveillance for H1N1 was in response to the expected severity of the pandemic
as the Department of Health and Mental Hygiene (DOHMH) appealed for all the
hospitalised H1N1 cases and confirmed deaths due to H1N1 to be reported (Lee et
al., 2010; Balter, Gupta, Lim, Fu, & Perlman, 2010). The surveillance system for
confirmed death due to influenza has been in place before the H1N1 pandemic but
only collecting data on influenza confirmed deaths in children (Lee et al., 2010).
According to Lee et al. (2010), the DOHMH removed the age criterion to make
the documentation suitable for the pandemic situation, and the surveillance system
was ready and credible for use. The bar chart on the number of H1N1 confirmed
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death in New York was digitised from the Lee et al. (2010) paper. DOHMH also
ensured the accuracy of the number of hospitalised H1N1 by following up with all
the 57 hospitals in New York daily by telephone to be notified of the total number of
hospitalised H1N1 patients within or outside the intensive care units (ICU) (Balter et
al., 2010). The number of ILI cases for New York was available from the United States
Centers for Disease Control and Prevention (CDC) website (CDC, 2009), which was
collected by the U.S. Outpatient Influenza-like Illness Surveillance Network made up
of more than 2,700 outpatient healthcare providers in all 50 states (CDC, 2009).
Japan: Ujike (2011) reports that the numbers of ILI and H1N1 cases were
collected by influenza sentinel and non-sentinel clinics in Japan. The number of
influenza cases per sentinel clinic was digitised and scaled to estimate the average
number per GP nationwide (Ujike et al., 2011). H1N1 cases were confirmed based
on random samples collected from the sentinel clinics and subjective samples in non-
sentinel clinics according to the different stages of surveillance rolled out at different
points in the pandemic (Ujike et al., 2011).
Republic of China, Taiwan: On 18 June 2009, Taiwan temporarily changed
their original influenza surveillance system to an influenza pandemic clinical surveil-
lance system which focuses on reporting the possible H1N1 cases (Chao et al., 2011).
This ad hoc surveillance system during the 2009 pandemic provides the number of
hospitalised H1N1 and confirmed H1N1 (Chao et al., 2011). Since Taiwan’s surveil-
lance is already extant, it is a natural node in our hypothetical network.
Singapore: The available data includes the number of H1N1 confirmed deaths,
the number of outpatient ILI and the number of confirmed H1N1 cases. The timing of
confirmed deaths were collated by reviewing news articles from Channel NewsAsia,
AsiaOne, and TR Emeritus, an independent Singapore online news site, since the
start of the pandemic until the end of 2009, 18 confirmed deaths were related to H1N1
(MOH, 2009) and cross checked against Ministry of Health (MOH) press releases for
completeness (MOH, 2009).
Since June 2009, Singapore started a sentinel GP network with 23 participating
GPs to report the number of ILI consultations on a daily basis (Ong et al., 2010).
We digitise the graph showing the average number of ILI consultations from each
GP and rescale by 2 138 times, the total number of GPs in Singapore in 2009 (Lee
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et al., 2011). Cutter et al. (2010) presented the number of imported and local cases
of H1N1 reported to MOH in a bar chart which we used as the number of confirmed
H1N1 cases.
Southern Hemisphere: Countries in the southern hemisphere only experienced
one pandemic wave in 2009 during their winter season and the countries explored in-
cludes Brazil, Peru, Bolivia, Australia, Chile, Argentina and New Zealand (Opatowski
et al., 2011). Opatowshi et al (2011) have extracted the number of confirmed H1N1
cases and ILI cases from the respective countries’ surveillance system websites or
public reports. We digitise the dataset from their graphical analysis for our use.
They also used a Bayesian approach with MCMC to find the posterior sam-
ple for the parameters of interest, but their parameters were distinguished by age
(Opatowski et al., 2011), while we assume the rate of infection and removal to be
the same for all age group. An additional move to build a hierarchical model could
easily exploit information from similar outbreaks from other areas. Our investigation
is more in depth as we have more countries in our analysis, involving countries from
most continents across the northern and southern hemispheres, as well as tropical
and temperate countries. We also have more types of surveillance data to provide
information to our model. We will also demonstrate that all these countries with dif-
ferent seasons can be modelled together using a hierarchical model for more accurate
predictions, by exploiting information from similar outbreaks of the same disease in
other countries.
4.3 Model
This project will explore the use of Bayesian hierarchical modelling on the 2009
H1N1 pandemic. MCMC techniques are used to sample the parameters and the
hyper-parameters over the large parameter space (Gilks et al., 1996). Advantages of
MCMC are that it allows model flexibility, for any distribution that suits the data
can be used, while it allows analysis of all parameters at the same time (O’Neill,
2002).
The unknowns that cannot be observed exactly at time t in the cth country are
the number of individuals infected with H1N1, Ic(t), and the cumulative number of
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recovered or dead individuals since the start of the observation, Rc(t).
In this analysis, the longitudinal observed statistics at time t in the cth coun-
try includes subsets of: the cumulative number of reported confirmed deaths due to
H1N1, Dc(t), the number of patients diagnosed with H1N1, Zc(t), the number of ILI
patients (Hospitalised and/or outpatient), Xc(t), the number of outpatient ILI pa-
tients (Government clinic and registered GP), Wc(t), and the number of hospitalised
H1N1 patients, Vc(t).
The observed statistics are either related to the number of infected individuals,
Ic(t), or the cumulative number of recovered or removed individuals, Rc(t), for the cth
country at time t. We show how evidence synthesis can be used to pool information
from these sources within the model to infer unknown quantities, such as Ic(t) and
Rc(t).
Parameters can inform about many severity estimates, like the Case Fatality Ra-
tio (CFR), Hospital Fatality Ratio (HFR), Case Hospitalization Ratio (CHR) and
Final Attack Rate (FAR). Because different types of data were collected, severity
estimates can be used to assess these different metrics of burden on the healthcare
system. Presanis et al. (2009) have demonstrated the estimation of CFR, CHR and
the Case Intensive care Ratio (CIR) by Bayesian Evidence Synthesis Framework.
Our approach can be seen as a generalisation of theirs, though excluding the severity
estimate for CIR which would require the data for number of H1N1 patients who
were admitted to the intensive care unit (ICU). The Bayesian Evidence Synthesis
Framework applied by Presanis et al. (2009) only considers each of these severity
ratios as probabilities of occurrences given symptomatic cases and using these prob-
abilities on a binomial model. It was also for the United States only, whereas our
approach used dynamic time series data, compartmental modelling and data from
many different countries.
The software used for this analysis is R (R Core Team, 2013).
4.3.1 Cumulative H1N1 Confirmed Deaths, Dc(t)
We model the cumulative number of confirmed deaths due to H1N1 as a negative
binomial distribution:
Dc(t) ∼ NB(nc(t), pc(t)) ∀c, t. (4.1)
A negative binomial distribution is preferred due to its support over the non-negative
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whole numbers, which is desirable for count data. Its flexibility in the shape of its
distribution, which is controlled by two parameters, nc(t) and pc(t), is also more
appropriate for providing different variance at different time points to account for the
magnitude difference within each of the collected data points. A Poisson distribution
is also not appropriate because of its inflexibility in the shape of the distribution
which is controlled by one parameter, λ. Similarly, a normal distribution is rejected
due to its support over the real numbers.
In the context of a negative binomial distribution, Dc(t) is the number of trials
until the occurrence of nc(t) number of successes based on the success probability of
pc(t). The parameters, nc(t) and pc(t), can be calculated from the mean, µc(t), and
variance, σ2c (t).















and n > 0
nc(t) =
µc(t)pc(t)
1− pc(t) ∀c, t. (4.5)
The mean is taken to be proportional to the modelled number of removals Rc(t),
which includes both recoveries and confirmed deaths,
µc(t) = θD(c)Rc(t) ∀c, t (4.6)
and the variance is also related to Rc(t) by another parameter, ηD(c),
σ2c (t) = ηD(c)Rc(t) ∀c, t. (4.7)
This parametrization ensures a manageable number of parameters while still cap-
turing the relationship between the model for infection and the mortality data. The
two additional parameters, θD(c) and ηD(c), were initially allowed to differ between
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countries to account for differences in each country’s population and health system
characteristics that might result in greater risk of adverse events: according to Barrau
et al. (2012), H1N1 patients with diabetes, cardiac insufficiency and morbid obesity
are more likely to become severe cases, requiring intensive care or even resulting in
confirmed death. As the prevalence of such risk factors differs in different settings
(Barrau et al., 2012) so too should in general the proportionality parameters differ.
In an emerging infectious disease outbreak, we are not sure what the proportion-
ality parameters ought to be. Case fatality ratios for different infections were 2.5%
(Spanish influenza (Taubenberger & Morens, 2006)), 14–33% (H5N1, estimated to
date, (Li, Choi, Sly, & Pak, 2008)) and roughly 90% (Ebola Virus, (King & Markan-
day, 2003)). Because of this, we assign the proportionality parameters for confirmed
death, θD(c) and ηD(c), uninformative prior distributions. The uninformative prior
for θD(c) is
θD(c) ∼ U(0, 1) ∀c (4.8)
because it is impossible to have more confirmed deaths than the actual number of
removed cases Rc(t). ηD(c) should be positive as variance is always positive, so the
prior distribution will be uniform over the non-negative range with an arbitrarily
large upper limit
ηD(c) ∼ U(0, 500 000) ∀c. (4.9)
Although θD(c) should take different values in different countries (see above),
the severity of the virus is unlikely to vary too greatly, and so evidence from one
country or setting should inform estimates for others. The parameters would ideally
be modelled hierarchically, but as we had data on mortality from three locations in
our hypothetical surveillance network (England, New York and Singapore), it proved
impossible to obtain good estimates on these parameters. We therefore changed the
mean to
µc(t) = θDRc(t) ∀c, t (4.10)
with the same prior for the proportionality parameter
θD ∼ U(0, 1). (4.11)
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To account for the longer time period between infection and confirmed death than
infection and recovery (Riley et al., 2003), an additional parameter δ is incorporated,
which is assumed to be the same for all countries. The mean and variance are then
related to the shifted number of removed individuals by
µc(t) = θDRc(t+ δ) ∀c, t (4.12)
σ2c (t) = ηD(c)Ri(t+ δ) ∀c, t. (4.13)
Again, a non-informative prior for the latent period, δ, (a discrete uniform prior)
is used:
δ ∼ Ud(1, 100).
4.3.2 Confirmed H1N1 Cases, Zc(t)
A similar model can be built for the number of confirmed H1N1 cases, using a
negative binomial distribution
Zc(t) ∼ NB(nc(t), pc(t)) ∀c, t. (4.14)
The two parameters, nc(t) and pc(t), can be calculated from the mean, µc(t), and
variance, σ2c (t), as illustrated in subsection 4.3.1.
Analogously, another pair of proportionality parameters, θZ(c) and ηZ(c), are used
for each country c. They should not be the same from country to country due to dif-
ferences in their testing regimes, partly due to different risk perceptions as explained
earlier. Since the parameter depends on the coverage of the surveillance network
more than biological factors, the knowledge from one country should not directly
affect the inference about other countries. Thus, the reporting parameters for these
data should be independent across locations. Although the testing paradigm can also
change within a country during the course of the pandemic, we will assume that the
proportionality parameter, θZ(c), will remain constant as time progresses. The mean
and variance for Zc(t) are proportional to the number of infected individuals, Ic(t)
by
µc(t) = θZ(c)Ic(t) ∀c, t (4.15)
σ2c (t) = ηZ(c)Ic(t) ∀c, t. (4.16)
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Again, uninformative prior distributions are used on the parameters, θZ(c) and
ηZ(c). The observed data should be less than the actual number of people infected
with H1N1, and so the proportionality parameter θZ(c) should also take values only
from 0 to 1
θZ(c) ∼ U(0, 1) ∀c. (4.17)
The prior distribution of ηZ(c) should also be positive and have a large upper bound,
ηZ(c) ∼ U(0, 500 000) ∀c. (4.18)
4.3.3 Reported ILI Cases, Xc(t)
The parameters governing the number of reported ILI, Xc(t), as a fraction of the
actual number of H1N1 infections is expected to be independent for each country
as the number of doctors or healthcare organizations under the surveillance system
will deviate greatly due to social, not biological, factors. For example, there are only
1300 volunteering GPs in France, in contrast to the 5000 sentinel clinics in Japan
reporting the number of ILI cases (Sentinelles, 2012; Ujike et al., 2011).
Similarly, differences in risk perception or medical usage may affect the proportion
visiting the doctor in different countries. The highest weekly number of ILI cases
reported as of 1 October 2009 are about 136 thousands and 24 thousands for France
and Japan, respectively (Sentinelles, 2012; Ujike et al., 2011). The obligation of
the physicians to report the ILI cases, as well as the stability of the surveillance
network may result in differences in the reported ILI cases. Since France started their
surveillance system in 1984, whereas Japan only started their surveillance system in
1997, the consistency of the system and the engagement of the physicians will be
different (Sentinelles, 2012; NIID, 1998). The proportionality parameter, θX(c), that
governs the portion of reported ILI data out of all those infected with H1N1 cases,
Ic(t), is therefore taken to be different for each dataset. Using the same negative
binomial distribution,
Xc(t) ∼ NB(nc(t), pc(t)) ∀c, t. (4.19)
The two parameters, nc(t), and pc(t), can be calculated from the mean µc(t) and
variance σ2c (t), as illustrated in subsection 4.3.1. In accordance with the above, the
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mean µc(t) and variance σ2c (t) are also related to the number of people currently
infected with H1N1, Ic(t)
µc(t) = θX(c)Ic(t) ∀c, t (4.20)
σ2c (t) = ηX(c)Ic(t) ∀c, t. (4.21)
As the number of ILI consultations will be under-reporting the actual H1N1
patients, θX(c) will be less than one and the prior distribution for θX(c) is chosen as
θX(c) ∼ U(0, 1) ∀c. (4.22)
Uninformative prior distributions with a large upper limit is also chosen for measuring
the spread as
ηX(c) ∼ U(0, 500 000) ∀c. (4.23)
4.3.4 Outpatient ILI Cases, Wc(t)
Surveillance systems in some countries only involved volunteer GPs to submit
the number of ILI consultations while some countries’ network relied on hospitals,
government clinics, as well as GPs. Data that come from the former will be classified
as outpatient ILI cases, Wc(t), and those from the latter will be categorised as the
reported ILI cases,Xc(t), described in the last section. Utilizing the negative binomial
distribution again,
Wc(t) ∼ NB(nc(t), pc(t)) ∀c, t (4.24)
where nc(t) and pc(t) are calculated from the mean µc(t) and variance σ2c (t), as
illustrated in subsection 4.3.1, where µc(t) and σ2c (t) are related to the actual number
of people infected with H1N1, Ic(t), by
µc(t) = θW (c)Ic(t) ∀c, t (4.25)
σ2c (t) = ηW (c)Ic(t) ∀c, t. (4.26)
Similarly, flat prior distributions are used for the proportionality parameters θW (c)
and ηW (c) as
θW (c) ∼ U(0, 1) ∀c (4.27)
ηW (c) ∼ U(0, 500 000) ∀c. (4.28)
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4.3.5 Hospitalised H1N1 Cases, Vc(t)
Countries with better healthcare systems may have more hospitalised H1N1 cases.
Within each country, the number of hospitalised H1N1 cases is modelled under the
negative binomial distribution,
Vc(t) ∼ NB(nc(t), pc(t)) ∀c, t (4.29)
while nc(t) and pc(t) can be calculated similarly from the mean µc(t) and variance
σ2c (t). The mean µc(t) and variance σ2c (t) will be proportional to the number of
individuals infected with H1N1, Ic(t), as
µc(t) = θV (c)Ic(t) ∀c, t (4.30)
σ2c (t) = ηV (c)Ic(t) ∀c, t. (4.31)
Because countries have a different proportion of patients being admitted into
hospital due to H1N1, they should have different proportionality parameter, θV (c),
but we assume this parameter to be hierarchical as the differences between countries
are likely to reflect biological differences and differences in health seeking behaviour
and not differences in the coverage of the surveillance system, so that similarities
between them can be measured and controlled by the hyper-parameters. The prior
distribution that is chosen for the θV (c) for the hospitalised H1N1 statistics, Vc(t),
will follow beta distribution,
θV (c) ∼ Beta(av, bv) ∀c (4.32)
to ensure that the parameter will only take values between 0 and 1. This prior dis-
tribution will be governed by the two hyper-parameters, av and bv, which represents
the shape parameters of the distribution. As these shape parameters should take
positive values, the hyper-prior is chosen to be
av ∼ Exp(1) (4.33)
bv ∼ Exp(1). (4.34)
Choosing the exponential parameters to be 1 will ensure that the (marginal) prior




There should also be a constraint of θV (c) > θD(c) for country c if the number
of hospitalised H1N1 Vc(t) and H1N1 confirmed deaths Dc(t) are both available.
Logically, there should be more hospitalised cases than confirmed deaths, which we
have verified against our datasets. To impose this, we reject parameter values that
do not meet this condition, i.e. the prior distributions are slightly modified to be
proportional to those described herein times the indicator function, I[θV (c) > θD(c)].
4.3.6 SIR Model
To impose a correlation between estimates of disease prevalence over successive
time points for country c, in particular in the number of H1N1 infections, Ic(t), and
the number of removals, Rc(t), at time t, a mathematical, compartmental model can
be used. The SIR model is the standard for large scale, respiratory outbreaks: in
this model, S(t) is the number of susceptible individuals, I(t) the number of sick
individuals and R(t) the number of recovered or dead individuals at time t.
4.3.6.1 Stochastic SIR Model
This model characterises the two most important epidemic changes to the population:
susceptible hosts becoming infected and infected hosts recovering or dying. The
parameters governing these changes are the rate of infection per susceptible-infected
pair, β, and the rate of removal per infected individual, α. Stochastically, the number
of individuals in the infected, I(t), and removed, R(t), state could be simulated using
the corresponding rates, β and α for each time t. These events simulation will then
be used in the likelihood calculation.
It is almost impossible for any surveillance teams to collect complete data of Ic(t)
and Rc(t) from the whole population, including the exact event time point and the
exact number of events. Censored data actually allow a window for all the events to
occur within the interval of data collection Hence, in this context, we will make use
of the representative subset as mentioned in the above data type and to synthesize
evidence for Ic(t) and Rc(t) by proportion.
If we are examining a small population, the problem of heavily censored obser-
vations can be overcome using data augmentation, a common inferential approach
for stochastic epidemic models (Cook, Gibson, Gottwald, & Gilligan, 2008; Cooper,
Medley, Bradley, & Scott, 2008; McKinley et al., 2009). This method of inference
regards the unknown events as parameters to be estimated alongside the other un-
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knowns in the model, typically with an MCMC routine in which unknown events are
changed at each iteration to explore the space of events that are consistent with the
data—for instance, having non-negative sizes in each category at all times.
If the exact event times and event types are not available, the likelihood cannot
be calculated directly. Data augmentation is a method to simplify the likelihood
(O’Neill, Balding, Becker, Eerola, & Mollison, 2000) as it allows the likelihood to be
replaced by the probability of the unobserved, augmented variables, which can be
calculated for most epidemic models. With the observed data D, event times can
be randomly generated based on the current parameter values θ and conditional on




f(D|A,θ) · f(A|θ)dA. (4.35)
Clearly, when the augmented events A do not agree with the observed data,
f(D|A,θ) = 0, giving f(D|θ) = 0. Else, if augmented events agree with data, it forms
a possible path for the epidemic, so f(D|A,θ) = 1. With the above, the posterior
distribution of all the parameters can be obtained by putting the idea of MCMC
and data augmentation together. Along with each set of parameter simulation using,
for instance, normal proposal distributions, a new set of augmented data are also
generated. They are checked for the consistency with the data. With a suitable
set of augmented times, the acceptance probability Pacc is calculated using the log
likelihood function log f(A|θ) and log prior density of all the parameters θ, log f(θ).
Then, the newly proposed parameter values θ∗ will be accepted with probability
Pacc.
Unfortunately, this approach is not feasible for an analysis of the H1N1 pandemic,
which affected the whole population, leading to too many event times and event types
to explore. According to the Population Reference Bureau 2009 World Population
Data Sheet (2009), the world population was 6.8 billion, and all of these individuals’
statuses would need to be explored by data augmentation. Most of the collected
data have a weekly frequency, which allows for even more variations in the number of
events that can take place. Moreover, it will be even more computationally extensive
if the number of individuals infected with H1N1 is computed separately for each
country. In this methodology, the trajectory can only be accomplished by including
every events in the each country based on their rate of infection and removal at each
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step of the MCMC iteration. Instead, we replaced the stochastic model described
above with a deterministic analogue, formed by solving a series of ODEs.
4.3.6.2 Deterministic SIR Model
In contrast to the stochastic model described in the last subsection, a deterministic
model treats the number of individuals in each state as a variable that can take
on any value and whose changing values over time are characterised by ordinary
differential equations (ODE). The structure of the ODEs for the SIR model for the
H1N1 pandemic is described below:
Infection can only occur when a susceptible individual is in contact with an in-
fected individual. There are Sc(t)×Ic(t) possible contacts that can result in infection
at time t. Thus, at any time t, the rate of decrease of Sc(t) for country i can be rep-
resented by the product of the rate of getting infected per SI pair in country c, βc,




We assume that infection across countries is negligible compared to infection
within countries and each country is a homogeneous population where the people in
the same country will react similarly to the disease.
Despite evidence that risks do differ in different sub-segments of the population
(Chen et al., 2010; Lim et al., 2011), the assumption of homogeneity simplifies anal-
ysis tremendously, while the additional variability caused by heterogeneity can be
partially accounted for via the observation model.
Correspondingly, at any time t, the rate of increase of Rc(t) for country c can be
represented by the product of the rate of removal in country c, αc, and the number




Since a susceptible individual S will become an infected individual I when in-
fected, the rate of decrease of Sc(t) will translate into the rate of increase of Ic(t).
Likewise, an infected individual I will become a removed individual R when recov-
ered or died, the rate of increase of Rc(t) will be interpreted as the rate of decrease
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of Ic(t). Together, the rate of change of infected individuals is
dIc(t)
dt
= βcSc(t)Ic(t)− αcIc(t). (4.38)
With these ODEs, the trajectories of Sc(t), Ic(t) and Rc(t) for any value of βc and
αc can be calculated numerically (we used the R package, odesolve (Setzer, 2012))
given initial conditions. As the time taken to compute the trajectory of the model
is non-trivial, it is important to design the inferential algorithm to be as efficient as
possible, since this solution of the ODEs will be required in every step of MCMC
for the calculation of likelihood. We will discuss how we achieved computational
efficiency for all the countries.
Because the rates of infection and removal are highly dependent on the number
of S and I, standard models which posit a constant incidence risk over the whole
period are inappropriate, as, for example, the risk of infection is much lower at the
start of a pandemic than at its peak when there are many infected individuals in the
population. One alternative, when data are informative enough, is to use a semi-
parametric model in which the per-capita rates of infection do not depend on the
state of the epidemic but are left to be free parameters that change over time, an
approach that multiplies the number of parameters to be estimated substantially.
This method has been successfully used by Cauchemez and Ferguson (2008) to study
measles transmission in London where the hazard changes fortnightly. The data used
by Cauchemez and Ferguson (2008) was collected fortnightly from 1948 to 1964. The
hazard rate for every fortnight will be used repeatedly for 16 years, allowing for
sufficient information to inform about the parameters. But, in our context, the
amount of information (over a few months and one epidemic wave) is insufficient to
do likewise.
4.3.6.3 Technical Challenges for solving ODE for Different countries
Because the data were collected in countries or territories of varying sizes, the
numbers in each compartment will vary substantially. One approach would be to
solve the system of ODEs separately for different countries. However, this would
increase the computation time of the algorithm as a whole. Hence, we worked with the
proportion of people in each disease state instead. In particular, we set Sc(t) = ncs(t),
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Ic(t) = nci(t) , and Rc(t) = ncr(t) where nc is the population size of the country in
year 2009 and the lower case variables are proportions. Most of the countries’ sizes
were taken from the World Population Policies 2009 (UN, 2010). The population sizes
of England, New York and Taiwan cannot be found from the above-mentioned report
as they are constituent parts of larger states (the United Kingdom, the United States,
and China, respectively) and so were taken from other sources; England’s population
size in 2009 was taken from their Office for National Statistics (2009), New York’s
was taken from the paper where we got the number of H1N1 confirmed death (Lee
et al., 2010) and Taiwan’s population size in 2009 was taken from the 2009 World
Population Data Sheet by the Population Reference Bureau (PRB, 2009).
It is assumed that the whole population is susceptible to the H1N1 disease before
the pandemic, so that s(0) = 1 − i(0) − r(0). (Although note that according to a
serological test of elderly in Finland, some had antibodies against this virus due to
the infection from previous influenza outbreaks due to a related virus, such as the
Spanish influenza (Ikonen et al., 2010). As the proportion was low, this complication
was omitted.)
We assumed an arbitrary small proportion of individual to be infected with H1N1
at the start of the pandemic, i(0) = 0.000001. The presumed small number of
infections prior to the declaration of the H1N1 pandemic by the WHO are ignored,
i.e. r(0) is set to 0. Using these initial conditions and different sets of values for α
and β, the trajectories of i(t) and r(t) at the indicated times t = 1, 2, . . . , 587—the
time from 1 Jan 2009 to 10 August 2010 when the WHO declared the end of the
pandemic—can calculated using the lsoda function in the odesolve package and
stored for use in the MCMC stage for all countries (Setzer, 2012) in an array, with a
grid of values for α and β and a set of times t.
Due to numerical approximations, it is possible for the solution to the ODEs to
take negative values towards the tail of the epidemic. To prevent this, we set all
negative entries of i(t) to 0.
As we store the solution of the ODEs to an array, there is a limit to the number of
sets of α and β that we can explore before storage becomes prohibitively expensive.
To allow other values to be used, apart from those stored, we used bilinear interpo-
lation on the two dimension space of α and β for the values of i(t) and r(t) for any
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values of α and β within a certain range. Both α and β are rates which should only
be positive. The upper limit for α is chosen to be smaller than or equal to 1 because
it is not biologically plausible that the number of days of being infective, represented
by the reciprocal of α, be less than 1. Suppose there is only 1 infected host and m
possible contacts with susceptible, the rate of infection per day is βm. If β is more
than 1, this infected host is able to infect more susceptible than he is able to meet.
Hence, we choose the upper limit for β to be less than 1.
Suppose the fifty values that we divide equally in the above range can be named
as α(1), α(2), . . . , α(50) and β(1), β(2), . . . , β(50). The solution of the ODE for the
i(t) trajectory with the simulated parameter α and β in the Metropolis-Hastings
Step that is lying between (α(j), α(j + 1)) and (β(k), β(k + 1)) will be represented
as i(t, α, β) in this bilinear interpolation context.
The first interpolation will be between the α(j) and α(j+1) while keeping β fixed
at β(k),
i(t, α, β(k)) = α(j + 1)− α
α(j + 1)− α(j) · i(t, α(j), β(k)) +
α− α(j)
α(j + 1)− α(j) · i(t, α(j + 1), β(k)). (4.39)
The same interpolation is done for α(j) and α(j + 1) while keeping β fixed at
β(k + 1),
i(t, α, β(k + 1)) = α(j + 1)− α
α(j + 1)− α(j) · i(t, α(j), β(k + 1)) +
α− α(j)
α(j + 1)− α(j) · i(t, α(j + 1), β(k + 1)). (4.40)
With these two sets, an interpolation can be done between β(k) and β(k + 1) to
get the final interpolation done by
i(t, α, β) = β(k + 1)− β
β(k + 1)− β(k) · i(t, α, β(k)) +
β − β(k)
β(k + 1)− β(k) · i(t, α, β(k + 1)). (4.41)
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Figure 4.3: Illustration of bilinear interpolation.
First, the values at the two grey crosses are calculated by interpolation between a(j)
and α(j + 1) while fixing at β(k) and β(k + 1) respectively. The black cross can be
computed by interpolating the values at the two grey crosses.
The above described bilinear interpolation is done for the trajectories for the
number of infected i(t, α, β) or r(t, α, β) over the required time t. If the simulated α
and β fall outside of the inspected range, we will use the odesolve to get the solution
(Setzer, 2012).
The basic reproduction number, the expected number of secondary infections
resulting from a single infected individual in a population otherwise susceptible
(Heffernan, Smith, & Wahl, 2005), R0 = f(α, β), is a threshold parameter which
is able to inform us whether the pandemic has the potential to take off (R0 > 1) or
will die out quickly (R0 < 1).
In this project, the historical data for the 2009 H1N1 pandemic will be analysed,
and prediction of the trajectory of Sc(t), Ic(t) and Rc(t) can be done and they could
be scaled to useful data type as described in the previous section. Nonetheless, we
focus on how hierarchical models can be implemented worldwide to improve estimates
for any emerging pandemic.
4.4 Hierarchical Model
In hierarchical modelling, information from multiple sources (here countries) is
pooled. In our context, there will be much variability between forecasts of the out-
breaks in each country if each country is modelled independently. However, if pa-
rameters across all countries take the same parameter value, differences between
countries’ experiences cannot be accounted for, and estimates will be unjustifiably
narrow. Hierarchical modelling can help to address this problem by introducing
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hyper-parameters to measure the variability of parameters for the different countries.
A hierarchical model also allows us to use information from countries which have
more data for countries which have limited local surveillance of the pandemic.
It is clear that βc should be different for each country c, since different countries
have different policies to deal with the rate of disease spreading. As forecast by
Kubiak and McLean (2012), if the control measure of school closure in England
had not been implemented, the number of infections by the end of the first wave
in England would have been much higher. To allow for such differences requires
the infection rate be different between countries with different control measures, but
if βc is nevertheless sufficiently similar for different countries, a hierarchical model
would be appropriate, because the infection rate per SI pair, βc, for country c should
still be exchangeable across different countries. Logarithmic transformation on the
parameters allowed a normal distribution to be used which takes continuous, real
values,
log(βc) ∼ N(µβ, σ2β), (4.42)
where the mean, and standard deviation can be characterised by the hyper-parameters,
(µβ, σβ).
Although βc must be positive, they can be any real numbers after taking loga-
rithms. Therefore, the hyper-prior distribution of µβ is flat and allowed to take any
values over a large range,
µβ ∼ U(−1 000, 1 000). (4.43)
Because the standard deviation cannot be negative, a similar arbitrary range over
small to large positive values is chosen as the hyper-prior distribution for σβ,
σβ ∼ U(0, 1 000). (4.44)
We assume that all αc are equal (αc = α) because the rate of removal of the
disease should be the same in all countries, representing as it does a purely biological
phenomenon.
4.4.1 Informative prior for removal rate
In contrast to the rate of between-host transmission for a novel variant of influenza,
the within host dynamics of (seasonal) influenza are well understood. This would
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allow an informative prior for the removal rate, α, using data from previous studies.
Carrat et al. (2008) did a detailed analysis on the duration of the course of virus
infection for H1N1 from multiple published research studies. It was found that for
(pre-pandemic) H1N1, the average duration for illness was 4.50 days, with the 95%
confidence interval from 4.31 to 5.29 days.
The above conclusion was about how long the illness will last, but we are in-
terested in how long is the infected individual infectious. For a better estimate of
the length of infection period for our prior distribution for α, we looked into the
sources that they cited for possible information that we can make use of. In the
daily serological tests on the volunteers, the H1N1 antibodies titers were recorded.
If the recorded titers are above certain threshold, they will be considered as infected
individuals. Once it falls below again, that marks the end of the course of infection.
We digitised six log mean viral titers plots for use (Barroso, Treanor, Gubareva, &
Hayden, 2005; Fritz et al., 1999; Hayden et al., 1994, 1996, 1998; Treanor, Betts,
Erb, Roth, & Dolin, 1987). These papers were studying the physical response of the
volunteers to the use of placebo and drugs, and so we digitised only data from the
placebo arms of these studies.
Other than the log mean of the viral titers at each day, the standard error (SE)
and the number of volunteers (n) can also be found, either from the plot or stated
in the paper. For each plot that we digitised, we calculate the standard deviation
(σ) of the viral titers by σ = SE√
n
. Assuming that the log viral titers for day k of the
dataset l, Tkl, follow normal distributions,
Tkl ∼ N(µkl, σ2kl) ∀k, l, (4.45)
the probability, pkl, that the log viral titers of day k of dataset l will exceed a given
threshold ε can be calculated for each day is
pkl = Pr(Tkl > ε) ∀k, l. (4.46)





The estimated duration of infection is estimated from the average and standard
deviation of Dl from all the six datasets. We trialed several different thresholds for
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infectivity, ε = {0, 1, 2}, selecting ε = 2 to be the most appropriate threshold based
on the face validity of the resulting infectious period. Note that this rate is actually
the recovery rate, but is used as a proxy for the removal rate, α, as the confirmed
death rate is close enough to 0 to be ignored.
At ε = 2, the mean and standard deviation of the expected duration of infec-
tion for all the dataset are 2.53 and 0.714 respectively. These values become the
information for the informative prior for the infectious period, 1α ,
1
α
∼ N(2.53, 0.7142). (4.48)
4.4.2 Modification to Overall Model on initial analysis
On fitting the model described above using MCMC, the routine would not converge
despite many attempts. The countermeasures discussed here are very common solu-
tions for MCMC non-convergence. MCMC was tried independently on each country
to allow higher rate of acceptance of proposed parameters. This is because when a
large number of parameters were proposed for the data for so many countries, the
chances that they will all suit the available data, and yield a high likelihood, is low,
which will then result in rejection of the proposal. We also tried to get better initial
values for the Markov chain to reach convergence quickly, and experimented with
proposal distributions of different covariances as well as mixtures of distributions.
4.4.2.1 Multiple waves
According to Borja-Aburto et al (2012), there have been four waves of H1N1 since
2009 and the virus has displaced the pre-pandemic H1N1 as one of three main sea-
sonal influenza strains (including influenza A/H3N2 and influenza B) (Belshe, 2010).
A territory which shows clearly that there is a change in pandemic trajectory is Hong
Kong. As stated by news.gov.hk, an online news platform launched by the Govern-
ment of the Hong Kong Special Administrative Region, Hong Kong changed from the
containment phase to the mitigation phase on 12 June 2009.
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Figure 4.4: Number of hospitalised H1N1 in Hong Kong Public Hospitals
collated by Riley et al. (2011).
The number of hospitalised H1N1 in Hong Kong is double peaked in June 2009
and September 2009. The grey and black rectangles at the lower panel show the
containment period and the mitigation period adopted by The Government of the
Hong Kong Special Administrative region.
Figure 4.4 supports the claim by Wu et al (2010) that Hong Kong’s policy changed
on 30 June 2009 to the criteria for the admission to hospital for H1N1 patients to be
based on medical needs, rather than for isolation. Other than Hong Kong, Finland
and England also displayed two peaks for the number of confirmed H1N1 cases Zc(t)
and number of outpatient ILI cases Wc(t) respectively. Japan also had two peaks
for both the number of reported ILI cases Xc(t) and the number of confirmed H1N1
cases Zc(t). Thus, we decided to introduce a new parameter, τc, to identify the date
of policy change which would cause a change in the shape of the trajectory for each
country c. Note that the date which the policy change takes effect is not necessary
the date of phase change.
The phase change in Hong Kong should involve the relaxing of H1N1 hospital-
ization policies. To account for the reduction in the numbers of admissions, the
proportionality parameter, θV (c), should change accordingly.
This parameter should conceivably account for the time of either a second wave
or a change in the country’s surveillance policy which can affect any of the data type.
Using the hospitalised H1N1 cases, Vc(t), as an example, the reporting parameter,
θV (c) was split into two, one to report before the change and the other to report after
the change.
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Recall that the model is
Vc(t) ∼ N(µc(t), σ2c (t)), (4.49)
where the mean is now characterised by the two proportionality parameters θ1V (c)
and θ2V (c)
µc(t) = θ1V (c)Ic(t)I (t < τc) + θ1V (c)θ2V (c)Ic(t)I (t ≥ τc) . (4.50)
Before the effective date of changes, τc, the proportion of individuals infected with
H1N1 should remain the same, and so the prior distribution for θ1V (c) is still
θ1V (c) ∼ U(0, 1). (4.51)
For a further reduction in the observations after τc, the prior distribution of θ2V (c)
should be
θ2V (c) ∼ U(0, 1). (4.52)
To avoid over-parametrization, parameters that measure the spread of the data
were kept the same as before
σ2c (t) = ηV (c)Ic(t), (4.53)
where the prior distribution remains as
ηV (c) ∼ U(0, 1). (4.54)
However, this analysis did not work as there was insufficient evidence from the
datasets to inform (i) the degree of change and (ii) when change occurred. As a result,
we focused only on the first, main wave of H1N1, and assumed constant reporting
rates within countries across time.
4.4.2.2 Start dates
Because H1N1 virus has been circulating in other countries prior to the WHO an-
nouncement (Chao et al., 2011), a parameter is introduced to describe the start date
for country c, t0(c). This parameter will shift the ODE solution down the time line
and replace the gap from the first day, 1 Jan 2009, to day t0(c) by the initial values
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of the trajectory, Ic(0) and Rc(0). It is beneficial to observe that there is a different
connotation for τc and t0(c). The former changes the proportion of the number of
cases but the latter only changes the time where the outbreak starts in the country
c. Because there is no prior knowledge on the starting date for each country, a flat
discrete uniform prior distribution is used on t0(c) from 1 Jan 2009 (day 1) to the
day that WHO declared the end of pandemic on 10 August 2010 (day 587) (WHO,
2010).
4.4.2.3 Seasonality
We initially attempted to account for seasonality differences between countries, ac-
counting for countries that are not near the equator having different seasonal patterns
at different times of the year. The rate of infection, βc, previously taken to be a pa-
rameter, was reformulated as a function of time, t. A sine function of time t was used
to give the smooth oscillating effect to mimic the seasonal effect within a year. A scal-
ing parameter for country c, κc, is used to adjust for the difference in the magnitude
of the rate of infection in the different seasons. The exponential function ensures that
βc(t) remains positive by transforming negative sine values to values between 0 and
1, which will reduce the value of βc during the warmer season; it will also transform
positive sine values to values more than 1, which will increase the value of βc during
the cold season. As there are 365 days in a year, there is approximately one complete
cycle is time t is in terms of degree in the trigonometrical function. Either a cosine
curve or a translated sine curve will coincide with the climatic patterns for a year,
where the latter is chosen. The function of βc with seasonal effect becomes








Chapter 4 Hierarchical Model of 2009 Pandemic H1N1 Transmission















Figure 4.5: Seasonality characterisation using a transformed sine function
of time t.
Different values of κc can affect βc(t). The grey dotted line is when βc is fixed at 0.5
(κc = 0) for no variation in βc(t) against time t. When κc < 0, the black solid line
shows the shape of the βc(t) function for the southern hemisphere and when κc > 0,
the black dotted and dotdash lines shows the shape of βc(t) function for the northern
hemisphere. The larger the value of κ, the more pronounced the variability in the
curve will be. At the lower panel, the grey rectangular box shows the range of the
days where the pandemic data is used if we do not want the seasonality to affect the
infection rate.
Recall that the trajectory of the pandemic is derived using the ODE solution from
an R package (Setzer, 2012). If βc becomes a function which varies with time, we
need to use a method such as Euler’s method (Atkinson & Kendall, 2008) to solve the
ODE. Similarly, Euler method can be a step-wise, deterministic way of finding the
trajectory of a pandemic. Presumably, the rate of occurrence, f ′(x), is the gradient
of the graph y = f(x), represented by
f ′(x) ≈ f(x+ ∆x)− f(x)∆x . (4.56)
Suppose for a small time step, h, the rate of decrease of Sc(t) is stated earlier to
be βcSc(t)Ic(t). If the rate of infection can vary with time and displaying using the
above relation,
−βc(t)Sc(t)Ic(t) ≈ Sc(t+ h)− Sc(t)
h
. (4.57)
The approximate number of susceptible in the next time step can be derived from
the above relation,
Sc(t+ h) ≈ Sc(t)− βc(t)Sc(t)Ic(t) · h. (4.58)
74
4.4 Hierarchical Model
Similarly, the number of individuals infected with H1N1 can be calculated by
Ic(t+ h) ≈ Ic(t) + (βc(t)Sc(t)Ic(t)− αcIc(t)) · h. (4.59)
With the above relation for Sc(t) and Ic(t), the whole trajectory could be cal-
culated from the initial values Sc(0) and Ic(0). Intuitively, larger h will lead to a
coarser trajectory that is a greater approximation to the true trajectory implied by
the model. This seasonal effect, coupled with the Euler’s method to replace the ODE
solution, was explored but was eventually abandoned because the data did not dis-
play sufficient seasonal effects for the estimation of the newly introduced parameters
to work. We also realised that the seasonal effect with double humps in the Ic(t)
trajectory will only happen when the values of α and β are similar to each other: in
other scenarios a single epidemic wave resulted and so the increase in complexity did
not seem warranted.
4.4.2.4 Correlation between α and βc
Previously, the posterior samples in the MCMC routine showed that α and βc are
correlated for certain countries. We will change to propose the basic reproduction
number for country c, R0(c), and the rate of removal, α, and calculated the infection
rate, βc, based on those.
Because we assume that all individuals are susceptible at the start of the pan-
demic, i.e. sc(0) = 1, at the start of the H1N1 outbreak in country c, if the rate of
infection is βcsc(0)ic(0) and rate of removal is αic(0), the basic reproduction number







where βc can be calculated by βc = α · R0(c). The original hierarchical model for
(α, βc) will be changed to model R0(c) of different countries,
R0(c) ∼ N(µ, σ2). (4.61)
The hyper-parameters are reduced to µ and σ. As we have no prior information
we wish to use, and since R0(c) should only be positive (and take values a little more
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than 1), we set a uniform prior with an arbitrary large upper limit,
µ ∼ U(0, 100). (4.62)
Similarly, σ should also take positive values,
σ ∼ U(0, 100). (4.63)
4.5 Model Fitting
As mentioned before, we fit a Bayesian hierarchical model to multiple data types
relating to the H1N1 pandemic for a hypothetical network of countries. The parame-
ter space for this model is large and the likelihood expensive to calculate. MCMC is
a method to sample from the posterior distribution of parameter given the available
observed data (Cauchemez et al., 2006) and that is well suited for our problem as it is
a sampling methodology that efficiently draws from the actual posterior distribution
using the Metropolis-Hastings algorithm to decide whether a proposed parameter
should be included into the posterior sample.
4.5.1 Metropolis-Hastings Algorithm
For this particular project on H1N1, due to the complexity of the model, the
implementation of the algorithm is non-trivial and hence summarised in the following:
1. We need to prepare an array of the proportion of infected individuals, i(t), and
proportion of removed individuals, r(t), over time t after introduction of the
virus, for values of infection rate, β, and removal rate, α, over a grid from 0
to 1. This array of information will be stored for use in all countries for the
likelihood calculation. To make use of the odesolve package, the ODE have
to be defined as a function. The initial values of the trajectories, as well as the
vector of time steps for exploring, should also be specified with the values of βc
and α.
2. The initial value for each parameter is chosen to be in the vicinity of the pos-
terior by trial-and-error, using graphical comparison of the model against the
data. This makes the routine less computationally unwieldy, especially impor-
tant due to the many parameters in this model.
76
4.5 Model Fitting
3. The likelihood is calculated based on the current initial parameter values θ0.
a) Using the bilinear interpolation method, we can find the trajectory of
the proportion of infected individuals ic(t) and the proportion of removed
individuals rc(t) for each country c using the proposed (or initial) rates
of infection and removal, β0c and α0. Recall that the number of H1N1
confirmed deaths, Dc(t), will relate to the removed individuals and the
other data types will relate to the infected individuals. Also, the rate of
infection β0c will be computed deterministically from the parameter value
of R00(c) and α0.
b) We need to incorporate the latent period of confirmed death, δ0, from the
time when the individuals get infected by shifting the time of the trajectory
for each of the country c relative to the H1N1 confirmed death data. The
data time for the number of H1N1 confirmed deaths should be reduced by
δ0 days temporarily for this iteration and stored as a temporary confirmed
death data,
D′c(t) = Dc(t− δ0). (4.64)
c) Next we need to combine the delay in the trajectory for country c based
on t00(c). The trajectory will only start for country c from day t00(c). We
will insert a baseline of proportion of infected individuals before t00(c) to
be ic(0) = 0.000001 and proportion of removed individuals before t00(c) to
be rc(0) = 0.













type for each country c, the proportion trajectories can be converted into
the actual numbers by multiplying with the population size of country c,
nc. For instance, the mean trajectory for the number of H1N1 confirmed
death cases for country c will be related by proportion to the modified
number of removed individuals by
µc(t) = θ0D(c) × nc × rc(t). (4.65)
Similarly, the trajectory for the number of confirmed H1N1 cases (or other
data types) in country c will also be related by proportion to the modified
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number of infected individuals by
µc(t) = θ0Z(c) × nc × ic(t). (4.66)
e) The parameter that measures the spread of the data from the trajectory is
computed. Recall the variance formula for the number of H1N1 confirmed
death cases is
σ2c (t) = η0D(c) × nc × rc(t). (4.67)
Similarly, for other data types, we relate the variance with the modified
number of infected individuals.
f) With mean, µc(t), and variance, σ2c (t), the parameters necessary for the







1− pc(t) . (4.69)
g) The likelihood for the H1N1 confirmed death data type for country c
can be computed using a negative binomial distribution with the above
parameters pc(t) and nc(t).
h) The likelihood for all the different data types of the different countries will
be computed in a similar manner and the product of all these likelihood
values will be the overall likelihood for the data given the all the param-
eters θ0. Here, we assume that data from each data type is independent
from the other data type, conditioned on the parameters that have been
proposed. Similarly, the data from each country will be also assumed as
independent conditioned on the parameters, as the amount of trans-border
mixing of infectious hosts from one country to another will pale into in-
significance relative to the number of infections acquired locally within the
country. It will be easier to work with log-likelihood, which will then be




4. Other than the log-likelihood, log f(D|θ0), we also need to calculate the log
prior density log f(θ0) for all these initial parameters θ0. The pseudo log
posterior density log f(θ0|D) can also be calculate by adding log-likelihood and
log prior density, as the normalizing constant will cancel with the subsequent
log posterior density.
5. In pilot rounds of the MCMC algorithm where our proposal distribution is not
well tuned, the parameters will be proposed individually. The first parameter
value, α∗, will be proposed using a normal proposal distribution centered at
the initial parameter value, α0 and an arbitrarily specified standard deviation,
0.0001,
α∗ ∼ N(α0, 0.00012). (4.70)
The choice of normal distribution is due to the preference of a symmetrical pro-


















where D is the collected data and θ0 is the initial values of the other parameters
which were not yet proposed.
6. We will check the proposed parameter value of α∗ based on the model condi-
tions, i.e. α∗ > 0. If the conditions cannot be fulfilled, they can be rejected
straight away without wasting time in their likelihood calculation.
7. If they satisfy the criteria, we will use likelihood procedure mentioned earlier in
step 3 to find the value of the log-likelihood for the new proposal log f(D|θ∗)
where θ∗ represent the set of initial values with the newly proposed α∗.
8. The log prior density for the new set of parameter log f(θ∗) can also be calcu-
lated.
9. As we subsequently will draw a uniform(0,1) variable and compare it to the
acceptance probability, outlined below, we can neglect the requirement that
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the acceptance probability be ≤ 1 for notational brevity. The log acceptance




logPacc = log f(θ∗|D)− log f(θ0|D) (4.74)
= log f(D|θ∗) + log f(θ∗)
− log f(D|θ0)− log f(θ0) (4.75)
where logPacc is essentially the difference between the pseudo log posterior
density under θ∗ and θ0.
10. A random number can be generated from r ∼ U(0, 1). The proposed parameter
values θ∗ will be accepted with probability Pacc. If log r > logPacc, we will
reject the proposed α∗ and α1 = α0, otherwise, we will accept the proposed α∗
and update α1 = α0.
11. After updating the rate of removal, α, we can propose for the next parameter
by repeating the step 5 to 10. The parameters change accordingly.
12. After all the parameters have been proposed and updated, we propose new
values for all the hyper-parameters. Because the acceptance probability for
hyper-parameters does not include the likelihood calculation, updating of the
hyper-parameters is faster. Suppose θ and η represent all the parameters and











The ratio of proposal density for the hyper-parameters equal to 1 because a
normal proposal distribution centered at the current value is used. The ratio
of the posterior densities can be simplified by
f(θ,η∗|D)
f(θ,η|D) =
f(D|θ,η∗) · f(θ|η∗) · f(η∗)
f(D|θ,η) · f(θ|η) · f(η) (4.77)
= f(θ|η
∗) · f(η∗)
f(θ|η) · f(η) (4.78)
because the likelihood, f(D|θ,η), is not affected by the change of hyper-
parameters. As such, the hyper-parameters will be updated 20 times for every
complete round of parameter proposals.
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13. The whole routine will have to be repeated a large number of times to give us
the posterior sample for all the updated parameters.
4.5.2 Solution for Non Converging MCMC
On initial runs, the traceplots of the posterior samples did not show convergence.
We first attempted to preserve the model and change the proposal distributions
similar to the tuning of proposals in simple algorithms: If the proposal of the new
parameters is always far from the posterior, because the variance of the proposal
is too large, the proposed parameters will invariably be rejected. Likewise, if the
proposed values are too close, because the variance is small, it will take too much
steps to move around the posterior.
Moreover, the posterior distributions of many of the parameters are closely corre-
lated. If one of the proposed parameters is inappropriate, the other parameters will
also be affected. Although each parameter can be proposed separately and a differ-
ent acceptance probability can be calculated for each parameter, it will become too
computationally intensive as there were many countries involved and the trajectories
have to be interpolated at every proposal for the calculation of the likelihood. So, we
propose changes to all the parameters individually for a small amount of iterations,
2500, with 500 burn-in and thinning on every 10 iterations as described in the pre-
vious section. The burn-in is chosen to be small because suitable initial parameter
values were used.
After completing this first trial round of proposal, we tuned the standard deviation
of all the parameters and hyper-parameters proposal distributions with the respective
standard deviation of the posterior samples. Following this update of the proposal
standard deviation, the actual MCMC routine was conducted afresh with 100,000
iterations and no burn-in, as the routine will start with the parameters values from
the previous step, itself assumed a draw from the posterior.
In this step of MCMC with better proposal distributions, the parameter, α, is
proposed independently from the other parameters and hyper-parameters while the
other parameters and hyper-parameters are proposed together in batches, within
countries where appropriate. α and β (from R0) are capable of affecting the propor-
tional trajectories of all the countries. So, this proposal approach will only change
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the trajectories twice at every round. Proposing all other parameters and hyper-
parameters together will most likely result in rejection, so, we propose the remaining
parameters by country, followed by the hyper-parameters.
4.5.2.1 Sequential Importance Sampling
Even the modified algorithm described in the previous section did not lead to conver-
gence. We proceeded with an alternative solution, Sequential Importance Sampling.
In Importance Sampling, parameters are simulated from a proposal distribution and
weighted using the likelihood, prior and proposal density. If we can sample from the
posterior distribution directly, this gives an unweighted sample, but otherwise the
weights correct for sampling from an incorrect distribution. Although the previous
results of the non-converging MCMC may not be the exact posterior distribution, it
should still be close to the desired posterior distribution, and so by approximating
the MCMC sample by a suitable multivariate distribution, we can generate samples
from a distribution close to the target distribution.
Since it is vital to sample from a distribution that is close to the desired distribu-
tion, we will progressively improve the distribution that we sample from, using the
weighted samples from the previous rounds. In the initial rounds, when the proposal
distribution is still not so similar to the target distribution, we reduce the weight
contributed by the likelihood density by an intensity constant, T . The value of T
will gradually increase from 0.1 to 1 in the sequential steps to successively allow the
weighted samples to inform about the target distribution.
The Sequential Importance Sampling algorithm is:
1. Using the mean and variance of the posterior sample for each parameter and
hyper-parameter and assuming independence between all parameters (a con-
servative assumption), set up a multivariate normal proposal distribution with
covariance matrix only having entries on the diagonals and zero elsewhere.
2. Sample 100 000 particles from this multivariate normal proposal distribution
and calculate the weights for each particle. Weights are represented by the
ratio of the posterior to the proposal density, where the posterior is proportional
to the likelihood, prior and hyper-prior density. In importance sampling, the
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Because the particles may not characterise the data well in the first round, the






We let T = 0.1 in this first round and gradually increase this amount to 1 when
the proposal distribution has been improved to become close to the posterior
distribution.
3. Taking logarithms, we can better see how the intensity T will be relating the
likelihood to the weights
logwl = T log f(D|θl) + log f(θl|ηl)
+ log f(ηl)− log q(θl,ηl). (4.81)
If we take exponential transformation to convert logwl back to wl for lth parti-
cle, many of the values will become 0 if the logwl is small. Hence, we overcome
numerical overflow issues by transforming the logwl to
(logwl)∗ = logwl −max(logw) (4.82)
before exponentiating to get
w∗l = exp (logwl)∗ (4.83)





so that all the weights, wl, sum to 1.
4. The particles, together with their respective weights, will be the information
for the next round’s multivariate normal proposal distribution, with weighted
mean of the particles and weighted covariance matrix of the particles. Repeat
step 2 to 3 and sequentially, increase the intensity, T , of the likelihood give
a better representation of the weights for the description of the next proposal
distribution.
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The intensity, T , started small to prevent over-concentration of the few particles with
good weights. As Sequential Importance Sampling progressed from the first round
to the tenth round, the particles will gradually become a good realization of the
posterior samples. In the final round, T = 1 and the routine above yields a weighted
sample from the correct posterior distribution; only this round is used for analysis.
Some challenges arose in the importance sampling step. The covariance matrix
that we calculated from the proposed samples was non-invertible, resulting in an
invalid proposal distribution in the next round. This problem was reduced by repa-
rameterising parameters by taking logarithms of rates and logit transformations of
probabilities.
After the transformation, the covariance matrix might occasionally still be non-
invertible. On investigation, we realised that for certain parameters, the weights
concentrate the proposed particles for certain parameters to a single value. This is
because the proposal distribution for that parameter became too focused due to the
weights in the previous rounds. This would lead to zero variance for the proposal
distribution in the next round, resulting in a singular covariance matrix. The solution
for this problem was to increase the sampling size sequentially and reduce the stepwise
increment of T , to ease the over-concentration at certain points.
This sequential importance sampling routine is repeated with the data available at
four different time points (1 June 2009, 1 July 2009, 1 August 2009 and 1 September
2009) to show the improvement in prediction and severity estimation with increasing
data in a real pandemic outbreak.
4.6 Results and Inference
This model for the outbreak of H1N1 at different territories has made used of
some fixed parameters, as well as parameters which were modelled independently
and hierarchically. To decide which parameters should be the same, one approach is
to use expert opinion. If they should be the same, the parameter can be fixed for
all the places, for example, the rate of removal, α, in the H1N1 project, due to the
similar biological capability of the infected individual to recover from the disease. On
the other hand, if the parameter should be different, for example, the proportionality
constant, θX(c), which accounts for the fraction of reported ILI patients in country
84
4.6 Results and Inference
c and that can be much affected by the capacity of the healthcare system in each
territories. The other proportionality constant, θZ(c), which represents the portion
of infected H1N1 who were confirmed by laboratory test for country c, would also
be affected by the testing paradigm in the different countries,and would be better
modelled independently.
In this case, we decide which parameter should be hierarchically modelled or
fixed depending on the amount of information we had. For example, there were only
three territories with mortality data, and so the information quantum to estimate
mortality rate was insufficient to allow useful hierarchical estimates. The solution for
the lack of data can be solved by using a fixed proportionality constant, θD, for all
territories. In contrast, as there were many areas with hospitalized H1N1 data, the
proportionality constant, θV (c), can be modelled hierarchically.
With a richer dataset, the ideal statistical approach is to model every parameter
hierarchically. This would allow us to estimate how similar or different they were. The
different ways of modelling can be compared against using the Deviance Information
Criterion (DIC). Using the posterior samples achievable from the MCMC simulations
(if convergence exists) or the sequential importance sampling (the alternative method
if there is non-convergence in MCMC), the average log likelihood of a sample of
parameters, D(θ¯) , and the average log likelihood from every set of parameters, D¯,
can be calculated. The DIC is pD + D¯ or D(θ¯) + 2pD where pD = D¯ − D(θ¯). The
model with the smallest DIC should be preferred out of all the trials, and this would
allow a statistically informed decision on whether a hierarchical model was needed.
The main motive of this model is to show that prediction of the severity of a
new outbreak at both a per country and global level can be done in real time using
a network of countries each providing their own outbreak information in real time.
This section assesses the feasibility of this goal by applying the method to the 2009
influenza pandemic as a case study.
Observing the peak for at least some countries is necessary to inform the param-
eters appropriately as there were no informative priors for the basic reproduction
number, R0. By the end of July 2009, about three months from the start of the pan-
demic, when some but not all of the countries had experienced their peak, the data
could give a good estimate to the parameters, which would lead to better prediction.
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We will present the results of each country sorted by latitude.
4.6.1 Finland



























































































Figure 4.6: Forecasts of pandemic H1N1 confirmed cases in Finland.
Solid circles indicate data available at the point the forecast is made, hollow circles
indicate future data, black lines indicate best forecast, shaded regions indicate un-
certainty (dark) and observation error (light). The black bar at the bottom of each
panel shows the change in the countries policy to change from containment to miti-
gation phase. The four time points used are the beginning of June, July, August and
September, 2009.
In the first panel, there were only three available data points for analysis. The
forecast was vague because of the limited information. Despite this the shape of the
best forecast of the pandemic was close to the actual shape as the hierarchical model
is able to draw information from the other countries. However, the magnitude of the
number of H1N1 cases were over predicted, as θZ(c) was independent for each country
and the information on this Finland-specific parameter was insufficient at the time
the first estimate was made to yield a good estimate of θZ(c).
In the next panel, data up to 1 July 2009 were used. As there were more points
showing an upward trend, the pandemic was projected to spread by the increasing
H1N1 cases. However, with the extra information collected over June, the uncertainty
was greatly reduced compared to the first panel.
In the third panel, the available data were still showing upward trend, but other
countries or territories—such as New York, Bolivia, Argentina and Chile—provided
a fair amount of data by 1 August 2009 to show the epidemic had peaked and was
waning, affecting the common removal rate, α, and the mean and variance of the
basic reproduction number, R0(c). As a consequence, the model forecast that the
number of H1N1 cases would fall, while fitting closely to the observed data available
at that time, even when there was as yet no sign of the epidemic having peaked. The
forecast does not characterise the data after the peak well, but the post-peak data
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do not appear to be consistent with the data before the peak, or with the SIR model
we are fitting. This may result from changes to the way H1N1 cases were tested as
the country switched from the containment to the mitigation phase on 22 July 2009
(Saarinen, Järvinen, Haikala, & Ruutu, 2009).
By the beginning of September 2009, when most of the data were available for
use, the model is able to provide a satisfactory prediction, by informing the H1N1
peak for Finland at the correct time point.
4.6.2 England

































































































































































































Figure 4.7: Forecasts of pandemic H1N1 confirmed deaths (cumulative),
H1N1 hospitalizations and ILI cases in England.
Features in this figure are as in figure 4.6.
The worst prediction for England occurs when early data up to 1 July is used. Because
of the change from containment to mitigation stage, there is a minor peak in the
outpatient ILI data up to 1 July, which the model misinterpreted and used to predict
a small magnitude pandemic that would end early (see the second column). The
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prediction performance of England for the other time points are similar to that of
Finland.
4.6.3 France

















































Figure 4.8: Forecasts of ILI cases during the pandemic H1N1 in France.
Features in this figure are as in figure 4.6.
The prediction range for the first panel was as ambiguous as that in Finland because
no data were available by the beginning of June 2009, and so the sole information
was that pooled from the countries with available data. In the last panel, as the
data available to the end of August are not consistent with the sudden rise that
accompanied September, the forecast, though it fits the data until the end of August
well, does not predict the data well thereafter. It is not likely that this is due to
reporting biases as the surveillance data from France is considered robust (Sentinelles,
2012), and the rise may be due changes not present in the model, such as the end
of the long August holidays in France and the return of children to school (Merler,
Ajelli, Pugliese, & Ferguson, 2011).
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4.6.4 New York












































































































































































































































Figure 4.9: Forecasts of pandemic H1N1 confirmed deaths (cumulative),
H1N1 hospitalizations and ILI cases in New York.
Features in this figure are as in figure 4.6. There is no grey bar at the bottom of each
panel because New York started off with the mitigation phase (Nicoll & Coulombier,
2009).
New York provided a very informative dataset. By the beginning of July 2009, the
available data were already sufficient to show that the pandemic was coming to an
end. The trajectories for the three data types for New York were reliable and precise,
with little noise. But we can still see a change in direction of the number of reported
ILI cases after 1 August 2009 which should not be due to the change in pandemic
phase. A possible reason for this mild increase in the number of reported ILI cases
could be due to the other influenza viruses that were also circulating in New York.
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4.6.5 Japan
















































































































































Figure 4.10: Forecasts of ILI cases and pandemic H1N1 confirmed cases in
Japan.
Features in this figure are as in figure 4.6.
Japan also shows a small peak before mitigation and another major peak after the
phase change in both available datasets. This resulted in a prediction that is not
able to capture the major peak when we are at the second time point. However, by
the third time point, the benefit of synthesizing evidence from multiple data type is
demonstrated. Because the number of confirmed H1N1 cases which has yet to show
an end to the pandemic, the trajectory of the pandemic was projected to peak at
September. By 1 September 2009, the available data shows the epidemic was still
growing but the hierarchical model provided information that the numbers should be
decreasing after that. An interesting fact for Japan is while the number of H1N1 cases
decreases starting from September, the number of reported ILI actually continued
to increase. This may also be due to the circulation of other influenza viruses, as
ILI is a syndrome caused by both influenza and non-influenza respiratory pathogens
(Babcock, Merz, & Fraser, 2006).
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4.6.6 Republic of China, Taiwan
















































































































Figure 4.11: Forecasts of pandemic H1N1 hospitalised and confirmed cases
in Taiwan.
Features in this figure are as in figure 4.6.
The spread of H1N1 in Taiwan started quite late and there was only one data point
by 1 July 2009. This would be an example of how a country could benefit from the
hierarchical model without even a single data point being collected. Despite the bad
prediction of the magnitude of confirmed H1N1 cases, due to θZ(c) being independent
between territories, the shape of the projection of the number of confirmed H1N1 cases
was appropriate. Another advantage of modelling θV (c) hierarchically is being able to
provide us with constructive projections for the number of hospitalised H1N1 cases
in the first and second time point by pooling information from the other countries.
By the third time point, the peak was not predicted at the right time using the
limited data that is available by 1 August. By the fourth time point, there was
sufficient information which resulted in a befitting shape for both type of data. The
sudden jump in the number of hospitalised H1N1 cases in September could not be
accommodated by the epidemic model used. It is not clear whether this is due to a
change in the hospitalisation rate or due to a change in the virulence of the pathogen.
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4.6.7 Singapore





















































































































































































Figure 4.12: Forecasts of pandemic H1N1 confirmed deaths (cumulative),
ILI cases and H1N1 confirmed cases in Singapore.
Features in this figure are as in figure 4.6.
Because the proportion of H1N1 confirmed deaths, θD, was treated as being constant
across territories, the cumulative number of H1N1 confirmed deaths was modelled
fairly well, even before there were available data on the mortality rate in the first two
time points. In the first column, the shape for the number of outpatient ILI and H1N1
cases was appropriate due to the common removal rate, α, and the hierarchically
modelled R0, but the magnitudes of these two projections were not consistent with
the subsequently observed data due to the independence of proportionality constants,
θW (c) and θZ(c) between countries and the paucity of data to estimate those for
Singapore at that time. Similarly, by 1 August 2009, the number of outpatient ILI
and H1N1 cases were still increasing, the model forecast an imminent decline by
borrowing information from other countries. However it was not able to predict
the sharpness of the decline observable in the data. By 1 September 2009, the
predictions for the number of outpatient ILI and H1N1 cases did not capture the
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observed patterns in the data, which may result from the two datasets not being
in synchrony. One possible explanation for this is that the outpatient ILI data was
collected by a small network of 23 Singapore GPs and so may be unreliable, while the
testing regime may have changed over time, leading to inconsistencies in the number
of confirmed cases.
4.6.8 Brazil, Peru and Bolivia




























































































































































Figure 4.13: Forecasts of pandemic H1N1 confirmed cases in Brazil, Peru
and Bolivia.
Features in this figure are as in figure 4.6.
These three countries in the southern hemisphere depicted similar patterns. When
there is no information yet available for analysis, the prediction is wide reflecting the
uncertainties in how the pandemic will evolve. If there is only an upward trajectory
at the second time point, the model will predict that the pandemic will be severe
in these countries. By 1 August 2009, only Bolivia’s data showed an end to the
outbreak and the model was able to model the shape of the trajectory well. With the
almost complete data for analysis in the fourth time point, the projection became
93
Chapter 4 Hierarchical Model of 2009 Pandemic H1N1 Transmission
very reliable.
4.6.9 Australia























































































































































Figure 4.14: Forecasts of ILI cases and pandemic H1N1 confirmed cases in
Australia.
Features in this figure are as in figure 4.6.
The first four data points for reported ILI for Australia provide a misleading impres-
sion that the pandemic had already peaked in early May, affecting the forecasts as
a result. It is not clear whether this problem might have been caused by anomalous
data collection methods or just stochasticity. Similarly, the shape of the ILI data for
Australia do not follow the standard epidemic curve, which resembles a Gaussian,
and it is not clear whether this is due to changes in data collection protocols, the
merging of data from different outbreaks across this large country, or some other
reason. Regardless of the reason, the sudden rise in the number of reported ILI in
July and August caused a poor fit for the second time point. If a consistent protocol
were available that stratified data spatially, this problem might have been averted.
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4.6.10 Chile


















































































































Figure 4.15: Forecasts of ILI cases and pandemic H1N1 confirmed cases in
Chile.
Features in this figure are as in figure 4.6.
By 1 June 2009, the prediction was considerably good with evidence from two data
points in number of H1N1 cases. The outbreak can be concluded by 1 August 2009
but the uncertainty in prediction was larger for the reported ILI than that of the
number of H1N1 cases. The predicted trajectory ‘tried’ to accommodate the number
of H1N1 cases more than the ILI data because there are more data points than the
number of reported ILI.
4.6.11 Argentina

















































Figure 4.16: Forecasts of ILI cases and pandemic H1N1 confirmed cases in
Argentina.
Features in this figure are as in figure 4.6.
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Forecasts for Argentina suffer similar problems to most other Latin American coun-
tries, in that the H1N1 cases are predicted to grow rapidly at the second time point,
and the model fits well only at the end of the epidemic.
4.6.12 New Zealand


















































































































Figure 4.17: Forecasts of ILI cases and pandemic H1N1 confirmed cases in
New Zealand.
Features in this figure are as in figure 4.6.
Similar to Australia, the number of reported ILI cases of New Zealand showed a
minor dip at the end of May, which might have misguided the model to think that
the pandemic started early and will be ending soon in the first time point analysis.
In the later time points’ analysis, it was shown that with sufficient data, the model
fits the rest of the data well.
Other than predicting the number of cases, hospitalisations and confirmed deaths,
have good, early severity estimates is essential when rolling out suitable changes to the
intervention strategies against the pandemic. These severity estimates are described
in the next subsection.
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Figure 4.18: Severity estimate of Case Hospitalization Ratio (CHR).
These are the real-time estimates if such a network had been established in 2009
for countries where hospitalised H1N1 cases are available. Dots represent posterior
medians and lines 95% equal-tailed credible intervals. CHR is the number of hospi-
talizations due to H1N1 over the estimated total H1N1 cases which is represented by
θV (c) in the model for the ith country.
The Case-Hospitalisation Ratio (CHR) is the ratio of the number of hospitalised
H1N1 cases, Vc(t), to the total number of individuals infected with H1N1, Ic(t).
Since the mean of Vc(t) is θV (c)Ic(t), CHR is represented by θV (c). Estimates are
available for three locations: England, New York and Taiwan.
The assessment of the CHR for England and New York are similar. At the last
time point, median estimate of CHR for England was 0.000219, or approximately
one hospitalised H1N1 case for every 5 000 H1N1 cases. For New York, the CHR was
0.000143, or one hospitalised H1N1 case for nearly every 7 000 H1N1 cases.
For Taiwan, wide credible intervals were found for the first two time points, due
to data scarcity then. However, for all three territories, the estimate of CHR would
have been precise by 1 August 2009.
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Figure 4.19: Severity estimate of Hospital Fatality Ratio (HFR).
Features in this figure are as in figure 4.18.
The Hospitalisation Fatality Ratio (HFR) is the ratio of the estimated cumulated
number of confirmed deaths due to H1N1 to the estimated daily cumulated number
of hospitalization H1N1 cases. The cumulative H1N1 confirmed deaths is estimated
by the ODE solution of R(t) using posterior samples of R0(c) and α with the pro-
portionality parameter, θD. The hospitalised H1N1 cases are found from the ODE
solution of I(t) and the proportionality parameter, θV (c) and the cumulated values
form the denominator.
By the last time point, the median HFR estimates for England and New York
are 0.165 and 0.235 respectively. These estimates can be understood as having a
confirmed death for approximately every 6 and 4 hospitalised H1N1 cases for the two
countries respectively.
In the earlier explanation for CHR, there was only about 1 hospitalised H1N1
case for every 7000 H1N1 cases in New York, which might possibly mean that only
patients with severe conditions were admitted. This could have indirectly caused a
much larger HFR for New York as compared to England.
98
4.6 Results and Inference




















Figure 4.20: Severity estimate of Case Fatality Ratio (CFR).
Features in this figure are as in figure 4.18.
The real-time estimate of Case Fatality Ratio (CFR) is the cumulative number of
confirmed deaths over the cumulative number of H1N1 infections. Because the mor-
tality proportion, θD, was constant for all countries/territories, the severity estimate
of CFR is expected to be similar across England, New York and Singapore (we will
only present the estimates for Singapore in figure 4.20). At the last time point, the
median estimate of CFR for all three territories was 0.000033. This corresponds to
a fatal H1N1 case for approximately every 30 000 H1N1 cases.
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Figure 4.21: Basic reproduction number, R0(c).
Features in this figure are as in figure 4.18. Every country can benefit from this
estimate as the model is formulated to synthesize evidence for the actual number of
H1N1 Ic(t), as well as the actual number of removed H1N1 cases Rc(t).
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Let us focus on the R0 estimates (which represent the expected number of infections
caused by a single infected individual during his or her infectious period) for two
cities, New York and Singapore. New York exhibited a complete wave of the pandemic
within the shortest time. Their estimate for R0 was precise at around 1.25 for all
four time points considered.
In contrast, in Singapore, where there were absolutely no information at the first
time point, the R0 estimate was to be pooled from the other countries, which resulted
in an unduly wide credible interval from 1.08 to 1.51. However, when there were data
available at the next time point, the uncertainty reduced substantially.
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Figure 4.22: Severity estimate of Final Attack Rate (FAR).
Features in this figure are as in figure 4.18. The values were computed by dividing
the predicted number of individuals in the removed epidemic class at the end of 2009
by the total population size.
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Most of the countries have showed that approximately 30% of the people will have
been infected by H1N1 by the end of 2009. We would like to draw the attention of
this figure to England and New Zealand where the initial FAR was predicted to be
higher at 0.398 and 0.358 and dropped to 0.299 and 0.218 at the last time point. The
first figures result from the time points when there were limited data available and
projections were over-predicted (Figure 4.7 and 4.17)
The higher peak in figure 4.7 for England may be due to the inaccurate propor-
tionality estimate but it was shown in figure 4.18 that θV (c) estimates for England
were similar across the four time points. Thus, a higher peak in figure 4.7 can be
translated to more predicted infections which led to a higher forecast FAR.
In figure 4.17 for New Zealand, not only is the peak of H1N1 cases larger in the
first time point than the other time points, the pandemic was also estimated to have
started on the 26 Jan 2009 based on the posterior sample of t0(c) for New Zealand.
If the prediction for New Zealand had started early, if would have also accumulated
more removed individuals Rc(t) by the end of 2009, resulting in a larger FAR.
By 1 August 2009, our model is able to estimate the median FAR of Singapore
to be 0.191, which is comparable to the results of FAR for all adults by Lee et al.
(2011) which they based on four different methods. This further suggests that our
model is promising in providing appropriate estimations for this H1N1 pandemic.
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Figure 4.23: Comparison of the estimated final attack rates for pandemic
H1N1 for each country or territory considered by the end of 2009 with
the estimate by van Kerkhove et al. (2013).
Van Kerkhove et al. (2013) used a meta-analysis of seroepidemiological studies,
which provide a proxy for the proportion infected and the result is represented by
the grey diamond. Dots represent posterior medians and lines 95% equal tailed cred-
ible intervals. The black diamond represents the pooled estimate from all countries
considered.




where x¯ and s are the sample mean and sample standard deviation of the posterior
medians from the 14 countries. Figure 4.23 demonstrates that our results (using data
up to 1 September 2009) coincide with the result from the seroepidemiological studies
by van Kerkhove et al. (2013), which could only be realised at the end of pandemic
by testing the population subset (52 479 sera samples from 27 published/unpublished
serological studies from 19 countries/territories) for seropositivity.
104
4.7 Considerations for Surveillance Network




























Figure 4.24: Estimated number of confirmed deaths worldwide by the end
of 2009.
Dots represent posterior medians and lines 95% equal-tailed credible intervals. The
estimated number of confirmed deaths worldwide is computed by multiplying the
world population (6.8 billion) by θD and the proportion in the removed state by the
end of 2009.
It is rewarding to see that the median estimated number of confirmed death by the end
of 2009 in the fourth time point is 181 300 (95% credible interval 87 200 to 271 900) is
comparable with the result found by Dawood et al. (2012) who concluded that the
estimated global confirmed deaths should amount to 201 200 (95% confidence interval
151 700 to 575 400). (Contrast to the number of laboratory-confirmed confirmed
deaths in 2009: 18 500.) Our forecast for the number of confirmed deaths worldwide
are comparable to those of Dawood et al. (2012) even if only the data available by
the end of June are used.
4.7 Considerations for Surveillance Network
In summary, although our model does not characterise all the epidemiological quirks
of each country’s data perfectly, our global estimates of attack rates and various
severity measures are accurate by the end of June 2009, a time in which Singapore (as
with many other countries) had seen just the beginning of community transmission
and there remained great uncertainty about how severe the pandemic would be and
what interventions to use. Our model succeeds in this regard by using a Bayesian
hierarchical model for a simple epidemic model (the SIR model) and synthesizing
information from various types of data that subsequently became available. Had
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they been available in real time, the impact of the pandemic control measures on
society and the economy might have been much less.
We believe that a network of surveillance data streams from a group of partic-
ipating countries would be invaluable to provide information on future pandemic
outbreaks. However, there may be some issues for considerations before this sys-
tem can be put up. Wrong or inappropriate data collection would lead to mistaken
conclusions, possibly resulting in inappropriate policies being implemented. It was
mentioned by Chao et al. (2011) that there was transmission of H1N1 in other parts
of the world before the confirmed case in Mexico, and so there is a real need for
the network of different countries to contribute surveillance data continuously rather
than merely reactively, so that any spread could be detected as early as possible.
The pandemic occurred in the Summer in the northern hemisphere, when when most
influenza surveillance programmes are on pause (they tend to run only during the
Winter months), and to have detected it early— and to have had information on its
severity—would require the data collection system to be in place year-round.
Currently, the numbers of cases reported from each country are based on their own
authorities’ criteria. Differences between countries’ criteria may affect the accuracy of
our model estimate and limit comparisons between countries. Hence, ideally criteria
should be standardised for all countries involved in the surveillance network to follow
in determining the classification of individuals and the coverage of each data stream
(for instance, the proportion of clinics that contribute within each territory should
be known and indicated in the network portal). This would ensure that the reported
number of cases can be compared appropriately, in contrast to the ad hoc approach
we were forced to use in extracting information from each country’s studies.
On top of this, the surveillance network should be validated on routine outbreaks,
such as seasonal influenza, before being used in a pandemic outbreak. Other than the
department that is responsible for collecting the data, another team could be set up
alongside with the involved organizations in each country at different times to collect
the data at the same time. A comparison between the data collected from both units
can be done and timely feedback could be given to the original data collection team
for improvement. This could ensure consistency if the same team is used to validate
the data collection from all the countries.
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The most feasible way to set up the network would be a confederation of perhaps
20 cities located in as many continents as possible, with a convenient and straight-
forward online portal for data submission and consistent protocols for data collection
and entry. This can boost the cooperation of the different organizations to share
data for the network without affecting their daily work routine. We also foresee a
great reduction in the time delay from data collection to data entry, permmitting
more time for analysis and incorporation within policy.
With a convenient data submission procedure, there would also be security and
confidential issues for consideration. We would need to keep the data secure to
encourage participation from all the countries and healthcare organizations. Fur-
thermore, in our model, we only need the daily or weekly number of cases from each
organization, not data on individual cases to reduce the risk of breaking confidential-
ity and also ease the management of these large scale data, though such data would
be valuable for analysis of clinical features.
Other than the confidentiality concerns, we should also be concerned about the
ethical issues of data collection. The main objective should always be treating the
patients and the questions or tests for classifying the patients into the various types
should not be done at the expense of the patients’ health condition or financing.
Although we believe that this proposed idea of a worldwide network of surveil-
lance, we would still need the mutual effort of all participating countries and organi-
zations to contribute to this data base. These collected data would belong to all the
countries, hence each country and organization involved in this program should also
be given easy access to the stored data. This will greatly encourage more countries’
voluntary involvement to get access to real time data for their own research purposes.
While giving access to use the collated data, there arises a problem of ownership
for all the data and who should be the provider of this network to hold the responsi-
bility of managing the network. In our opinion, the best candidate for organizing this
network would be the WHO, which has the relevant sophisticated technology and also
the experience to lead all the participating countries in this long term surveillance
project.
United in Tackling Epidemic Dengue (UNITEDengue) is an example of such long
term surveillance network which shares dengue surveillance information between their
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members (restricted to institution only), including Singapore, Malaysia and Indonesia
(Unitedengue, 2014). Another transnational collaboration in the European Union
(EU) is the European Centre for Disease Prevention and Control (ECDC) (ECDC,
2014). They will collect and share infectious diseases data between coordinating
competent bodies, for example POLYMOD study for new and re-emerging epidemics
(Mossong et al., 2008).
4.8 Future Work
With the above considerations for the surveillance network, the model described in
this chapter can be used to fit real time data to predict any potential pandemic
outbreak. However, future work can be done to improve the model against various
assumptions used here.
It was shown by Rhim et al. (2012) that 94% of all the H1N1 cases, from a
study conducted in one of the South Korea hospitals during the pandemic, were
children and young adults, younger than 40 years old. Similar results have been
found elsewhere, for instance in Singapore (Lee et al., 2011). Older people might
have a lower risk because of prior exposure to previous pandemics which resulted in
pre-existing immunity that are not detectable by cross-reactive antibodies (Dudareva
et al., 2011).
If the assumption of homogeneous population were relaxed, the rate of infection
should be set for each individual j in country c as
βcj = βcφj , (4.85)
where each individual can be differentiated by another risk score parameter φj which
informs whether the individual j is more easily infected by φj > 1. Without this ho-
mogeneity constraint, an enormous number of parameters would need to be explored.
Moreover, the ODE structure will not hold if each individual is allowed for different
risk. Instead, we might simulate this parameter from a log normal distribution,





This distribution will guarantee a positive risk score, φj , that will either increase
the rate of infection for individual j if φj > 1 or decrease the rate of infection for
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individual j if φj < 1. There will be no difference in the infection rate if all the φj
are equal to 1 when σ2 = 0. As such, the estimated risk of the whole population will
be βc
∑
φj . From this approach, we will not be able to tell how the rate of infection
will differ from each of the different groups of individuals, but we will be able to tell
the discrepancy in the rate of infection across individuals by σ2. Larger σ2 implies
more inconsistency in the rate of infection.
One alternative solution would be to use an age-structured model, rather than
one model for the whole population or one rate per individual, with the application
of different rates for each groups of people. However the absence of good age-specific
data in many locations prohibit this approach, which would result in a substantial
increase in the number of parameters to be explored but little additional information
to do so. However, this would only be possible if the surveillance network is able to
collect these relevant age-specific data to model it, and if data on contacts between
people of different ages could be collected for more than the handful of high-income
countries that have done so so far (Mossong et al., 2008).
Future work could also involve the exploration of the proportion of people within
each country with immunity to counteract the weak assumption for initial susceptible
proportion, s(0) = 1. This would require a substantial amount of laboratory tests
to be conducted in these countries to estimate the required proportions before any
pandemic outbreak. Better inference could be made if an appropriate initial number
of susceptibles were used. But, we can foresee more technical challenges for solving the
ODE as each country would have a different initial condition and separate calculation
of ODE solutions is required for each country.
4.9 Conclusion
The results described in this chapter provide an enticing view of the use of hier-
archical modelling for emerging infectious disease outbreaks. Not only can we pool
information from countries with no or limited data, accurate severity estimates could
have been achieved much earlier than was actually the case.
We have also showed how different data types can be integrated together by
Bayesian evidence synthesis to capture the evolution of the spread of H1N1 in 2009.
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Although MCMC proved difficult to converge due to the high dimensional parame-
ter space, we have successfully incorporated the sequential importance sampling to
estimate parameters, pandemic trajectory predictions and severity estimates.
The predicted trajectory for the various data type of all countries in our basket
were also preferable after including the numerous factors, like the delay in trajectory
for country i since the 1 Jan 2009, t0(c), and the latent period between the occurrence
of the first confirmed death and the first removal event, δ. These estimated results
compared well with those by other research teams, using other data, in particular the
FAR (Lee et al., 2011) and the estimated worldwide confirmed death due to H1N1
(Dawood et al., 2012).
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Bayesian Optimal Design of
Seroepidemiological Studies
5.1 Introduction
Seroepidemiological studies are important for judging population immunity to
various infectious diseases based on factors like age. Time and money are needed
to acquire and test sera from individuals and, as a result, studies should be de-
signed efficiently: specifically to provide the maximum information within any fixed
budget. Straight-forward or naïve designs may be inferior if sera are collected from
unnecessary population groups. For instance, for a childhood disease with near 100%
prevalence by age a, sampling additional children aged a+ 1 yields little useful infor-
mation. The objective of this chapter, therefore, is to demonstrate how to find the
best designed sample characteristics to estimate prevalence in different groups in the
population.
We apply the methodology to design studies to estimate the age-specific preva-
lence of Enterovirus 71 (EV71), making use of similar studies in other settings using
Bayesian hierarchical modelling and assuming the new study’s setting is exchange-
able with past studies’. This is achievable for this virus because many such serological
studies have been carried out in Singapore (Ooi, Phoon, Ishak, & Chan, 2002; Ang
et al., 2011) and other countries from East and South East Asia in which EV71 is
a topical public health issue, including China (Yu et al., 2011; Zeng et al., 2012),
Taiwan (Lu et al., 2002) and Vietnam (Tran et al., 2011).
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EV71 is one of the main viruses capable of causing Hand, Foot, and Mouth Disease
(HFMD), mostly affecting in children (Shih et al., 2004). The endemic caused by this
virus is predominant in children below 5 years old (Ang et al., 2011) and as a result,
most existing serological studies on EV71 have concentrated on young age groups.
Most seroepidemiological studies have collected purportedly ‘random’ samples
from healthy individuals without specifying the sampling strategy (Yu et al., 2011;
Lu et al., 2002; Tran et al., 2011). Only Zeng et al. (2012) sampled according to the
age distribution of Shanghai and Ang et al. (2011) determined the sample size based
on the estimated prevalence. None designed an optimal experiment.
Hierarchical models can be built on these data, collected from different countries
at different years. So doing facilitates the search for an optimal design as it pools
information from these different sources to represent better how the disease will affect
the population in the upcoming studies (Chaloner & Verdinelli, 1995). Inferring a
hyper-prior distribution for the parameters governing incidence/prevalence allows
the resulting information to be fed into a Bayesian optimal design framework whose
objective is to select the number of individuals in different demographic segments
to maximise the precision in the estimates of the parameters in the future study
(Atkinson, Donev, & Tobias, 2007). A well designed study, that in the context
of estimating age-prevalence samples some age groups disproportionately, will allow
more information to be obtained for the same cost, or the same amount of information
at lower cost. In a previous study of the spatio-temporal spread of plant disease by
Cook et al. (2007), 25% of the original observations can yield the same information
content as a more intensively observed population, if they were arranged carefully.
Although these optimal design methods are explored in other areas, especially in
engineering (Hollister, Maddox, & Taboas, 2002), it requires considerable adaptation
to make them work in the non-linear problems anticipated in seroepidemiology.
Serological studies are very expensive. The sequential serological study of about
2900 individuals from four different groups of people—namely the general population,
military personnel, staff from an acute care hospital, as well as residents and staff
from long-term care facilities—carried out during the 2009 influenza pandemic cost
around S$1.1 million to conduct (Mark I-Cheng Chen, personal correspondence).
At such costs, if the experimental study designs can be more efficient in providing
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more information per dollar spent, potentially the saving could be large. Even though
optimal design methods would need to be applied differently for each virus under
study, we predict that researchers will be able to adapt our methodology to their
pathogen and obtain the optimal design that is appropriate to the illness that they
are interested in.
5.2 Data from Past Studies on EV71
Data were extracted from previous serological studies performed in Singapore
(Ooi et al., 2002; Ang et al., 2011), the People’s Republic of China (Lu’an City (Yu
et al., 2011) and Shanghai (Zeng et al., 2012)), the Republic of China (i.e. Taiwan)
(Lu et al., 2002), and Viet Nam (Tran et al., 2011). They are collated from tables,
text or figures found in these journal articles. Due to the irregular structure of
the data, we standardised them before analysis. Since EV71 is dominant in young
children, we limited attention to data corresponding to children up to the age of 12.
As there may be carried over maternal immunity in newborns (Ooi et al., 2002), we
also limit attention to sera collected from children at least one year old.
Singapore: In the 1997 Singapore study, convenience sampling was done at a
paediatric clinic in the National University Hospital (NUH) (Ooi et al., 2002), among
healthy individuals aged below 12 who were attending regular visits to the clinic for
vaccination for which they gave a blood sample, residual sera of which was then used
in the study. A consequence of the study design is that it may result in a biased
sample as those who visit the NUH clinic may not be a good representation of the
whole population.
Subsequently, in 2008 to 2010, Singapore’s Ministry of Health administered a
serology study which acquired samples from 1200 individuals aged below 17 who
were at KK Women’s and Children’s Hospital and NUH for inpatient services or day
surgery but not concurrently diagnosed with HFMD (Ang et al., 2011). Based on an
estimated prevalence of 33%, they targeted a minimum of 340 sample size for each
age group (1–6, 7–12, and 13–17 years) (Ang et al., 2011). The minimum sample






Note that this was the minimum sample size to obtain a specified accuracy without
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the smoothing of a model to borrow strength from nearby ages, and is not directly
optimising the design. Furthermore, due to the use of residual sera, there remains
the risk of unrepresentativeness.
People’s Republic of China: Before the large EV71 epidemic outbreak in
China in 2008, Yu et al. (2011) had collected 472 ‘random’ serum samples from
children below 15 years who stayed in Lu’an City and had no symptoms of HFMD.
The number of samples were equally distributed across each age group (<1, 1, 2–4,
5–7, 8–11, and 12–15 years). Using the same sample size for all age group may result
in unnecessary, or insufficient, sampling in certain age groups. After the outbreak,
83 additional serum samples were collected from healthy children below 15 years (Yu
et al., 2011). For this, the sampling method was not mentioned in the paper and the
sample sizes were no longer uniformly allocated across each age group.
Zeng et al (2011) was the only one amongst the past studies we identified to sample
according to the age distribution of the target population (Shanghai). This stratified
sampling design using proportional allocation is simple to apply and yet useful since
it will sample more from the larger age group to get a better representation of the
whole population. However, this might lead to wastage of resources if redundant
samples were taken from a large age group. They collected a total of 614 samples
from children below 5 years during their health check at the Children’s Hospital of
Fudan University (Zeng et al., 2012). Again, the samples might be biased due to the
single location of serum collection and possibly due to a selection bias in favour of
sicker children.
Republic of China: Serum samples were collected in Taipei City, Taiwan, in
1994, 1997 and 1999, the latter to compare the prevalence before and after the major
outbreak in 1998 (Lu et al., 2002). There was no mention about how the decision
was made for the experimental design in these three years. In 1994, 202 specimens
were collected from those above 4 years whereas in 1997 the focus was on those
below 4 years, among whom a total of 245 samples were taken (Lu et al., 2002).
Participants lived in Taipei but there was no mention if the samples were collected
during a routine health check or during a visit to the physician, for instance, due to
illness (Lu et al., 2002). Additional effort to guard against biased sampling was made
in 1999 by extending sampling to 1 258 participants from the city as well as nearby
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non-urban areas (Lu et al., 2002).
Viet Nam: 794 samples were collected from the Hung Vuong Obstetric Hospital,
Ho Chi Minh City, in 2007 (Tran et al., 2011). Again, there was no indication of how
the design was set up and it may be convenience sampling from those who visited
the hospital amounting to almost equal sample sizes in the three age groups.
As the age intervals of the samples vary across datasets, we represent the intervals
by their respective start and end age in months. The unit is chosen to be months
and not years because some datasets had age gaps in months, and so no information
would be lost in this representation.
5.3 Hierarchical modelling of past studies
Leveraging on past experimental studies, we fit a hierarchical model to those
data discussed in the previous section. Here, we use a discrete time survival analysis
approach to transform the data into information that will later be used to design an
optimal experiment using Bayesian decision theory.
T is defined as the age when an individual gets infected. In a continuous survival
analysis, the hazard function, h (t), is the instantaneous rate at which failure (here,
infection) occurs at time t. In our discrete time version, h (t) takes the form of a
probability of infection within the 1-year interval starting at integer time t (where
data are in fractions of a year, the hazard is assumed to be constant throughout the
year, see later for details) conditional on non-infection to time t−1 (Singer & Willett,
1993), i.e.
ht = Pr(T = t|T > t− 1). (5.2)
The infection risks are allowed to vary non-parametrically from one year to another,
from one country to another. Since ht is seen as a probability, the values are restricted
to 0 ≤ ht ≤ 1.
A negative serology test implies that infection has not occurred for this individ-
ual by age i. The survival function, S (t), is the probability of surviving (i.e. not
experiencing the event) to time t. In the discrete case, St is the probability of not
being infected by age t. By the conditional probability relationship, St can be related
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to the hazard rate by
St = Pr(T > t) (5.3)
= Pr(T > t|T > t− 1) Pr(T > t− 1) (5.4)
= (1− Pr(T = t|T > t− 1)) Pr(T > t− 1) (5.5)
= (1− ht)St−1. (5.6)
Iterating, the relationship between the survival function and hazard rate for a




(1− hj) . (5.7)
Intuitively, survival to age t means not having been infected at any age before t,
implying that the survival probability up to age t is the product of all the (1− hj)
up to age t−1, where (1− hj) represents the probability of not being infected at age
j.
The density (technically, mass) for the random variable T , represented by ft, is
the probability of an individual being infected at age t,
ft = Pr(T = t) (5.8)





(1− hj) . (5.11)
Our data include the number of positive samples for individuals from age t to
t+ 1 as x(t,t+1) and the total number of samples contributed by the individuals from
age t to t+1 as n(t,t+1). We will model x(t,t+1) as a binomial distribution with n(t,t+1)
trials and the probability of success as the probability of being identified as infected






This may be appropriate if the number of individuals in the sample is small
relative to the population as a whole, so that the effects of non-independence can be
ignored. Being identified as infected at age t implies that the individual was infected
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in age t or before, so pt is represented by ft as follows:
p0 = h0
= f0 (5.13)
p1 = (1− h0)h1 + h0
= f1 + f0 (5.14)
pt = (1− h0) . . . (1− ht−1)ht + . . .+ (1− h0)h1 + h0
= ft + . . .+ f0. (5.15)
Most data come reported to a yearly interval, but there were some cases of ir-
regular intervals. In particular, we set p(t,t+1) = pt for the small number of datasets
with an age interval of less than a year, while if the interval is more than a year, we
will take the average of the yearly probabilities of being seropositive, which assumes
equal sampling across the age range. For example, the probability of being identified
as infected in a three year age interval from 7 to 10 is p(7,10) = 13 (p7 + p8 + p9).
Different datasets have information up to different maximum ages and in addition
may lack data for some age groups within the age range. However, hazards for
gaps in the data at earlier ages provide information at later ages by contributing
to the density calculation ft for the later age groups t. In addition, by taking a
hierarchical approach (using MCMC to sample the resulting parameter space) the
inference routine will pool information across different countries to fill the gaps for
countries with missing data for those countries.
Due to the condition of 0 ≤ htj ≤ 1 for hazard rate of age t in dataset j, the logit
transformation of htj ,
logit(htj) = log
htj
1− htj , (5.16)
will lead to parameters with support on the real line. This allows a multivariate
normal hyper-distribution for logit(hj) where hj = (h0j , h1j , . . . , htj) will be governed
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where σkl = ρk,lσkσl and σkl = σlk.
As there is no prior knowledge for the hyper-parameters, non-informative hyper-
prior distributions are used. Since µk can be any real numbers, a normal distribution







Since the standard deviation should be positive, hyper-prior for σk is assigned an
exponential distribution,
σk ∼ Exp (1) (5.19)
where a larger hyper-parameter σk will indicate a more differences in the hazard rate
parameter between countries. Similarly, the correlation hyper-parameters ρk,l govern
the relationship between the parameters hk and hl. If they are positively correlated,
0 < ρk,l < 1; if they are negatively correlated, −1 < ρk,l < 0. A flat hyper-prior is
used on all the correlation hyper-parameter,
ρk,l ∼ U (−1, 1) . (5.20)
With the above model, we employ a Metropolis-Hastings algorithm with MCMC
methodology to explore the parameters and hyper-parameters. We discard 1% of
the sample as burn-in, select the choice of initial values to be close to the actual
posterior (see below), allowing the chains to converge quickly. Thinning is used to
reduce the correlation between subsequent stored values, by retaining only at every
10th iteration.
To make the initial values of the parameters suitable, we take a point estimate of







where the number of positive samples in the interval is di, the length of the interval,
li, and the total number of samples is ni−1.
Having selected the initial values for the parameters, we take the following steps
in the MCMC routine:
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, calculate the log likeli-



















, for subsequent use.
a) The log likelihood density is calculated using the built-in binomial dis-
tribution function, dbinom, in R, where the data for country j, Dj , will
include the number of trials, n(i,i+1), and the actual number of infected,
x(i,i+1), and the probability of being infected in age i, f(i,i+1), using the









b) The log prior density is calculated using the multivariate normal distri-
bution function, dmvnorm, from the mvtnorm package in R. Using the
hyper-parameters, µ0, as the mean vector, we also calculate the covari-




as stated in the
model earlier. The covariance matrix is singular if there are non-positive
eigenvalues, in which case we let the log prior density be −999 999, an
arbitrary negative number which approximates 0 on exponentiation. The
hazard parameter is logit transformed before calculating the prior density.
c) The log hyper-prior density is calculated as normal distributions for µ0,
exponential distributions for σ0 and uniform distributions for ρ0 using
the build-in distribution function in R.
d) The pseudo log posterior density (ignoring a constant) is computed by
summing the three log densities. Note that posterior density is only pro-
portional to the product of the three densities,
f(h0j ,µ
0,σ0,ρ0|Dj) ∝ f(Dj |h0j ,µ0,σ0,ρ0) ·
f(h0j |µ0,σ0,ρ0) · f(µ0,σ0,ρ0). (5.22)
The proportionality constant that leads to the actual posterior density is
not available but cancels in the step of calculating the acceptance proba-
bility.
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2. Propose new hazard parameter values, h∗j , for country j from a multivariate
normal distribution with mean h0j . In pilot runs, the covariance matrix of
the proposal distribution is initially a diagonal matrix, since the correlation of
hazard rates across ages is unknown. This covariance matrix will be improved
in subsequent rounds by the information from the posterior samples of previous,
pilot rounds, leading to better proposals in the later rounds as the covariance
matrix becomes a better representation of the actual posterior distribution of
the hazard rates. After proposing changes, the legality of the move is assessed
(i.e. that 0 < h∗j < 1) and the proposal is rejected if the condition is not
fulfilled. A multivariate normal proposal distribution is preferred due to its
symmetrical property, in the Metropolis- Hastings algorithm, the acceptance











f(Dj |h∗j ,µ0,σ0,ρ0) · f(h∗j |µ0,σ0,ρ0)
f(Dj |h0j ,µ0,σ0,ρ0) · f(h0j |µ0,σ0,ρ0)
)
. (5.24)
With probability Pacc, the proposed h∗j will be accepted and updated as h1j ,
otherwise, the proposal is rejected and we let h1j = h0j . This step will be
repeated for each dataset sequentially.
3. After updating all the hazard rates, we propose the hyper-parameters
(µ∗,σ∗,ρ∗) using independent normal proposal distributions with arbitrary
initial standard deviations for all the hyper-parameters. Proposed values should
satisfy σ∗ > 0 and −1 < ρ∗ < 1, and are otherwise rejected. The acceptance















This does not involve recalculating the likelihood and hence is computationally
efficient, so the hyper-parameters are updated 50 times for every round of
proposal for the hazard parameters.
4. Step 2 and 3 will be repeated 10 000 times and the covariance matrix and
standard deviations of posterior samples will be used in subsequent proposal
distributions.
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5. The improvement of proposal distribution will be done for 10 rounds. The final
round, with Markov chains that have apparently converged to the posterior dis-
tribution, is used to create samples of all the parameters and hyper-parameters,
which are stored for the second stage of the analysis—designing a future study
efficiently.
5.4 Optimal design of a future serological study
Instinctively, more information can be obtained as more samples are collected.
However, as the number of serological tests varies proportionally with the study
cost, and there is always a limit to the amount of money that can be spent on a
single epidemiological study (experiment), suggesting only a fixed total number of
serological tests can be performed. Naturally, a design for the experiment that gives
the most information using a fixed expense is preferred to one giving less.
Atkinson (2001) argues that, in this context, we should fix the total number of
serological tests while optimising over the characteristics of each participant to be
tested. Treating each age as a cluster, in Atkinson’s terminology, ni represents the
number of serological test needed for individuals of age i, which is subject to the
restriction on the total number of tests, n = ∑
i
ni. (This assumes no difference
in the cost for sampling in different age groups, which allows us to focus on the
number in each cluster rather than the cost). In this stage of the analysis, we will
explore different possible combinations of (n0, n1, . . . , n11), i.e. up to age 12, with
the condition that they should sum up to a certain sample size.
Optimal designs are dependent on the precise choice of model (Rasch, Pilz, Ver-
dooren, & Gebhardt, 2011). Later in this chapter, we show that the hierarchical
model described earlier gives a good characterisation of EV71 prevalence for coun-
tries with the same characteristics as those we obtained data for.
In classical optimal design, in the situation where the optimising of the function
that forms the design criterion relies on the exact values of the (hazard, in our case)
parameters, Berger and Wong (2005) argue that point estimates of the parameters,
i.e. from an extremely informative prior distribution, should be used to find the deter-
ministic solution of the objective function, as this might more efficiently achieve the
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best optimal design. In contrast, in Bayesian optimal design (Chaloner & Verdinelli,
1995), we typically sample parameter values from an informative prior, perhaps draw-
ing on an analysis of past data, and simulate multiple datasets for each design, taking
the average of a defined utility function over repeat Monte Carlo sampling for each
point in the design space to obtain the optimal design, a more computationally in-
tensive solution (Müller, Sansó, & De Iorio, 2004). The next subsection described
classical experimental design, followed by a description of Bayesian optimal design.
5.4.1 Classical optimal design
Classical optimal design is categorised according to the objective function using so-
called alphabetic optima. According to Atkinson (2007) , A-optimality is based on
the criterion of minimizing the sum or average of all the variances of the parameter
estimates (typically MLEs). The argument is that for an optimal design to provide us
with the most information on all parameters, the resulting sampling variance should
be small, which coincides with the A-optimality criterion.
If we only required a certain parameter to be precise, Ci-optimality will choose
the best design based on the decision that can minimise the variance of parameter
i (Rasch et al., 2011). A variant is E-optimality which minimises the variance of
the parameter with the poorest precision (inverse variance) (Atkinson et al., 2007).
This has a stronger benchmark than Ci-optimality criterion since it ensures that no
particular parameters will have too much sampling error under the selected optimal
design. It does however require that parameters have a common scale to facilitate
sensible comparison.
The D-optimality criterion is the most popular classical design criterion, and
motivates the optimal design in our project. According to the General Equivalence
Theorem, the optimal design will minimise the imprecision or in other words, max-
imise the expected utility where utility is the determinant of the information matrix
(Atkinson et al., 2007). As the expected utility for the design space may not be
smooth, we will probe into different approaches for exploring an uneven design space.
The observed Fisher Information is the expectation of the negative second deriva-
tive of the log likelihood. To see why this is a sensible choice of objective function,
consider the one dimensional case, where the reciprocal of the Fisher Information is
the variance of the MLE (Efron & Htnkley, 1978), and so maximizing the determinant
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of the information matrix will minimise the uncertainty in the parameter.
5.4.2 Bayesian optimal design
Classical experimental design makes use of point estimates for the parameters but
does not account for the uncertainty in them. The Bayesian framework provides a
more natural framework to overcome this problem by allowing the design to account
for the uncertainties in the parameters using their posterior distribution.
In the Bayesian paradigm, information on the model’s parameters is encapsulated
by the prior or posterior distribution. In the context of a decision problem, the
information prior to observing the outcome is relevant. If data are available to guide
the decision, this ‘prior’ is the distribution after observing them, i.e. the posterior.
The optimal decision, D?, is that which maximises the expected utility u (or objective
function) over the uncertainty in the outcome X and in the parameters, θ (Cook,
Gibson, & Gilligan, 2008), i.e.
D? = arg max
ˆ ˆ
u(X,D)p(X|θ,D)p(θ|D)dθdX. (5.27)
In practice, typically the integration is done using Monte Carlo sampling, assuming
the prior can be sampled, along with the data conditional on the prior. In the context
of experimental design, the decision is the design (Chaloner & Verdinelli, 1995).
This approach requires defining a utility function that allows a good design
that provides substantial information to correspond to a high expected utility value
(Atkinson et al., 2007; Verdinelli & Kadane, 1992). According to Bernardo (1979),
translated to the seroepidemiological scenario, whenD is the decision of how to divide
the sample size between age groups, p(θ|D) is the reported posterior density function
of the parameters resulting from the experiment conducted under the decision D, the
utility will be a function of the reported density function and the decision, u(X,D).
We foresee that the design space will be complicated due to its high dimension-
ality, which has implications for how the design space is searched for the optimum.
The method to explore the design space will be examined in the later subsections. As
the estimated expected utility for the design space will not be smooth, we will probe
different approaches for exploring the design space that account for this imperfect
observation of the expected utility.
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In simulating the utility for one realisation, for a specific design, we use the set of
sample sizes allocated for each age group defined by the design,(n0, n1, . . . , n11), draw
hazard rates from the hyper-posterior distribution of the hierarchical model, reflecting
an assumption that the study we are designing is exchangeable with those previously
analysed, and use these to simulate the number of positive samples, (x0, x1, . . . , x11),
in each group. If the experimental data are to be analysed classically, as is frequently
the case in epidemiological research, the appropriate objective function represents
how much information will be captured in a classical analysis. To derive this, the
likelihood function (of a model, either the generating model or a simpler model used
for reporting) under this experiment can be used to compute the MLE, hˆ. The utility
function, inspired by the D-optimality criterion, is the determinant of the information



































The algorithm to maximise the expected utility over a set of designs is:









2. By assumption the logit of the hazard rates follows a multivariate normal dis-
tribution governed by hyper-parameters. We sample a set of hyper-parameters
from the hyper-posterior distributions and compute the covariance matrix.
With the mean vector, µ, and covariance matrix, Σ, simulate logit(hij) from
the multivariate normal distribution and perform an inverse logit transfor-
mation to derive the set of true hazard rates under this experiment, using
hij = 11+exp(−logit(hij)) .
3. With this set of simulated true hazard rates, the probability of having a positive
test at age i, pi, can be calculated from the hazard rates directly. The proba-
bility of having a positive test can be compared with the propensity, φ (to be
explained later) to simulate the experimental data, where φl < pi will indicates
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that individual l of age i has a positive test result. Tallying over individuals,
we will get the data of this experiment, x = (x0, x1, . . . , x11).
4. With the design, n and data, x, the MLE, hˆ, is found using a numerical method
(see later).
5. The utility value for these simulated data is the determinant of the information
matrix at the MLE.









of times (I use 100). The expected utility for this decision is the mean of the
sampled utilities.
7. Repeat step 1 to 6 for the kth decisions Dk for k = 2, 3, . . . to acquire their
respective expected utilities. The same hazard rates and propensities will be
used for all decisions to reduce unnecessary variability in the expected utili-
ties. Thenceforth, the Bayesian optimal design can be identified by maximum
expected utilities.
Here, we shall demonstrate how to calculate the utility for a given dataset. The
number of positive samples for age i , xi, follows by assumption a binomial distribu-
tion with ni number of individuals of age i at risk and pi as the probability of being









pxii (1− pi)ni−xi . (5.29)
Taking logarithms of the likelihood function and dropping the constant of pro-




(xi log pi + (ni − xi) log(1− pi)) . (5.30)
The first derivative of the log likelihood function with respect to the hazard
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Similarly, we can find the second derivative of the log likelihood function with































































− ni − xi1− pi
)
. (5.34)
We calculate the first and second derivatives of pi with respect to hj and hk as




fj and fi = hi
i−1∏
j=0
(1− hj), we let a pseudo function gi to represent
i−1∏
j=0
(1− hj) for the subsequent calculation. Then, the probability of being identified
as infected in age i is
∵ pi−1 = (1− h0) . . . (1− hi−2)hi−1 + . . .+ (1− h0)h1 + h0 (5.35)
pi = (1− h0) . . . (1− hi−1)hi + . . .+ (1− h0)h1 + h0
= gi−1hi + (1− h0) . . . (1− hi−2)hi−1 + . . .+ (1− h0)h1 + h0
= gi−1hi + pi−1. (5.36)








+ dpi−1dhj j ≤ i
gi−1 j = i
0 j > i
1 j = i = 0.
(5.37)



















j 6= k, j 6= i, k 6= i
dgi−1
dhj










k = i, j < i
dgi−1
dhk
j = i 6= 0, k < i
0 j = i = 0, j > i.
(5.38)
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This re-arrangement is beneficial because the derivative of the pseudo function gi is
simple. To elucidate this pattern, the first derivative of the function gi with respect





− gi1−hj j ≤ i
0 otherwise.
(5.39)











(1−hj)(1−hk) j 6= k, j ≤ i, k ≤ i
0 otherwise.
(5.40)
Putting all of these together, we can calculate the second derivative of the log
likelihood with respect to hj and hk. Inserting the MLE then gives the utility.
The stochasticity in the utility surface makes identification of a maximum difficult.
To remedy this, we stabilised the information content between neighbouring design
points as follows. Before starting the algorithm, we simulate hazard rates from the
hyper-posterior sample to act as the true hazard rate, storing them and reusing them
across the design space. This induces correlation between neighbouring points that
makes identification of which is greater easier, for the same reason that paired t-
tests typically have more power than two-sample t-tests. Furthermore, to reduce the
variability in the information, we use fixed propensity scores for the individuals at
each design.
A propensity score φl is associated to each individual l. The propensity scores,
uniformly distributed from 0 to 1, are compared against the computed probability
of being identified as infected at age i, pi. Since each individual at age i will test
positive with probability pi, we can let the individual l of age i be tested positive
if φl < pi and contribute to the number of positive samples x. Using the same set
of propensity score to get the simulated datasets will induce a positive correlation
between them and result in smoother utility surface, while maintaining the correct
marginal distributions of the utility at any point, more computationally efficiently
than using larger number of sets of simulated data.
Apart from the above set-up to simulate potential future data, x, the MLE of
the hazard parameters is also required. In the one dimensional case, the MLE is the
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point where the likelihood is at its highest point, as evaluated numerically e.g. with
a grid search, which is also the solution of the first derivative of likelihood function
when equated to zero. But due to the complexity of the likelihood function, it is
difficult to solve for the MLE (and more to the point, time consuming). Thus, we
have explored several approaches to find the MLE.
5.4.3 MLE search using Newton-Raphson method
The Newton-Raphson method is a numerical approach to get to MLE through a
deterministic series of iterative moves (Ypma, 1995). This method often works well
for multidimensional problems. For demonstration, consider just two age groups to
improve cognitive ease of visualization. Let the number of samples from age i be
ni = 250 where i = 0, 1, the true hazard rate is set at 0.1 and 0.05 respectively. The
steps are as follows.
1. Using the true hazard rate, calculate the probability of being infected at each
age and simulate the number of infected individuals using a binomial distribu-
tion. The initial parameters values are chosen to be the true hazard rate values,
h00 = 0.1 and h01 = 0.05. Because the Newton-Raphson method is a stepwise
procedure, we can get to the MLE faster if appropriate initial parameter values
are chosen (Lauritzen, 2008). In this case, because the data were simulated,
the true values are known.
2. Calculate the first derivative of the log likelihood function, ddhj (log l(n,x,p))








for j = 0, 1 and k = 0, 1 using the initial values of h00
and h01. These are commonly termed the score S(h) and observed information
J(h) respectively.






, are set to be
h1 = h0 + λJ(h0)−1S(h0), (5.41)
where 0 < λ ≤ 1 is a constant that varies directly with the size of the steps.
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4. Repeat step 2 and 3 until the sum of the absolute first derivative is less than
a small preselect value  = 0.0001. If all the first derivatives are close to zero,
the parameter values will be close to the MLE.
Figure 5.1: Effects of different λ (controlling the size of steps) used in the
Newton-Raphson method.
Panel (a) shows the stepwise moves when λ = 0.01, (b) is when λ = 0.1 and (c)
is when λ = 0.9. Panel (d) shows the hazard distribution when we simulate 500
points from multivariate normal distribution centred at the MLE parameter values
and covariance matrix from the observed information based on the MLE parameter
values. In the background image plots in all the panels yellow corresponds to a
high magnitude of the likelihood, and red low. The grey dots represent the stepwise
movement of the particles, with increasing intensity of darkness, whereas the light
blue cross shows the position of the MLE.
In figure 5.1, we explored the values of λ that control the size of the stepwise
movement of the parameter values. Because of the small value of 0.01 used in panel
(a), the steps are so small that it required 1 373 steps to reach the MLE. The moves
of the dots were so close that they overlapped. This is inefficient as computer time
will be wasted to compute the score statistics S(h) and observed information J(h)
at every step when there is not much change in every subsequent iterations.
In panel (b), λ = 0.1 only required 132 reasonable steps to reach MLE. Although
λ is increased tenfold, it is clear that the path is effectively the same as that in panel
(a). Panel (c) shows that if λ is larger, λ = 0.9, it only required 9 steps to reach
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MLE. But the big steps had a high chance of moving immediately out of the region
of high likelihood. Propitiously, in the subsequent steps, the algorithm is still able
to bring the point back to the MLE parameter values as long as the routine has not
stop. However, we experienced problems in the high dimensional case as the routine
did not recover from overly big steps.
In panel (d), we tried to validate the complicated calculation of the second deriva-
tive of the log likelihood function. The inverse of the observed information matrix
will represent the covariance matrix. The black dots represent h˜ which are simulated
from the multivariate normal distribution, centred at MLE hˆ and covariance matrix


























Since the simulated h˜ are located around the region of high likelihood, the in-
formation matrix calculation using the expressions that we have derived is correct.
This empirical demonstration is important for confirming the accuracy of the in-
formation matrix, an important factor in determining the optimal design, and the
implementation of the computer algorithm.
5.4.4 MLE search using Cross Entropy
Unlike the deterministic approach in Newton-Raphson method, which exploits the
gradient of the (log) likelihood to determine good subsequent parameter values to
search, Cross Entropy is a stochastic, and hence more volatile, method of optimising
functions. Implementing Cross Entropy is straightforward even in high dimensional
problems. The steps are adopted from De Boer et al. (2005) and applied to the same
two dimensional problem where the number of samples of age i is ni = 250 where
i = 0, 1, and the true hazard rate is set at 0.1 and 0.05 respectively.
1. Since the MLE should be close to the true hazard rate, we let the initial hazard
rate be h00 = 0.1 and h01 = 0.05 (for this simulation, these are the true param-
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eters). The log likelihood for this initial set of hazard rates is calculated and
stored as l0.
2. Simulate npart particles containing h∗, the hazard rates, from independent












∀i = 0, 1. (5.44)
3. For each particle, calculate the log likelihood based on h∗. Amongst all these
points, the mean hazard rates of the top ntop particles with the highest log
likelihood will be calculated and stored as h1.
4. If the maximum log likelihood, l∗, of all these npart sets of particles is larger
than the current log likelihood l0, we will update the log likelihood for the next
stage l1 = l∗ and also update the current best hazard rate hˇ1 with the values
of the particle that corresponds to the maximum log likelihood. Otherwise,
l1 = l0 and hˇ1 = h0.
5. The Cross Entropy procedure is terminated if the consecutive hazard values
differ by less than ,




6. Repeat step 2 to 5 until the routine stops. The estimated MLE will be the
particle with the maximum log likelihood, hˇ.
In round j of particles simulations, the normal distribution is centred at hj , the mean
of the top ntop particles with the highest log likelihood, and not the current best
hazard rate hˇj . Because the best hazard rate hˇj will only be updated if the maximum
log likelihood of the current round is more than the maximum log likelihood of all the
previous rounds, hˇj may stay the same for several rounds, resulting in inefficiency in
exploring the whole parameter space.
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Figure 5.2: Effects of different argument values in the Cross Entropy
method.
Image plots are as in figure 5.1, but the grey dots represents the stepwise move-
ment of the mean of the top ntop particles, hj . Panel (a) is the result of(
σ = 0.01, npart = 500, ntop = 10,  = 0.0001
)
, (b) is the result of changing  in (a)
to 0.01, (c) is the result of changing σ in (a) to 0.1, (d) is the result of changing ntop
in (c) to 25, (e) is the result of changing npart in (a) to 100 and (f) is the result of
changing ntop in (a) to 25.
The arguments
(
σ, npart, ntop, 
)
will also affect the efficiency of the procedure
in finding the MLE. In panel (a) of figure 5.2, we tried more particles, npart = 500,
while keeping the other arguments small σ = 0.01, ntop = 10,  = 0.0001. This trial
required 21 rounds of simulations. This is computer-time-consuming because the log
likelihood will be calculated 500 times but only the top ten particles’ information
will be used. From the plot, the points around the MLE are very dark, symbolizing
hj was at the similar location for many rounds. Because the top ten particles are
used, the variability between the means hj at each round will be large, resulting in
difficulty for the stopping condition
∣∣∣hj − hj−1∣∣∣ <  to be fulfilled.
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Then, we increased  to 0.01 so that the routine can stop once it is close to the
actual MLE. Results presented in panel (b) only required six rounds of simulations to
attain the MLE. But the size of  affects the precision of MLE. To achieve accurate
MLE, it is still advisable to keep  small.
In panel (c), we raised σ to 0.1 for the proposed values to be more dispersed.
The routine is able to reach the region of high likelihood immediately. Because
ntop = 10, the inconsistency in consecutive mean values resulted in 1992 simulation
rounds before termination.
Panel (d) demonstrated the improvement in performance when ntop is increased
to 25, while keeping the standard deviation σ = 0.1. As expected, the routine required
many (308) more simulation rounds near the MLE than that in panel (c) to stop.
Therefore, a larger ntop will draw more information from the simulated particles and
be more efficient in getting to the MLE.
In panel (e), we reduced the number of simulations, npart, to 100, while the
other arguments stayed the same as that in panel (a). This reduced the number
of log likelihood calculation at every round. Because fewer particles were simulated
at every round, the chances of them having a high likelihood are reduced. This is
justified by the smaller initial steps in panel (e) as compared to those in the earlier
trials. Considering the small and cautious steps taken, this set of arguments required
221 steps before coming to a stop. It can be observed that the routine got near to
the MLE within 5 steps but could not terminate because the condition was not met
easily. This problem is likely to escalate when the dimension of the parameter space
increases. So, we stay with the initial choice of npart = 500.
In the last panel, we increased ntop from panel (a) to 25 to leverage on the
information provided by the 500 particles at each round. When comparing panels
(e) and (f), steps became larger due to the amount of information extracted from
the proposed particles. Although it is faster, it still required 20 steps before the
routine stopped. This performance in panel (f) is similar to that in panel (a), but,
the steps in (f) appeared more regular. Thus, the argument in (f) was preferred since
we wanted the search to have regular steps and terminate without wasting too many
computation rounds, as well as not losing precision of the MLE result.
The details of the six trials may differ slightly due to the randomness in Cross En-
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tropy algorithm, but we expect the qualitative interpretations of different arguments
should still be valid.
The Cross Entropy method only works for uni-modal surfaces. If the log likelihood
is multi-modal, the routine might stop at one of the local maxima which need not
be the global maximum. Conservatively, then, Cross Entropy should be initialised at
several starting points to verify that the same or similar hˇ results.
5.4.5 MLE search using Monte Carlo Method
In Bayesian inference, Monte Carlo is a methodology which samples from the
posterior distribution as discussed in Chapter 2. We can reduce the size of the
parameter space if we simulate from the posterior distribution, rather than simulating
over its whole support, in most of which the MLE is unlikely to be (for instance the
same hazard example, if we only know 0 < hi < 1, we might sample uniformly over
0 and 1 even if the posterior is focused around 0.1). Although this is not equivalent
to finding the MLE, if the posterior sample is large, the MLE can be estimated by
the draw from the posterior with maximum (log) likelihood.
MCMC is a typical variant of Monte Carlo, but it is implausible to do MCMC on
every simulated dataset to get the posterior sample, as for every dataset, there will be
a different posterior distribution for the parameters, and the MCMC routine may need
tuning to each. However, we could sample from a pseudo-‘posterior’, an appropriately
selected Beta distribution (with support over [0,1]) where the shape parameters are
formulated to focus on plausible hazard functions based on the simulated data.
Using the same two dimensional problem, where the number of samples of age i
is ni = 250 for i = 0, 1, the true hazard rate is set at 0.1 and 0.05 respectively. We
assume a pseudo posterior distribution for the hazard rate for age i to be
hi ∼ Beta (αi, βi) , (5.45)




Recall that hazard rate can be related to the probability of being identified as in-
fected pi = gi−1hi + pi−1 where gi =
i−1∏
j=0
(1− hj). The estimated hazard rate can be
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where pi can be estimated by the ratio of the number of positive samples to the total
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n0 − x0 i = 0∏i−1
j=0 (nj − xj)− αi i > 0.
(5.49)
Certain combinations of ni and xi may result in non-positive αi and βi, violating
the condition of the shape parameters of a beta distribution. If this happens, we
apply αi = βi = 1 for the beta distribution to transform into a uniform distribution.
This implies that if an informative posterior distribution does not exist, a vague
distribution is used as a replacement.
We can simulate a large number of hazard rate particles from the pseudo poste-
rior distributions and calculate the log likelihood value based on the corresponding
dataset. The MLE could be identified as the particle with the largest log likelihood.
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Figure 5.3: Demonstration of how different proposal distributions affect the
MLE search by Monte Carlo method.
The image plot is as in figure 5.1. The simulated points are represented by the grey
points. In panel (a), we sample 250 particles from the beta distribution, described
in equations 5.48 and 5.49, where most particles are located at the region of high
likelihood. In panel (b), we sample 25 particles from the same beta distribution,
there were fewer points in the yellow region. To illustrate for other distributions in
panel (c) and (d), we increase the range of the plot. In panel (c), we do a larger
sample of 1000 particles from uninformative uniform distribution ranging from 0 to






In figure 5.3, we demonstrate the importance of proposing particles from a distri-
bution that is akin to the likelihood. In the first panel (a), we only need 250 particles
to obtain an estimated MLE that is consistent with the numerically calculated one.
Comparing with panel (b) with 25 particles, having more particles will increase the
chance of getting an accurate MLE. If more particles are preferred, computation for
likelihood should be vectorised to reduce processing time.
The distribution in panel (c) can explore the whole parameter space but the
chances of the simulated particles getting high likelihood are low. This will result in
a poor MLE despite using 1 000 particles. The problem is analogous to that in panel
(d) where the informative proposal distribution is targeted at the wrong part of the
parameter space. For the same number of particles, the possibility of capturing a
point with high likelihood is even lower.
In conclusion, with the consideration of computational time, we will search for
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MLE using this Monte Carlo method. For higher dimensional problems, like in the
original problem, we will need to increase the number of particles to be simulated to
prevent a problem analogous to that faced in panel (b).
5.4.6 Design search using Grid Search
An experiment with three age groups and total sample size of n = 500 has
500(500+1)
2 = 125 250 possible decisions. It will be very computational expensive to
compute expected utilities for all decisions and we can expect the number of decisions
to magnify with more age groups.
Atkinson et al. (2007) suggested searching the decision space by adding and sub-
tracting 1 to the sample sizes of two randomly chosen age groups, but this mechanism
took a long time to explore the decision space when tried on a simplistic three age
group example. Instead, we use an iterative grid search, where initially a coarse grid
is formed and the expected utility assessed on each point, and then the design space
is restricted to high utility parts of the grid with increasingly fine grids overlaid.
Assuming the expected utility is uni-modal and smooth over the entire decision
space, we form a grid of sample sizes for the first two age groups. The third age
group will depend on the first two groups to satisfy the total sample size condition.
1. Setting the gap between each decision points to be 50 for the initial grid, the
expected utilities of the decisions lying on the grid will be calculated.
2. With the expected utilities of the decisions on the grid, the decision with the
highest expected utility is identified.
3. The next grid is re-centred at that decision with neighbouring points as limits
and with the gap between new decision points reduced by 23 . This allows us to
sequentially focus at the point where we believe the maximum expected utility
will be.
4. Repeat step 2 and 3 until the gap is 1.
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This is only feasible if the number of age group is small. For increased number of
age groups, there will be too many decision points on the grid even if the gap is big.
An optimal design might be missed in large grid gap when the mode is not close
enough to the preselected decision points. It is also risky to use this method due to
the assumption of uni-modal expected utility.
5.4.7 Design search using Cross Entropy
We use the Cross Entropy idea brought up in section 5.4.4 on the design search
in 12 age groups, where the ith age group will have ni samples.
1. To simulate npart equally likely design points, a Dirichlet distribution is consid-
ered. The k dimensional Dirichlet distribution is multivariate and has support
over the unit simplex, i.e. [0, 1]k while ensuring that the simulated entries sum
to 1. If the Dirichlet’s concentration parameters, α, are the same, the mean for
each dimension is 1k , with the magnitude of the α determining the spread. We
multiply the total sample size, n = 500, to the simulated values from Dirichlet
distribution. After rounding each entry to the nearest whole number, we alter
the last entry such that they total to n = 500.
2. After calculating the expected utility for each design, we identify the point with
the maximum expected utility, u1, as nˇ1. The mean of the top ntop designs
with the largest expected utility is stored as the current best design n1.
3. We simulate the npart new particles, n∗, from the algorithm in step 1 using




where α is the concentration parameters which relates the centre location of
the distribution to the current best design by
α = θ × n1, (5.51)
and θ controls the dispersion of particles from n1. The bigger the value of θ,
the more concentrated the simulated n∗ will be from n1.
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4. We calculate the expected utility for all new designs. If the maximum expected
utility of these designs is larger than the current maximum expected utility u1,
it will be updated as u2 and its corresponding design as nˇ2, otherwise, u2 = u1
and nˇ2 = nˇ1. The current best design, n2, is updated with the mean of the
top ntop designs.
5. The routine stops if the absolute distances between subsequent best design
points for all age groups are less than ,




6. Repeat step 3 to 5 until the routine stops. The optimal design experiment is
the design with the maximum expected utility, nˇ.
Unfortunately this methodology arrived at completely different design points for three
different seeds and was therefore not considered further.
5.4.8 Changes to Optimization Criterion
Currently, the optimization criterion is to maximise the estimated expected utility,
which is the determinant of the information matrix under the decision of D and
the MLE hˆ. However, utilities calculated based on the MLE of the hazard rate
demonstrated a high volatility due to the dimensionality of the parameter vector h.
In the optimal design search, the ‘best’ design is the one which corresponds to the
maximum expected utility. If the expected utility is unstable, the optimal design
will be difficult to estimate accurately. We therefore sought a less unstable objective
function.
In changing the optimization criterion, we aim to reduce the irregularity in the
estimation of the expected utility for each decision, D. Instead of depending on the
larger number of parameters in h, we fit a parametric survival regression model to the
simulated data, characterised by only two parameters. This can readily be effected
using built-in functions in R using the survival package (Therneau, 2013). This
reduction in the number of parameters will alleviate the problem of volatility in the
utility calculation.
139
Chapter 5 Bayesian Optimal Design of Seroepidemiological Studies
Fitting survival regression models in R requires creating a ‘survival object’ which
indicates the type of censoring for each individual, the start and end of event time.
If an individual is seropositive at age i, infection has happened between birth and
age i when the serum was collected. We categorise this event as left-censored. The
likelihood for such individuals will be accounted by the density of the lower tail,
P (T ≤ i). Otherwise, it is right-censored if the individual is seronegative at age i,
as infection has not taken place. In such cases, the upper tail, P (T > t), will be
required since the event might take place after the specimen was collected.
In the survival regression model, we do not regress on any covariates and the
survival times are assumed to follow a Weibull distribution, whose support is over the
non-negative range, and whose distribution is characterised by the shape parameter,
κ, and scale parameter, λ, both positive. These parameter estimates can be derived




a = log λ. (5.53)
The Weibull distribution parameters are less uncertain if the chosen design experi-
ment can provide much information. If the parameters are dispersed, the determinant
of the variance-covariance matrix will be large, symbolising a large parameter area.
Thus, we change the optimization criterion to be based on a utility that is the recip-
rocal of the absolute determinant of the variance-covariance matrix. Maximising the
utility value will correspond to the best design point that leads to the least dispersed
Weibull distribution parameters.
The problem of randomness in the survival regression model could be reduced
by using the same idea of propensity and prevalence to simulate the data. In this
survival regression model, the Weibull distribution parameters and the corresponding
variance-covariance matrix will be estimated deterministically and classically for each
set of simulated data.
5.4.9 Design search using Monte Carlo Method
Since both the grid search and Cross Entropy were not feasible or reliable from
one run to the next in our high dimensional (and possibly multi-modal space), we
used the Monte Carlo method to search the whole design space for the best design.
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This algorithm took ca. 20 days to explore ca. 40 000 design points on a standard
desktop computer with four processors, and yielded in three independent runs ‘opti-
mal’ designs that were rather consistent with each other. Note that to allocate 500
individuals into 12 groups, we need to choose 11 partitions. These partitions are
considered as individuals to be added to the total 500 individuals. Hence, it was not




= 1.4× 1022 designs.
The algorithm is as follows:
1. A large number of design points are simulated for exploration. The same de-
scription can be found in section 5.4.7 step 1.
2. For each design, compare a set of propensity φ and the prevalence p for all the
n individuals. If φl < pl, the lth individual is seropositive. Set up the survival
object for these simulated data by creating appropriate censoring and event
times according to the test results.
3. Run the survival regression model for the survival times and compute the re-
ciprocal of the absolute determinant of the variance-covariance matrix as the
utility for this simulated data.
4. Repeat step 2 and 3 for every set of propensity and prevalence and represent
the expected utility of this design point with the average of the utilities.
5. Repeat step 2 to 4 for each design points simulated in step 1. The design
point with the maximum expected utility is the optimal design based on this
criterion.
This time-consuming approach could be improved by running the routine in parallel
on a server.
5.5 Result and Discussion
The optimal design experiment is an interesting mixture of methods Bayesian
141
Chapter 5 Bayesian Optimal Design of Seroepidemiological Studies
and Classical. In the first step, we use hierarchical modelling to synthesize data
from historical studies; in the second step, we used Bayesian decision making with a
Frequentist objective function to seek for the optimal design.
Results from the hierarchical model are presented in figure 5.4. Within country
estimates are provided in the first 8 panels, with the hierarchical model fits in blue




red. The goodness of fit can be readily observed. The hierarchical model also allows
the posterior distribution of the true prevalence for a subsequent study, such as the
one being designed, in a similar country using the hyper-parameters. This may be
found in the green panel in figure 5.4. Note that although we are concerned about the
hazard rate from age 1 to 12, i.e. the pre- and primary school years, not all datasets
in our literature review have the necessary length. Hierarchical modelling has been
shown to draw information from available data to provide information for gaps such
as this, or other potential datasets, based on the assumption that the populations
are similar (i.e. exchangeable) across these countries and that seropositivity has not
changed much across the time period 1994–2011.
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Result from Hyper Posterior
Figure 5.4: Seropositivity of the eight datasets, as well as the projection
using the hyper posterior from the hierarchical model.
The light blue shades are the projection of the seropositivity using the posterior
samples of the hazard rates hi for age 0 < i < 12 where the median of the pro-
jection is symbolised by the blue lines. The thick red lines represent the empirical
mean seropositivity calculated from the dataset and the thinner red lines represent
the confidence interval. The last plot of green shades shows the seropositivity for
any randomly chosen country, simulated from the hyper-posterior sample, where the
median is also illustrated by the green line.
The simulated seropositivity is narrow for age below 2 because of the abundance
of information below age 2. If less information is collected for certain ages, the
prediction will be vague. There were only three datasets with information up to age
12. Almost 90% of the older children from China Lu’an in 2010 were projected to
be seropositive by age 12, in contrast to the estimates in the same location at 2006–
2007 and Singapore in 1997 which were about 80% and 60% respectively. Due to
this variability, the prediction from the hierarchical model using the hyper posterior
samples is less precise, as shown by the wide green prediction for older children in
the last panel.
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Figure 5.5: Optimal sample sizes for each age.
The black dots represent the optimal designs from each of the three runs and the
grey bars represent the mean from the three optimal designs. Panel (a) and (b) are
the results when maximum sample size is set at 500 and 1000 respectively. Panel (c)
are the sample sizes used in Singapore from 2008 to 2010.
Both sample sizes considered (500 and 1 000) are consistent and have a ‘U’ shaped
optimal design with approximately the same proportions in each age group. In the
2008–2010 study by Ang et al (2011), the design had a minimum of 340 sample size
for each age group (1–6, 7–12, and 13–17 years), where we dropped the information
above age 12 for proper comparison with our optimal design. Fortuitously, the Ang
et al. (2011) study had a large number of samples at age 2 (close to the spike age
3 in the optimal design) and again around 10–12 (close to the second spike in the
optimal design), and as a result, we expect the dataset from Singapore in 2008-2010
to be very informative.
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Figure 5.6: Comparison of the performance of 3 different experimental
designs.
The result of sample sizes used by Singapore in 2008–2010 is presented in panel (a)
and (b); one of our optimal designs scaled up to the same total as that in Singapore
(729 sera samples) in panel (c) and (d), and equal sample size for all ages in panel (e)
and (f). Assuming the underlying prevalence is coming from our hierarchical model,
the first row shows the plot of prevalence against age. The grey shades represent
the prediction interval of the prevalence for each age. The red line is the underlying
prevalence that is simulated from our hierarchical model. The blue lines are the result
of the survival regression where the solid lines are computed from the parameters
estimated from the model and the dotted blue lines are the 95% confidence interval of
the computed prevalence using the Weibull parameters simulated from multivariate
normal distribution with mean and variance-covariance from the estimates in the
regression model. The second row is showing heat map of the Weibull parameters κ
and λ. Yellow represents the point where likelihood is the highest and red when it is
the lowest.
The grey shades in figure 5.6, panel (a), (c) and (e), are the 95% prediction interval
of prevalence computed by dividing the simulated number of infected based on the
underlying prevalence and the chosen sample sizes using a binomial distribution, by
the sample sizes.
As expected, the grey shades for the sample size used by Singapore in 2008–2010
show a nice fit in panel (a). The wider grey shades for optimal design in panel (b) is
due to the poorer prevalence estimation for older children. Due to an equal sample
size for all ages used in panel (e), the size of the prediction intervals were consistent
across ages.
The dotted blue lines in figure 5.6 are prevalence estimates computed using the
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result of survival regression. They are narrowest for our optimal design in panel (c),
followed by Singapore’s design in panel (a) and the widest in equal sample size in
panel (e).
The heat map in figure 5.6 is based on the likelihood that is computed from the
densities of all the survival times from the samples based on a Weibull distribution.
Panel (d) with the optimal design has the narrowest spread of the Weibull param-
eters, followed by panel (b) from Singapore 2008–2010 samples and the least precise
parameter estimates from panel (f) of equal sample size.
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Figure 5.7: Comparison of the performance of 3 different experimental
designs using a different underlying prevalence.
This is done by assuming the underlying prevalence comes from the Singapore 2008–
2010 dataset. The features in this figure is the same as that in figure 5.6.
Although the grey shades are still wider for our optimal design in panel (c) as
compared to the design used by Singapore in 2008–2010 in panel (a) and the equal
sample size design used in panel (e), the Weibull parameters estimates for the survival
time is still the sharpest for our optimal design as seen in panel (d). Our optimal
design is still the one that provides the best information about the parameters that
can inform about the survival time.
The ability of having the focused Weibull parameter estimates supports the cri-
terion that was used to achieve this optimal design. Recall that our optimal designs
were identified as the design with the maximum expected utility, where utility is
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the reciprocal of the absolute determinant of the variance-covariance matrix of the
Weibull parameter estimates derived from the survival regression model.
5.6 Conclusion
In this example, different seropositivity estimates in different Asian populations will
lead to a wide seropositivity projection for any future seroepidemological studies.
Because the optimal design is solely based on the efficiency in the seropositivity
projection, the performance of the optimal design may deteriorate if the past stud-
ies cannot properly represent the population that the optimal design experiment is
constructed for. To boost the performance of our optimal design might require more
datasets with information on older children from more directly comparable studies be
fitted in the hierarchical model. This will narrow the seropositivity estimates for the
prevalence in the country being investigated which will lead to a more appropriately
tailored design.
One discovery, not anticipated when we started this chapter, was the importance
of the specific choice of optimality criterion. Clearly, optimal designs under different
criteria will differ. We anticipated that the results using an objective function based
on a parametric survival analysis would provide good estimates even under a more
complex non-parametric model, but while our optimal designs did minimise the width
of confidence/credible intervals for the survival function conditional on a Weibull
model, the prevalence estimates using the non-parametric approach were sometimes
broader under the optimal design than under an equal sampling approach. Thus,
it is important to understand the motivation for the new serology experiment and




Conclusion and Future Work
6.1 Summary
We have demonstrated that hierarchical models can boost the accuracy of parameters
estimates and prediction in the area of infectious diseases. We applied the method
to clinical data from patients with Dengue and Chikungunya, epidemiological data
from multiple countries on pandemic influenza A H1N1 and seroepidemiological data
on EV71 to design optimal future studies. Hierarchical models were fitted to the
available data flexibly and the algorithms have been illustrated in this thesis.
In chapter 3, we encountered the separation problem in data from patients with
Dengue or Chikungunya when first presented at Tan Tock Seng Hospital, Singapore’s
main referral centre for infectious diseases. In a previous publication, we resolved this
problem using Firth’s penalised likelihood logistic regression method (Firth, 1993).
Without using some form of penalty, whether classical or Bayesian (via an informa-
tive or semi-informative prior), the significantly predictive variable of Platelet counts
would have been excluded before the regression model was developed as being not
statistically significantly different from 0. A hierarchical model was established for
characterizing the time course of laboratory and clinical measurements of Dengue and
Chikungunya patients. The precise analysis of the trend of disease course can facili-
tate the diagnosis and treatment of the patients of these two diseases with otherwise
similar symptoms.
Subsequently, a hierarchical compartmental model was developed for data from
the 2009 H1N1 pandemic for a basket of countries that would have allowed early and
accurate severity estimates. Several factors of this worldwide pandemic outbreak
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were encompassed in the model formation. Different forms of data type collected
by independent research groups or government agencies in different territories were
used to synthesize evidence for the unobservable components in the SIR model. This
involved extending the methodology used when the MCMC algorithm would not lead
to convergence. The technique of importance sampling solved this problem, providing
necessary parameter information for updating the severity estimates of the pandemic
in real time.
In chapter 5, we explored how hierarchical models can be used to improve the ac-
curacy of the posterior estimates for hazard rates of EV71, using previously collected
serological data from several Asian countries. The search for an optimal experiment
design for any Asian country was done based on the hierarchical model, assuming
exchangeability between past and future epidemic conditions. The idea is to sample
from the appropriate population group to get the most desirable age effect estimates
in a serological study, rather than using convenience sampling which may be wasting
resources by over-sampling age groups that are no longer at risk of infection.
6.2 Future Work
Here we discuss possible extensions of our work.
In the hierarchical modelling for trends in observation for Dengue and Chikun-
gunya patients, future work can involve integration of the hierarchical model with
real time data. Importance sampling can be done by using the current weighted sam-
ples as a hyperprior distribution and new weights can be calculated based on new
and incoming patients’ data. This allows the project to be ongoing and the weighted
samples can be constantly refined. However, we should manually exclude patients
with abnormal observations. These type of observations might give higher weights
to inappropriate parameter values, leading to distortion of the parameters samples.
Hierarchical models could be integrated with risk calculators which can be de-
veloped to predict risk of complications in dengue (risk of developing Dengue Hem-
orrhagic Fever, and risk of requiring to the Intensive Care Unit or of death). This
could be done if data collection could be improved by being more organised. Pa-
tients’ observations were recorded daily but at irregular times. The model could be
more precise by replacing the discrete time model with a continuous time model to
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leverage on the information of the measurement times.
As mentioned in chapter 4, the data collection from each country was based on
different criteria. If a surveillance network can be set up for each country to submit
the data counts based on a standardised criteria conveniently, real-time analysis can
be done and data can be fitted better to the SIR trajectory. For analysis in real-time,
a different approach should be done to replace the sequential importance sampling
which will take a long computational time.
The earlier importance sampling routine was inefficient and not able to analyse
the pandemic in real-time. Ong et al. (2010) have demonstrated in the context of
Singapore how real-time analysis can be done by sequential importance sampling for
a stochastic model. Parameters’ particles could be simulated independently for each
country and weight could be calculated daily based on the likelihood and proposal
density, presuming that data from every country was entered into the system daily.
For the period with no data input, there will be no addition to the weights. The
cumulated weights can be representative for each particle and the credible interval
for each parameter at each day can be achieved by resampling the particles based
on the cumulative weights. Since each country can be analysed in parallel at this
stage, computation time could be reduced. For each country, the same number of
set of particles is resampled and a set of hyper-parameters are simulated to pair up
with the particles from all countries. Weights could be calculated daily based on the
hierarchical model and the sets of parameters and hyper-parameters can be resampled
based on this weight. The result of this can be used for trajectory projection and
severity estimation and we anticipate that this development into a two stage process
will greatly reduce the computation time and the ability to provide daily credible
interval and estimations will be more beneficial than having a monthly prediction in
a real pandemic outbreak.
If such a network were established, age specific estimates of attack rates and
severity indices could be established if the age of patients were also collected auto-
matically. This would require extension to an age structured model in which case
estimates of mixing between different age groups would be useful (Mossong et al.,
2008). At the moment, these are lacking in most countries especially low to middle
income ones.
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In the last analysis for EV71, the countries that we have chosen to fit the hierar-
chical model have relatively different prevalence for older children. This resulted in a
wide prediction interval for prevalence in any future serological study. This might be
addressed by introducing additional structure in the hierarchical model where cities
have random errors about their country’s mean, while all countries still remain to
be modelled by the hierarchical model. Alternatively, hazard rates can be regressed
based on each country’s risk factors before being combined with the hierarchical
model. The risk factors which account for the difference in the prevalence for older
kids can be explored/identified based on the school attendance (i.e. age of attending
pre-school). This would allow better designs in a country with the risk factors being
accounted for.
Other than the above applications of hierarchical model to the context of in-
fectious diseases, other works could involve assessing the differences in outbreaks
of Hand, Foot, and Mouth Disease in preschools across Singapore or other small,
closed populations like army camps. Each of these small, closed populations could
be governed by parameters which would be modelled hierarchically. Dengue cluster
outbreak with more than 2 cases within 2 weeks of onset and 150m radius (usually
from patients’ homes) might also be modelled hierarchically if the data, collected
by the Singapore Government, could be made available for research purposes. The
analysis of dengue infection forms the basis for vector control operations in different
regions of Singapore, allowing prioritisation of mosquito control, especially during
a large outbreak like that in 2013. By more sophisticated application of statistical
methodologies, the impact of diseases such as dengue, influenza and hand, foot and
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